Biophysical Mechanisms of Protein Aggregation by Khare, Sagar
BIOPHYSICAL MECHANISMS OF PROTEIN AGGREGATION  
 
 
 
 
 
Sagar Khare 
 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Biochemistry and Biophysics (School of Medicine). 
 
 
Chapel Hill 
2005 
 
 
                                                                                                                Approved By 
 
Advisor: Nikolay V. Dokholyan, PhD 
 
Committee Chair: Sharon L. Campbell, PhD 
 
Reader: Michael Caplow, PhD 
 
Reader: Brian A. Kuhlman, PhD 
 
Reader: Max L. Berkowitz, PhD 
  
 
ABSTRACT 
SAGAR KHARE: Biophysical mechanisms of protein aggregation   
 
(Under the direction of Nikolay V. Dokholyan, PhD) 
 
     Protein aggregation related toxicity is implicated in a variety of neurodegenerative 
diseases including Alzheimer's, Huntington’s, prion and Amyotrophic Lateral Sclerosis 
(ALS). The proteins or peptides known to aggregate in disease are unrelated in their amino 
acid sequence and native structure but form structurally similar aggregates – amyloids. 
Studies outlined in this dissertation were aimed at uncovering the underlying biophysical 
mechanisms of amyloid formation, and lay the groundwork to develop rational strategies to 
combat neurodegenerative diseases.   
More than 100 point mutations in the homodimeric metalloenzyme Cu, Zn superoxide 
(SOD1) dismutase are involved in a genetically inherited familial form of ALS (FALS). We 
have discovered a mechanism of in vitro SOD1 aggregation in which the native SOD1 dimer 
dissociates, metals are lost from the monomers and the resulting apo-monomers oligomerize 
in a rate-limiting step. Further, we have computationally estimated that a majority of FALS-
associated point mutants in SOD1 (70 out of the 75 studied) decrease dimer stability and/or 
increase dimer dissociation propensity. Thus, we have proposed that the underlying 
biophysical basis of FALS-linked SOD1 aggregation is the mutation-induced increase in the 
propensity to form apo-monomers.   
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 To uncover the molecular determinants of SOD1 apo-monomer oligomerization, the 
rate-limiting step in aggregation, we have developed two complementary in silico 
approaches: (a) we have identified sequence fragments of SOD1 that have a high self-
association propensity, and (b) we have performed molecular dynamics simulations of model 
SOD1 monomer and dimer folding and misfolding. In both cases, we have identified key 
residue-residue interactions in SOD1 responsible for maintaining fidelity to its native state. 
We have proposed that the disruption of one or more of these key interactions (“hot spots”) is 
implicated in non-native oligomerization.  
 To understand the effect of FALS mutations on the key interactions involved in 
maintaining native-state fidelity, we have studied the nanosecond dynamics of wild type 
SOD1 and 3 FALS-associated mutant apo-dimers and apo-monomers. We found that in wild 
type SOD1 the motions of the dimer interface are mechanically coupled to the motions of the 
structurally distal metal-coordinating loops of both monomeric subunits. We further found 
that the strain induced in the protein by dimer dissociation, point mutations, or by exposure 
to high temperature is transmitted to a specific hairpin in the protein, previously found to be 
implicated in maintaining fold fidelity. The altered dynamics of mutant SOD1 dimers and 
monomers provides structural insights into the flexibility required for oligomerization.             
Collectively, findings in this dissertation have enhanced our understanding of the 
complex mechanisms of protein aggregation. Mechanisms established and structural insights 
obtained herein may facilitate rational design of small molecules to prevent protein 
aggregation, hence provide a therapeutic intervention strategy in neurodegenerative diseases.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein aggregation-related toxicity is implicated in a plethora of neurodegenerative 
diseases including Alzheimer's, Parkinson's, prion, and motor neuron diseases1-5. The 
proteins found to aggregate in diseases are unrelated in their native structures and primary 
sequences, but form similar fibrils with characteristic cross-β sheet morphologies (amyloid6) 
when aggregated. The aggregates can be intra- or extra-cellular; however aggregation and the 
induced cytotoxicity are tissue-specific. A small number of the cases of the diseases, called 
familial cases, are linked to genetically inherited mutations in the respective aggregating 
proteins, in contrast with most sporadic cases.  
1.1 Aggregation and cytotoxicity in disease. 
The existence of a causative link between protein aggregation and cytotoxicity in 
neurodegeneration remains controversial. While aggregation is usually co-incident with cell 
death, it is not clear if aggregation is the cause of cytotoxicity or an effect – it may represent 
a protective response of the cell which depletes the pool of the cytotoxic soluble protein. 
Evidence has accumulated that soluble oligomeric species, rather than the insoluble fibrils, 
may cause cytotoxicity. For example, in various animal models7-11, it was observed that the 
triggering of cell-death mechanisms precedes the appearance of insoluble plaque12,13. The 
injection of soluble assemblies into cultured neuronal cells causes substantial neuronal 
dysfunction before aggregation14. In models of Huntington’s disease, it was found that 
soluble oligomers accumulate in the nucleus and inhibit the function of key transcription 
factors15.  Inhibition of oligomerization by the azo-dye Congo red, or by overexpression of 
the Hsp70/Hsp40 chaperone system, exerts marked protective effects in vivo and in 
vitro16,17,14.  Thus, toxicity may arise by aberrant interactions with and/or sequestration of key 
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cellular components, such as transcription factors and the proteasomal machinery18. Another 
mechanism of oligomers-induced cytotoxicity is the permeabilization of membranes, which 
disrupts ion-homeostasis and results in cell death19. While membrane permeabilization is 
known to occur by the spontaneous formation of oligomeric ion-channels in mixtures of 
disease-associated peptides and artificially reconstituted membrane bilayers in vitro20, 
evidence for ion-channels in vivo, in studies where ion homeostasis was found to be 
disrupted upon aggregation, remains controversial21,22. Finally, in some instances, cell death 
can be ascribed to mechanical disruption of the cell by the large quantities of insoluble 
material23. Thus, several scenarios linking aggregation and cytotoxicity have been proposed, 
and cytotoxicity may well be multi-factorial involving simultaneously more than one 
mechanism of cell death24. It is clear, however, that aggregation is an important event during 
neurodegeneration, and given the proposed direct involvement of oligomers in cytotoxicity, 
the mechanism of aggregation provides insights into the molecular basis of disease.    
 It has been shown that many proteins unrelated to any known disease can form 
disease-like ß-sheet amyloid aggregates in vitro, indicating that amyloid-formation is a 
common property of polypeptides chains25. Amyloid fibrils of different peptides share 
common structural features: they bind to dyes such as Congo Red, and Thioflavin T, and 
display a characteristic X-ray diffraction pattern called the cross-β pattern25. An antibody 
raised against oligomers of one peptide cross-reacts with oligomers of several other proteins, 
suggesting that the oligomers, like the amyloid fibrils, may also share a common structural 
epitope26. A better understanding of the underlying biophysical principles of aggregation may 
lead to therapeutic intervention aimed at inhibiting aggregation and cytotoxicity. For 
example, small-molecule inhibitors of transthyretin aggregation that were designed based on 
 3
the knowledge of its in vitro aggregation mechanism, are under clinical trials for treating 
transthyretin aggregation-associated systemic amyloidosis27.   
 
1.2 Amyotrophic Lateral Sclerosis and mutant Cu, Zn superoxide dismutase. 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that targets 
the motor neurons in the spinal cord, brain stem, and cortex24,28. It is typically a disease of 
mid-life, with an average age-of-onset of 55±15, and is the most common motor neuron 
disease24. The symptoms start first with weakness in peripheral limbs and death generally 
occurs because of respiratory failure within 2-5 years of the appearance of the first 
symptoms. Most (90-95%) of the disease cases have no known cause and are called sporadic 
ALS (SALS), in the remaining (5-10%) cases there is a family history associated with the 
disease and these cases are called familial ALS (FALS). Of the familial cases, 20-25% of the 
cases are associated with inheritable mutations in a gene on chromosome 21 that codes for 
the ubiquitous cytoplasmic enzyme Cu, Zn superoxide dismutase (SOD1)29. More than 100 
point mutations in SOD1 have been identified as linked to FALS30. The FALS mutations are 
scattered throughout the three-dimensional structure and primary sequence of the protein and 
do not show any obvious chemical patterns in their distribution. 
Proteinaceous aggregates rich in mutant SOD1 have been found in tissues from ALS 
patients, mutant SOD1 transgenic mice, and in cell culture model systems, suggesting that 
that SOD1-associated FALS is a protein conformational disorder31. Mutant SOD1 also forms 
amyloid-like aggregates in vitro more readily then the wild type32,33. The inclusions in 
SOD1-linked FALS contain neurofilament proteins, ubiquitin, and a variety of other 
components in addition to SOD124, but it is not known if copper, zinc, or any other metal 
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ions are present in the inclusions or are involved in their formation in vivo (it is known, 
though, that SOD1 aggregates formed in vitro are not active32). It is also unknown if the 
SOD1 polypeptide is fragmented or covalently modified in the aggregates in vivo. As in the 
case of other aggregation-associated diseases, it is not clear of the final insoluble aggregates 
themselves are toxic or represent a dysfunction of the protective response of the cell where 
the toxic misfolded SOD1 protein cannot be degraded sufficiently by the proteasomal 
machinery. Soluble oligomerized species of SOD1, which may be toxicity-related, are found 
in the spinal cords of mice expressing mutant SOD1 well before disease onset or the 
appearance of the much larger microscopically visible fibrils or inclusions34. Nevertheless, it 
is well-accepted that mutant SOD1 proteins represent a toxic gain-of-function that facilitates 
misfolding and/or oligomerization in the disease24,29. 
Mitochondrial dysfunction coupled with excitotoxicity has been postulated as a 
mechanism of tissue-specific toxicity in ALS35. A fraction of the SOD1 is transported to the 
mitochondria36, and mitochondrial abnormalities have been identified in transgenic mouse 
models of FALS expressing mutant SOD137. It was found that these abnormalities begin 
prior to the clinical and pathological onset of the disease, suggesting that mitochondrial 
dysfunction may be causally involved in pathogenesis38. Although the mechanisms by which 
mutant SOD1 damages mitochondria remain to be fully understood, mutant SOD1 is known 
to form aberrant aggregates and protein interactions in mitochondria39. It was found that 
misfolded mutant SOD1, but not wild type, was selectively associated with mitochondrial 
membranes in motor neurons40. Motor neurons are known to be particularly sensitive to the 
disruption of mitochondria and Ca2+-dependent signaling cascades41. Thus, in one scenario of 
cytotoxicity, misfolded/oligomerized mutant SOD1-induces disruption of mitochondrial and 
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Ca2+-related cascades (resulting in excitotoxicity) and thereby, tissue-specific 
neurodegeneration. 
 There is evidence that the metal-content of SOD1, in which each subunit contains one 
copper and one zinc ion, may be implicated in the mechanism of toxicity33. The copper ion is 
the catalytically active constituent, and zinc is believed to stabilize the protein. Since 
metallation has a large stabilizing effect on the protein in vitro42, it has been argued that the 
metallation-state of the protein is important for its misfolding and oligomerization in vivo – it 
has been postulated that the metal-free forms of the protein may be the oligomerization 
precursors33. Furthermore, transport of SOD1 into mitochondria requires the loss of metals 
from the protein, suggesting that the metallation-state of the protein may vary between 
compartments in the cell. It is also established that some portion of the SOD1 protein is 
normally present in cells in a copper-deficient state. In human lymphoblasts, the pool of 
copper-free protein was estimated to be about 35% of the total SOD1 protein33, but there are 
no estimates of the population-size of apo-SOD1 available for motor neurons. The case for 
the involvement of the apo-state in FALS is strengthened by two observations: (i) FALS 
associated mutations were able to provoke the disease even in the absence of the metal 
loading chaperone CCS indicating that a copper-free precursor state of SOD1 is responsible 
for neurotoxicity43; (ii) several FALS mutants, in the holo-enzyme state, have wild-type-like 
stability and activity both in vitro and in vivo but are markedly destabilized in apo-forms33. 
The copper chaperone for SOD1 (CCS) is known to be responsible for the delivery of copper 
to the protein, but the details of zinc delivery and homeostasis are unknown. However, in rats 
fed with a copper-deficient diet, there was a significant amount of protein that was both 
copper- and zinc-free44, suggesting that there may be coupling between the delivery and 
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homeostasis of both metals. A possible dysfunction of metal homeostasis may lead to a 
higher proportion of misfolding- and aggregation-prone apo-state of the protein.  
Thus, the picture that emerges from studies of FALS suggests that a toxic gain-of-
function that is related to the misfolding and/or oligomerization of mutant SOD1 is causally 
implicated in the disease. The molecular mechanism of misfolding and aggregation is not 
well-understood.      
 
1.3 Statement of the problem. 
In view of the important biological role of protein misfolding and/or aggregation in 
neurodegenerative diseases in general, and mutant SOD1 misfolding and/or aggregation in 
FALS in particular, this dissertation attempts to answer the following questions: What is(are) 
the molecular mechanism(s) of SOD1 aggregation? What, if any, key sequence and structural 
elements of the SOD1 dimer determine the aggregation pathway of mutant SOD1? Why do 
more than 100 structurally and chemically diverse genotype changes (point mutations) in 
SOD1 all result in an identical aggregate phenotype? 
 
1.4 Structural frameworks for the mechanism of polypeptide aggregation. 
It is well known that large conformational transitions occur during the aggregation of 
proteins from their native states into amyloid fibrils, suggesting that partial unfolding and/or 
misfolding 45-51 are necessary for aggregation. The thermodynamic stability of a protein 
determines the propensity of the protein to adopt native-like structures. Thus, the formation 
of stable protein aggregates is linked to changes in the thermodynamic stability of 
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aggregating proteins, and conditions which promote aggregation are expected to destabilize 
the native-state. Such conditions include mutations in the protein 52-55, changes in the local 
cell environment that affect processing of the polypeptide chain during localization/transport 
into organelles, post-translational modifications, interactions with reactive metabolite 
species, and aberrant interactions with the proteolytic or chaperone machinery 56.  
While it is long established that destabilization or (at least partial) unfolding is 
necessary for aggregation, the driving forces for formation of a specific aggregate topology, 
the cross-β amyloid fibril, are less well understood. There are three main proposed driving 
forces for amyloid formation from partially unfolded or misfolded states of polypeptides:  
Edge-strand hydrogen bonding.  In the non-diseased cell, a large fraction of proteins folds 
to its native state, avoiding off-pathway processes that might lead to aggregation. It has been 
postulated that in the course of evolution, nature has selected sequences which not only fold 
into stable native states but also avoid non-native aggregation into amyloid fibrils. This is the 
so-called principle of negative design57, which offers structural clues into protein 
aggregation. Upon a systematic analysis of the database of protein structures, it was 
postulated that all β-sheet proteins can form edge-to-edge aggregates unless they employ 
some ‘blocking’ strategies to prevent aggregation. There are two such ‘blocking’ strategies: 
1. Minimization of unsatisfied hydrogen bonds (H-bonds) 2. Inward-pointing charged 
residues that block aggregation58.  
In the folded states of naturally occurring proteins, the number of unsatisfied H-bonds 
is minimized, and the presence of a large number of unsatisfied H-bonds promotes 
aggregation. It was shown that for pathological monomeric conformations of the prion 
proteins from mouse and Syrian hamster the proportion of unsatisfied H-bonds (14%) is 
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significantly larger than the average number of unsatisfied H-bonds in naturally occurring 
proteins (6%)59. Furthermore, the β-helix, which is a putative topology of amyloid fibrils, 
does not contain unsatisfied H-bond donors/acceptors. Thus, the formation of H-bonds may 
be the driving force for protein aggregation.  In this scenario, formation of protein aggregates 
is governed by a competition between specific amino acid interactions within proteins, and 
non-specific hydrogen bond formation between the unprotected edge-strands of different 
proteins54,60.  
The template hypothesis of aggregation61,62 states that preformed oligomers or 
aggregation nuclei provide edge-strands, and these interaction centers cause the conversion 
of a normally soluble protein into an aggregation-prone conformation. The docking of the 
aggregation-prone conformation to the pre-formed nucleus results in growth of the oligomer. 
Consistent with the template hypothesis, computational studies have shown that pre-formed 
or spontaneously-formed templates with hydrogen-bond donors/acceptors can cause the 
inter-conversion of α-helical peptides to β-strands that propagate the aggregate63. 
Domain-swapping. In this scenario, aggregates are formed from partially unfolded protein 
chains by a mechanism called “runaway domain swapping”. Three-dimensional domain 
swapping is an event by which a monomer exchanges part of its chain with other identical 
monomers to form an oligomer in which each subunit has a similar structure to the monomer, 
albeit the subunit is now made of more than one chains. Domain swapping, initially proposed 
as a mechanism of functional regulation, has also been proposed to lead to misfolding and 
aggregation64-66. Although there is little direct evidence for domain swapping as a mechanism 
for aggregation and amyloid formation, several experimental (Ref.65 and references therein) 
and computational67-69 studies support the role of domain swapping in aggregation. For 
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example, a correlation between domain swapping propensity of the protein p13suc1 was 
found to be correlated with its rate of aggregation70. Eisenberg and coworkers have designed 
both domain-swapped dimers and high-order oligomers from the same three-helix bundle 
structural motif but with different topologies64,71,72. Furthermore, domain-swapped forms of 
both the human prion protein and the amyloidogenic human cystatin C67,73 have been 
crystallized.  
Domain-swapping has been most clearly implicated in the aggregation of 
polyglutamine (polyQ)-containing model systems. The aggregation of polyQ-containing 
proteins is implicated in at least nine neurodegenerative diseases, and model systems in 
which polyQ stretches are inserted into small, well-characterized, non-disease-associated 
proteins have been used to understand the structural basis of aggregation. It has been found 
that at small repeat lengths of polyQ, the destabilization induced by their insertion can be 
overcome by domain-swapped dimer formation by the chimeric protein74. For longer repeat 
lengths, the presence of polyQ stretches can destabilize the protein sufficiently to form 
higher-order oligomers and fibrils. A striking example of this phenomenon was recently 
demonstrated in the model system ribonuclease A by Eisenberg and co-workers75. They had 
previously found that ribonuclease A chains form domain-swapped dimers and trimers by 
exchanging identical structural elements on either side of a hinge region64,72. Upon a Q10 
insertion in this hinge loop of ribonuclease A, polyQ self-association induces a “runaway” 
domain swap i.e. higher-order oligomerization and amyloid fibril formation.  
Computational studies67-69 using simplified native-structure based Gō-models76,77 
have shown that the monomeric protein topology alone is sufficient for predicting how a 
protein will form domain-swapped complexes, including higher-order oligomers. In 
 10
computational domain-swapping studies of the SH3 domain69,78, two types of topologies have 
been detected: “closed” domain-swapped dimers which are observed in X-ray crystal 
structures79, and more “open” oligomers which can be propagated to form fibrils by a 
“runaway domain swap”. Structural features of the computationally obtained fibrils agree 
with the X-ray diffraction pattern of amyloid fibrils obtained in experiments80.  
 Thus, in the domain-swapping framework, the strong bias towards the native-state of 
the protein leads to “closed” domain swapped dimers or trimers upon small destabilization. 
As the degree of destabilization increases, lower-order oligomers can no longer stabilize the 
protein chain in a native-like conformation. Instead, a “runaway” domain-swap occurs, 
resulting in the formation of amyloid fibrils, in which elements of native structure may still 
be retained. 
Self-association of amyloidogenic fragments. In this scenario, unfolding may result in the 
exposure of amyloidogenic sequence fragments which, in turn, self-associate to induce 
oligomerization. This scenario is supported by the findings that several small (>5 residues 
long) sequence fragments of many aggregating proteins themselves form amyloid fibrils in 
vitro81. In some cases, these amyloidogenic sequence fragments have been found in the 
aggregated state to be arranged as parallel β-strands in a sheet in which the amino acid 
sequence is in exact register82. Thus, it has been argued that unfolding makes the self-
association of amyloidogenic “hotspots” possible, and the self-association of amyloidogenic 
fragments nucleates the aggregation of the entire chain.  
Mutational analyses of fragment aggregation in vitro and in silico suggest that 
hydrophobicity, net charge and β-sheet propensity modulate fragment self-association 
propensity83. Algorithms have been developed to predict the location of amyloidogenic 
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fragments based on polypeptide sequence alone, and it has been found that in well folded 
globular protein sequences amyloidogenic fragments are surrounded by residues that have a 
very low aggregation propensity (“amyloid-breakers”)84. Analysis of protein structures also 
suggests that natural selection has led to amyloidogenic sequence fragments being protected 
in the native states of protein structures found in nature57,85. Therefore, the ability of 
amyloidogenic sequences to induce aggregation is modulated by the global stability and the 
structure of proteins. Protein aggregation propensity is then, the interplay between the 
stability of the native structure, which prevents protein aggregation, and the self-association 
of amyloidogenic sequence fragments from different polypeptide chains into in-register 
structures, which promotes protein aggregation. Consequently, mutations associated with 
familial forms of neurodegenerative diseases may promote aggregation by either 
destabilizing the native state and/or increasing the self association propensities of exposed 
sequence fragments under destabilizing conditions. 
 It should be noted that the three frameworks for aggregation outlined above are not 
mutually exclusive – for example, as we will see in Chapter 3, it is possible self-association-
prone regions of the protein are in regions that also have a high propensity to domain-swap, 
i.e. in this case, domain swapping and self-association of amyloidogenic fragments occurs 
simultaneously during the oligomerization process, and this may lead to the formation of 
stabilizing hydrogen bonding networks in the oligomers.  Further, it is also possible that the 
underlying driving forces are protein-dependent – i.e. a protein with a high content of hinge-
regions aggregates via a runaway domain-swap, whereas a protein with a high content of 
amyloidogenic fragments aggregates primarily by the self-association of these fragments. 
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These different scenarios provide statistical mechanical frameworks to understand the 
molecular mechanism of polypeptide aggregation. 
 
1.5 Biophysical properties of mutant and wild type SOD1  
Stability. SOD1 is an unusually stable protein, both in vitro and in vivo. The FALS 
mutations that occur throughout the SOD1 polypeptide have been shown to decrease the half-
life of the protein in vivo. Mouse wild-type SOD1, expressed in human kidney cells, had a 
half-life of 100 hours whereas mouse A4V and I113T had half-lives of 14 and 45 hours, 
respectively86. Human SOD1 overexpressed in COS1 cells was extremely stable with a half-
life of 30 hours, whereas FALS mutants (I113T, G93C, G37R, G41D, G85R, and A4V) 
exhibited decreased half-lives from 20 hours for I113T to 7.5 hours for G85R and A4V87. 
A4T also exhibited a significantly reduced half-life of 18 hours when expressed in COS7 
cells compared to human wild-type SOD1 which had a half-life of 25 hours88. 
The SOD1 dimer is also exceptionally stable in vitro. It retains its native 32 KDa 
molecular weight in 8 M urea for 72 hours at 25oC and is active in 4% SDS89. The 
conformational stability of mutant forms of SOD1 has been analyzed using differential 
scanning calorimetry by measuring the irreversible unfolding of the distinctly metal-bound 
species of SOD1: a study by Rodriguez et al. revealed that some FALS mutants, isolated as is 
from an insect-baculovirus expression system, are destabilized relative to the wild type42. The 
mutations they studied are scattered over the three-dimensional structure of SOD1: in the 
active site region, the dimer interface, one pole of the β-barrel, and associated loops. Thus, 
the mutant-induced destabilization is not confined to particular structural regions of the 
proteins. Chemical denaturation studies of SOD1 carried out by Cardoso et al.114 show that 
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the most common mutant SOD1 found in FALS patients (A4V) unfolds at a guanidine-
hydrochloride concentration 1M lower than the wild type enzyme.  
The metal-content of SOD1 is a crucial determinant of its stability. It was shown that 
for five FALS mutants – A4V and C6F (dimer disrupting), G93A and G93C (decreasing 
backbone flexibility) and D90A (surface mutant) – the apo-state of the mutants is markedly 
destabilized compared to the wild-type while the holo-state is not significantly affected 
(except for the dimer disrupting mutations)33 suggesting that for some classes of mutants, the 
apo-state of the enzyme may be the species contributing to FALS linked pathology. Further 
support for the involvement of the apo-state in FALS was found in a weak correlation 
between the in vitro stabilities of 15 mutant apo-dimers and average survival times of 
patients with these mutations90. However, the stability of the apo-state may not be the 
“common denominator” responsible for FALS, as postulated by Lindeberg et al90 based on 
their folding studies on fifteen mutants. It was shown by Valentine and co-workers that other 
mutations in the metal-binding regions of SOD1, distinct from the ones considered by 
Lindeberg et al., have similar or, in some cases, higher stabilities compared to the wild type 
apo-dimer, but cause FALS nevertheless91. Therefore, although decreased stability of FALS 
may be an important factor in disease, it is not the single underlying factor. These finding 
suggest that events downstream of unfolding affect the aggregation-propensity of mutants or 
the toxicity of oligomers, at least in some cases. A more complete understanding of the 
aggregation pathway, on the lines of the one developed in Chapter 2, is required to elucidate 
the common biophysical denominator of mutant SOD1 in causing FALS. 
Monomer-dimer equilibria. SOD1 is a homodimer, with a dissociation constant, Kd ~ 10-11 
M, making it a very stable dimer92. FALS-associated mutations are known to affect the 
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monomer-dimer equilibrium (see Chapter 3), and as shown in Chapter 2, dimer dissociation 
is required for the aggregation of protein. A range of parameters affects the dimer 
dissociation properties of SOD1 in vitro93, most importantly, the metal content of the protein 
and the presence of an intact disulfide between Cys57 and Cys146.  It is therefore possible 
that mutant SOD1 may affect the monomer-dimer equilibrium either by structurally 
destabilizing the disulfide bond or by diminishing the ability for the protein to bind metals.  
Crystal structures. Several crystal structures of mutant and wild type SOD1 have been 
solved, and in all known crystal structures mutant SOD1 adopts the same fold as wild type, 
the differences between them are limited to subtle changes in backbone and side-chain 
packing29. This observation is not surprising given that most mutants are known to be active, 
and are therefore expected to maintain the active-site geometry required for activity. 
However, subtle packing differences between the wild type and mutant, and, as we will see in 
Chapter 6, the dynamic propagation of these packing defects may be responsible for the 
enhanced aggregation propensities of the mutants. A comparison of the crystal structures 
shows that the A4V mutation causes significant shifts in side-chain positions in the vicinity 
of the mutation site causing defects in local packing94. In addition, a crystal structure of the 
G37R mutant shows higher atomic displacement parameters (B-factors) for the side-chains 
compared to the wild type, but the backbone conformation is not significantly different, thus 
indicating greater molecular flexibility in some portions of the structure possibly explaining 
the observations that mutant SOD1s exhibit accelerated turn-over in vivo or increased 
susceptibility to proteolytic digestion95. Thus, one scenario for SOD1 aggregation evident 
from an examination of the crystal structures of mutant SOD1 is the decreased 
conformational stability of mutants by a so-called “framework destabilization”. 
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Protein dynamics. Mutations in the SOD1 polypeptide may destabilize the protein by 
altering the protein dynamics. It was found that the apo-state of the A4V FALS mutant had 
much higher rates of H/D exchange compared to the wild-type SOD191. The higher exchange 
rate of the mutant persisted even at low temperatures (4oC), indicating that the mutant has 
significantly higher flexibility.  Using Protein NMR to probe motions on the ps-ns timescale, 
it was also found that holo-G93A shows a general increase in backbone mobility which is 
localized to two specific β-strands of the SOD1 fold important for maintaining fidelity to its 
native fold96 (Chapter 5). Moreover, as we will see in Chapter 6, the motion of the two β-
strands may correspond to a transient opening of the β-barrel fold of SOD1, and is observed 
in molecular dynamics simulations of apo-SOD1 wild type mutants, suggesting a specific 
dynamic signature of the mutations on the ps-ns timescale. Mutant SOD1 was also found to 
be more prone to disulfide-reduction97. Since the native disulfide bond is well-buried in the 
structure of SOD1, the observation of increased reduction susceptibility implies a greater 
dynamic tendency of mutant SOD1 to open. The increased flexibility of mutant SOD1 is also 
reflected in the observation that mutant SOD1 shows significantly higher affinity to bind 
hydrophobic beads in vitro compared to wild type98. However, the details of the motions 
implicated in misfolding and aggregation are not fully understood, especially in the μs-ms or 
higher timescales.  
 
1.6 Outline of the Dissertation 
 The studies outlined in this dissertation were aimed at uncovering the molecular 
mechanism of SOD1 aggregation implicated in FALS. In Chapter 2, in vitro studies 
leading to the discovery of a mechanism for the aggregation of SOD1 are outlined. We 
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found that aggregation involves dimer dissociation and metal-loss from the resulting 
monomers, suggesting that FALS mutations enhance the dimer dissociation and/or metal-
loss propensities of SOD1. In Chapter 3, computational estimates of the effect of FALS 
mutations on SOD1 thermodynamic stability and dimer dissociation propensity are 
presented, where we show that most FALS mutations destabilize the dimer and increase 
the dimer dissociation propensity. To identify events downstream of apo-monomer 
formation in the aggregation mechanism, in Chapter 4, studies leading to the 
identification of putative sequence and structural determinants of SOD1 aggregation are 
presented. In Chapter 5, a molecular mechanism for SOD1 monomer folding is outlined, 
in which regions of the SOD1 molecule responsible for maintaining fold fidelity are 
identified. In Chapter 6, the effect of mutations on native-state SOD1 dynamics are 
studied, and we found that the aggregation-prone “hot-spot” regions identified in 
Chapters 4 and 5 undergo significantly altered dynamics, leading us to a proposal for an 
atomic-resolution molecular scenario for the conformational conversion of SOD1 into 
fibrils. Finally, in Chapter 7, conclusions of the dissertation and recommendations for 
further investigation are discussed.  
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CHAPTER 2 
 
AN IN VITRO MECHANISM FOR SOD1 AGGREGATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as a manuscript in the Proceedings of the National Academy 
of Sciences USA and is formatted in the journal style. 
2.1 Abstract 
Mutation-induced aggregation of the dimeric enzyme Cu, Zn superoxide dismutase (SOD1) 
has been implicated in the familial form of the disease ALS (FALS), but the mechanism of 
aggregation is not known. Here, we show that in vitro SOD1 aggregation is a multi-step 
reaction that minimally consists of dimer dissociation, metal loss from the monomers, and 
oligomerization of the apo-monomers:  
                                       
-
off m agg
on m
holo apo2 2
k k k
k k
D M M+⎯⎯→ ⎯⎯→ A⎯⎯→←⎯⎯ ←⎯⎯  
where Dholo, Mholo, Mapo and A are the holo-dimer, holo-monomer, apo-monomer and aggregate 
respectively. Under aggregation-promoting conditions (pH 3.5), the rate and equilibrium 
constants corresponding to each step are: (1) dimer dissociation: Kd≈1μM; koff ≈1×10-3 s-1, 
kon≈1×103 M-1s-1; (2) metal loss: Km≈0.1μM, mk
− ≈1×10-3 s-1, mk
+ ≈1×104 M-2s-1; (3) assembly 
(rate-limiting step): kagg≈1×103 M-1s-1.  In contrast, under near-physiological conditions (pH 
7.8), where aggregation is drastically reduced, dimer dissociation is less thermodynamically 
favorable: Kd≈0.1 nM, and extremely slow: koff≈3×10-5s-1, kon≈3×105 M-1s-1. Our results suggest 
that FALS-linked SOD1 aggregation occurs by a mutation-induced increase in dimer 
dissociation and/or increase in apo-monomer formation.   
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 2.2 Introduction 
Amyotrophic Lateral Sclerosis (ALS) involves selective motor neuron death in the 
brain and the spinal cord (1-6) initiating a progressive paralysis in mid-life. Point mutations in 
the cytoplasmic homodimeric enzyme Cu, Zn superoxide dismutase (SOD1, Mw≈32kDa) were 
identified as the primary cause of approximately 20% cases of the familial form of ALS 
(FALS) (7, 8) in contrast with the sporadic form (SALS). Approximately 90 distinct FALS 
mutations are known (9). The toxic gain-of-function of the mutants is believed to be associated 
with either intracellular misfolding and aggregation or oxidative damage caused by mutant 
SOD1-catalyzed aberrant reactions, although the two scenarios may not be mutually exclusive 
(10, 11). The aggregation hypothesis is supported by the observations that in both mice and cell 
culture models, death of motor neurons is preceded by formation of cytoplasmic aggregates 
containing mutant SOD1 (12-15), that SOD1 knockout mice do not develop motor neuron 
disease (16), and that even Cu-depleted SOD1 mutants cause the disease in mice (17). 
Although aggregation of SOD1 has also been found in some cases of SALS (18-20), the 
sporadic disease is believed to have a different molecular basis (1). FALS and SOD1-linked 
SALS may belong to the general class of protein conformational disorders in which 
perturbation of protein folding leads to a relatively higher population of misfolded or partially 
folded (21) protein molecules which then aggregate into regular (22) structured fibrils. Toxicity 
may arise due to the saturation of the cellular chaperone machinery by the misfolded or 
aggregated SOD1 molecules (23).  
ALS is an age-related disease occurring in mid-life or later, and it is not surprising that 
the in vitro aggregation of SOD1 solutions under physiological conditions is slow. Therefore, it 
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is common to study SOD1 aggregation by perturbing the environmental conditions – by 
lowering the pH to 3.5 (24), by adding mild denaturants such as trifluoroethanol, or by heat-
treatment (25) – such that disease-like aggregates can be detected on experimental time-scales. 
Aggregation-prone FALS mutations and/or loss of metals also decrease SOD1 stability (26, 
27), indicating that exposure to non-physiological conditions, such as low pH, mimics the 
effect of mutation by similarly lowering the barrier for SOD1 aggregation. Although the rate of 
aggregation can be enhanced in vitro, the molecular mechanism of SOD1 aggregation is not 
well-understood. 
We show here that the relatively rapid aggregation of SOD1 that results from 
perturbations in the environmental conditions occurs because these promote dimer dissociation 
and/or the loss of metals, and that the thus formed apo-monomers undergo multimeric 
assembly.  We propose that this same reaction path holds for some or all FALS mutant forms 
of SOD1 and that increased aggregation results from perturbation of one or more of the steps in 
the pathway demonstrated here: dimer dissociation, metal loss from monomers, aggregation of 
apo-monomers.  
 
2.3 Methods 
Protein and buffers.  
Bovine and human erythrocyte Cu, Zn superoxide dismutase (E.C. 1.15.1.1) were 
obtained from Sigma chemicals. Protein concentration was measured spectrophotometrically at 
258 nm for the bovine enzyme (28). Buffers used in SPR at various pH values were: pH 7.8, 
pH 6.6, pH 5.8: 50mM phosphate, 150 mM NaCl; pH 4.8, pH 3.5: 100mM acetate, 150mM 
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NaCl, pH2.5, pH2.7, pH3.0. pH 10.8, pH 11.85, pH 12.5: 50mM phosphate buffer,150mM 
NaCl. All incubations were at 37 0C. 
 
Biotinylation reaction.  
Biotinylated SOD1 was prepared at low stoichiometry (1 mol equivalents of 
biotinylating agent/SOD1 dimer) for Surface Plasmon Resonance (SPR) studies and high (10 
fold excess of biotinylating agent/SOD1 dimer) stoichiometry for Size Exclusion 
Chromatography (SEC) studies as  previously described (29). Biotinylated SOD1 was found to 
be fully active after biotinylation ((30); data not shown) and had identical chromatographic 
properties compared to the unmodified protein (Supplementary Material S1).  
 
Analytical ultracentrifugation (AUC).  
The Kd for SOD1 dimer dissociation was determined using a Beckmann-XLA 
ultracentrifuge at a speed of 16,000 rpm at 40 C or 250C using a Ti-50 rotor. Radial UV 
absorbance (258 nm) was monitored every 2h in cells with a path length of 12 mm. One blank 
buffer sample was used for each protein sample to obtain baselines. A total of 7 scans were 
obtained for each sample and the corresponding blank cell to reach equilibrium, followed by 
over-spinning at 45,000 rpm to obtain another estimate of baseline absorbance (typically 0.01 
units). The UV-absorbance profiles were superimposed to ensure equilibrium, analyzed for 
residuals and the equilibrium profile(s) were fit to the Lambert equation to obtain estimates of 
Kd and apparent molecular weight Mw. 
 
Size exclusion chromatography.  
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SEC was performed with a Pharmacia Akta chromatography system using an 
Amersham-Pharmacia Superdex HR 10/30 column (Piscataway, NJ), with a 200-µl injection 
loop, total volume of 23.56 ml and a void volume estimate of 7.8 ml, working at 5°C. The 
column flow rate was 0.45 ml/min. Fractions (150-250 µl) were collected in glass tubes and 
these were analyzed immediately after completing the chromatogram. In reactions with low 
(nanomolar) SOD1 concentrations, the reaction mixture and the column buffer contained BSA 
at 10 mg/l to prevent nonspecific binding of SOD1 to test tubes and to the column matrix. UV 
absorbance was monitored spectrophotometrically at 254nm.  
 
Dot blotting.  
Column fractions were analyzed by a dot-blot assay, with Avidin-AP, as previously 
described (29) and/or by immunostaining with anti-SOD1 antibody (Supplementary Material 
S2).  
 
Surface Plasmon Resonance measurements.  
Plasmon resonance sensor chips, pre-coated with strepavidin, were obtained from 
Biacore Corp. (Piscataway, NJ) and used with a Biacore Model 2000 instrument. The chips 
were pretreated with NaOH/50mM NaCl (pH 12.7) before biotin-SOD1 was immobilized. The 
volume of each flow cell (4 per chip) was 7nl and a buffer flow of 2μl/min was used at 250C. 
Low stoichiometry (≤1 biotin/dimer) biotin-SOD1 was immobilized on one flow cell surface 
such that an increase of approximately 3000 Resonance Units (RU) resulted. After binding was 
complete, SOD1 dimer dissociation was induced with protein-free buffer. A small correction 
for the signal drift was applied using the signal from the flow-cells that had not received biotin-
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SOD1 but received protein-free buffer. To obtain the pH dependence of the rate constant, the 
zero-order dissociation reaction was followed sequentially with increasing or decreasing pH, 
starting at pH 7.8.  
 
2.4 Results 
We show that the minimal sequence of steps constituting the aggregation pathway is: 
-
off m agg
on m
holo apo2 2
k k k
k k
D M M+⎯⎯→ ⎯⎯→ A⎯⎯→←⎯⎯ ←⎯⎯      (1) 
where Dholo, Mholo, Mapo and A are the holo-dimer, holo-monomer, Zn-free monomer (31) and 
aggregate respectively. Next, we show that: (i) the Kd and koff for SOD1 dimer dissociation are 
enhanced under aggregation-promoting conditions; (ii) aggregation requires dissociation of the 
SOD1 dimer to monomers and a subsequent loss of metals. Based on the observed aggregation 
kinetics, we calculated the rate and equilibrium constants for each step in the reaction 
sequence. 
 
The Kd for SOD1 dimer dissociation is 6×103-fold higher under aggregation-enhancing 
conditions than under near-physiological conditions. 
 The Kd and molecular weight Mw of SOD1 under aggregation-enhancing conditions 
were determined using analytical ultracentrifugation (AUC, Table I), fitting the absorbance 
profiles to a dimer-monomer equilibrium. 30μM SOD1 was entirely dimeric (apparent 
Mw≈36kDa) at pH 7.8 and was entirely monomeric (apparent Mw≈16kDa) when metals were 
chelated by incubation with 10mM EDTA at pH 3.5. A Kd ≈1μM was calculated for the dimer-
monomer equilibrium by a combined fit to the AUC profiles of 30, 20 and 10μM SOD1. Thus, 
at pH 3.5, where aggregation was previously observed (24), 30µM SOD1 was ≈84% dimer and 
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≈16% monomer. In contrast, 30μM SOD1 was ≈100% dimer under near-physiological 
conditions (pH 7.8), where aggregation does not occur.  
 The Kd for SOD1 dimer dissociation at pH 7.8 could not be measured by AUC because 
the optical system used to detect the protein is limited to micromolar concentrations. However, 
nM SOD1 concentrations could be analyzed by using size exclusion chromatography (SEC) 
and a dot-blot assay. Based on the calibration of the Superdex HR 10/30 column (Fig. 1A), the 
SOD1 dimer and monomer are expected to elute at 15.5 and 17.0 ml respectively; SOD1 at 
30μM in pH 7.8 buffer eluted as ≈100% dimer at 15.6 ml (Fig. 1B), in accord with AUC 
measurements (Table I). The Kd at pH 7.8 was estimated with 5nM SOD1 which gave column 
fractions at the limit of detection. The bulk of the protein eluted as a dimer at 15.3 ml with a 
small reproducible monomer peak at 16.8 ml, comprising ≈20% of the total protein (Fig. 1C). 
The dimer and monomer were expected to elute as distinct peaks because they were in slow 
equilibrium: the half-time for dimer dissociation was ≈6 h at pH 7.8 and 250C (see below), 
whereas the time required for chromatographic separation was ≈10 minutes at 50C. A Kd≈0.16 
nM was calculated from a double-Gaussian least-square fit to the data, and is in reasonable 
agreement with the Kd≈1nM estimated from the unfolding studies of human SOD1 (32). Thus, 
the Kd≈1×10-6 M at pH 3.5 is larger than the Kd≈1.6×10-10 M at pH 7.8 by a factor of 6×103. 
This corresponds to a large (≥5.2 kcal/mol) reduction in dimer stability, indicating that a higher 
fraction of SOD1 is monomeric under aggregation-enhancing conditions than under near-
physiological conditions.   
Since identical Mw estimates were obtained for 10μM SOD1 at pH 3.5 with and without 
a 24 h incubation (Table I) incubation, dimer dissociation is presumably reversible and the 
irreversible (33),(34) step in the aggregation lies downstream of dimer dissociation. The 
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reversibility of dimer dissociation under aggregation-promoting conditions was directly 
demonstrated by SEC (Supplementary Material S4).    
  
The koff for SOD1 dimer dissociation is 30-fold higher under aggregation-enhancing 
conditions than under near-physiological conditions. 
Having determined that the Kd for dimer dissociation was enhanced at least 20,000-fold 
at pH 3.5, we used Surface Plasmon Resonance (SPR) to determine the kinetics of dimer 
dissociation. SOD1, biotinylated at low stoichiometry (≤1 biotin/SOD1 dimer), was 
immobilized on a strepavidin-coated gold surface. As shown in Fig. 2A, the biotinylated dimer 
has one subunit bound to strepavidin and the non-biotinylated subunit is progressively lost by 
flowing SOD1-free buffer through the flow-cell, leading to a SPR signal decrease of 
approximately 50%. The dissociation is made irreversible by a 2000 nl/minute flow of protein-
free buffer through the 7 nl flow-cell. The rate constant for dissociation koff was determined by 
an exponential fit to the entire signal decay corresponding to a first-order reaction (Figs. 2B 
and 2C), or by a linear fit to the initial signal decay corresponding to a zero-order reaction (Fig. 
2D). The dissociation at pH 3.5 had a half-time of ≈600 s (koff ≈1.0×10-3 s-1; Fig. 2B) whereas 
the dissociation at pH 7.8 had a half time of ≈6 h (koff ≈ 3.1×10-5 s-1; Fig. 2C). Therefore, under 
conditions where aggregation was observed (pH 3.5), the rate of dimer dissociation is a 30-fold 
faster than under near-physiological conditions. This corresponds to an approximately 2.0 
kcal/mol reduction in the energy barrier for dissociation.  
 
SOD1 dimer dissociation may be induced by the disruption of salt-linkages. 
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The dramatic increase in koff at pH 3.5 suggests that insights into the forces stabilizing 
the SOD1 dimer could be obtained from the pH-dependence of the reaction. The koff increased 
sharply on the acidic and basic ends of the pH range 2.5-12.7 (Fig. 2D and 2E). In the simplest 
unified model to account for this effect, dimer dissociation is linked with the titration of 
carboxyl (Asp, Glu) and amine (Lys, Arg) groups forming a salt-linkage. At any given pH, the 
observed koff reflects the dissociation of three sub-populations of the SOD1 dimer, in which the 
salt-linkage is: (i) intact; (ii) disrupted because of the protonation of the carboxylic acid; and 
(iii) disrupted because of the de-protonation of the amine. The species from sub-populations 
(i), (ii), and (iii) have intrinsic dissociation rate constants kind, kacid, and kbasic respectively, 
which are weighted by their pH-dependent population size, so that the observed koff is: 
[ ]
[ ] [ ]
obs b
off acid basic ind
a b
KHk k k k
H K K H
+
+
⎧ ⎫ ⎧ ⎫= +⎨ ⎬ ⎨ ⎬+ +⎩ ⎭ ⎩ ⎭+
+     (2) 
where Ka and Kb are the equilibrium constants for the de-protonation of the carboxyl 
and amine groups involved. The first and the second term dominate at low and high pH 
respectively, and the rate is pH-independent at intermediate pH values. According to Eq.(2), in 
the low pH regime the titration-induced increase in log  is predicted to have a slope of -1 
when
obs
offk
apH pK>> . Similarly, a slope of 1 is predicted for the corresponding increase in the 
high pH regime when , and such increases were observed at both low and high pH 
(Fig. 2E).  The apparent pKa and pKb values of <2.5 and >12.5, presumably correspond to 
carboxyl (Asp; free pK=3.86) and amine (Arg; free pK=12.48) groups forming a highly 
stabilizing salt-linkage. The linkage of the protonation of the carboxylic acid and the de-
protonation of the amine to the dimer dissociation leads to the abnormal apparent pK values. 
The 100-fold change in the observed koff in the intermediate pH range 4.8-10.8 is indicative of 
bpH pK<<
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other titrations, possibly of charged amino acid side-chains which may not form salt-linkages, 
so that they have a smaller effect on the rate kind.  
Human SOD1 (hSOD1), which is highly homologous (82% sequence identity) to the 
bovine enzyme, exhibits a similar pH-dependence of dimer dissociation. The koff values were 
similar at pH 6.6 (Fig. 2D, inset) and at pH 7.8: 2.74×10-5 s-1 for hSOD1 (data not shown) and 
3.13×10-5 s-1 for bovine SOD1 (Fig. 2B).  
It is interesting that there are no salt-linkages on the dimer interface of either bovine or 
human SOD1 so that the enhanced dissociation rate is caused indirectly by the titration of a 
salt-linkage that is not in the proximity of the dimer interface. The Arg79-Asp101 interaction 
was identified as a candidate for such a salt-linkage (Supplementary Material S5). This salt-
linkage mechanism provides a unified framework that accounts for the steep pH-dependence of 
the reaction at low and high pH, and is consistent with the previous finding that charge-charge 
interactions in SOD1 contribute substantially to its stability and folding kinetics (21). An 
alternative mechanism in which ionization of surface exposed residue(s) dramatically 
influences dimer stability is less likely since it does not simultaneously predict the behavior at 
extremes of pH, and the modest pH-dependence of the rate at intermediate pH values. 
 
Rapid oligomerization of SOD1 occurs under conditions where it is monomeric. 
To test directly whether SOD1 monomer or dimer is the aggregation-competent 
species, we characterized the initial phase of aggregation as a function of the degree of dimer 
dissociation at pH 3.5. Based on a Kd ≈1μM, as determined by AUC (Table I), a 30μM SOD1 
solution was 84% (25μM) dimeric, while a 1μM solution was 39% (0.39μM) dimeric, 
corresponding to a ≈60-fold excess of dimer in the 30μM sample compared to the 1μM sample.  
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30μM SOD1 eluted predominantly as a dimer (elution volume 16.5 ml; Supplementary 
material Fig. S2A) on incubation for 40 minutes (Fig. 3A, top panel). 40 minutes was sufficient 
for the establishment of equilibrium since the dimer dissociation has a half-time of ≈600s at 
this pH (Fig. 2B). The elution profiles remained largely unaltered for 48 h (Fig. 3A, middle and 
bottom panels) and there was little aggregation since nearly identical peak heights and areas in 
the UV-absorbance profiles were obtained after incubation. This agreed with AUC results in 
which 30µM SOD1 gave nearly identical UV-absorbance signals and apparent Mw estimates 
(Table I). After 48 h, most of the protein remained dimeric or monomeric (Fig. 3A), and less 
than 10% was aggregated.  
Relatively rapid aggregation occurred with 1μM SOD1 (Fig. 3B). After 40 minutes of 
incubation, the protein eluted in a broad peak centered at 17.2 ml corresponding to a 40:60 
mixture of dimer and monomer, as expected from Kd≈1μM. The rate of aggregation was 
initially rapid and after 24 and 48 h approximately 60% of the protein was aggregated. The 
aggregation rate is expected to decrease markedly with time, and the failure to observe a 
significant increase in the fraction of aggregated protein at 48 h can be attributed to 
experimental error. These results show that at a given concentration, SOD1 aggregation is 
proportional to the fraction of monomer, rather than dimer, in solution.  
 
Rapid oligomerization of SOD1 occurs under conditions where metals are lost 
irreversibly. 
  Since the chelation of metals is known to destabilize SOD1 (26) and promote 
aggregation (24), we postulated that the reactive species for aggregation is the apo-monomer. 
To test this, we determined the time-course of aggregation of 30μM SOD1 under conditions 
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where metal loss was made irreversible by dialysis against metal free buffer. Dialysis at pH 3.6 
results in a rapid loss of 95% of the Zn (31) and the unbound metals were expected to be 
removed rapidly since we had found that the loss of cupric acetate from the dialysis bag has a 
concentration-independent (range 100μM-10mM) half-time of 10 minutes under the conditions 
of the experiment (data not shown). A substantial amount of aggregation was expected if the 
loss of metals from SOD1 induces formation of a species that is aggregation-competent.  
 During incubation under dialysis conditions the amount of dimer rapidly decreased, the 
degree of dimer dissociation increased, and the protein was almost completely aggregated in 21 
h (Fig. 3D). Electron micrographs of the aggregates obtained by negative staining, show that 
they have fibrillar morphology (Fig. 3D, inset). Despite the fact that the dimer concentration 
decreased monotonically, the monomer concentration initially increased and subsequently 
gradually decreased (Fig. 3E), indicating that under dialysis conditions, dimer dissociation is 
coupled to metal loss and aggregation of the apo-monomers in the reaction sequence: 
-
off m agg
on m
holo apo2 ( ) 2
k k k
dialysedk k
D M Zn M+⎯⎯→ ⎯⎯→ A+ ⎯⎯→←⎯⎯ ←⎯⎯     (3) 
where Dholo, Mholo, Mapo and A are the holo-dimer, holo-monomer, Zn-free monomer and 
aggregate respectively.  In contrast, in AUC studies described above, the dominant species 
after incubation remained Dholo and Mholo and there was no detectable aggregation. The 
coincidence between the increase in Mapo and the increased rate of aggregation shows that the 
apo-monomer is the reactive species for this process. Moreover, since the apo-monomer 
accumulated before aggregation, it is concluded that the oligomerization of apo-monomers is 
the rate-limiting step in Eq.(3). 
For a more detailed characterization of SOD1 aggregation at pH 3.5, the rate-constants 
in the reaction sequence Eq. (3) were obtained. The value koff ≈1×10-3 s-1 (Fig. 2B) was 
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determined from SPR and kon≈103 M-1s-1 was calculated from Kd ≈1µM. The constants 
≈1.2×10-4 s-1, ≈5.2×104 M-1s-1, and kagg ≈0.1×103 M-1s-1 were estimated from the 
observed kinetics of dialysis-induced aggregation (Supplementary material S3). The estimated 
value of ≈1.2×10-4 s-1 agrees well with the previously measured 
mk
−
mk
+
mk
−
mk
− =4.2×10-4 s-1 (31) for the 
loss of Zn from SOD1 at pH 3.6 (half-time of ≈27 minutes at 20oC). The differential master 
equations corresponding to Eq.(3) were solved numerically (Supplementary Material S3) and 
the above rate constant estimates were refined, fitting to the observed time-profile of dialysis-
induced aggregation (Fig. 3E). The values that best account for the experimental results are: koff 
= 3×10-3 s-1, kon= 1.6×103 M-1 s-1, mk
− = 1×10-3 s-1, mk
+ = 9.8×103 M-1 s-1 and kagg = 1×103 M-1s-1. 
The rate constant values were found to be robust within an order of magnitude: the fit 
worsened dramatically on variations in rate constants greater than an order of magnitude. In 
accord with the above rate constants, which predict 12% aggregation in 30μM SOD1 after 24 h 
under non-dialysis conditions, we had found little aggregation (Fig. 3A). Similarly, 14% and 
63% aggregation is predicted at 30 and 1μM in 48 h (Fig.3F), which is in good agreement with 
the observed values of 10% and 60% respectively.  
 
2.5 Discussion  
To create amyloidogenic conditions under which the aggregation of proteins can be 
readily induced, acidic conditions are routinely employed. For example, amyloidogenic 
intermediates of transthyretin (TTR), β2-microglobulin, prion and lysozyme have been 
characterized at pH 4.5 (35), pH 3.6 (36), pH 4.4-6 (37), and pH 2 (38) respectively. Under 
conditions where SOD1 aggregation is experimentally accessible (pH 3.5), we have 
demonstrated an aggregation pathway in which the dimer dissociates, metal is lost from the 
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resultant monomer, and the apo-monomers aggregate in a rate-limiting step. The absence of 
any discontinuity in the rate of dimer dissociation when the pH is reduced from pH 7.8 to 3.5 
(Fig. 2E) provides evidence that this same pathway holds at physiological pH, but at a 
drastically reduced rate (Fig. 4). Similarly, the pH effects on the metal content of human, 
bovine and yeast wild type and yeast mutant SOD1 (in the range pH 3-9) have previously been 
shown to be continuous, reversible, and related to conformational changes in the protein (39), 
further indicating that the holo- and apo-monomer equilibrium is also a representative property 
of the protein.   
 
The sequence of events and the reactive species in the aggregation of SOD1. 
To identify the sequence of events in the aggregation reaction and the aggregation-
prone reactive species, we characterized the concentration and metal-content dependence of 
SOD1 aggregation. For the former, conditions such that there was a preponderance of either 
dimer or monomer were chosen, and the profiles of the initial phase of SOD1 aggregation 
under these conditions were compared. Total SOD1 concentrations of 30μM and 1μM were 
chosen so that at equilibrium there is an approximately 60-fold excess of dimer at the higher 
concentration. If aggregation is dependent on a bimolecular dimer-dimer reaction, a 3600-
fold greater aggregation rate is expected at the higher concentration. Similarly, a 60-fold 
greater aggregation rate is expected if a unimolecular isomerization reaction i.e. a 
conformation change in dimer, leading to an aggregation-competent dimeric species, is rate-
limiting. In stark contrast, we found rapid aggregation at the lower of the two concentrations, 
demonstrating that the dimer is not the reactive species for aggregation. The amount of 
aggregate at time t is kagg[M]2t where [M] is the concentration of the aggregating species. 
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Although there is an 8-fold excess of the total monomer at 30μM compared to 1μM, the 
concentration of the aggregating apo-monomer is 3-fold higher at 30μM. The total protein 
concentration is 30-fold higher in the 30μM sample and therefore, the fraction of the protein 
in aggregates, fagg = kagg[M]2t/cT, where cT is the total concentration of the protein, will be 
higher at 1μM than at 30μM, in agreement with the data in Fig. 3C. 
To ascertain whether the reactive species for aggregation is a metal-bound or metal-free 
monomer, aggregation kinetics were determined with 30µM SOD1 under conditions where the 
loss of metals from the protein was irreversible. We found that the dimer concentration rapidly 
decreased whereas the monomer concentration initially increased and then gradually decreased 
(Fig. 3E), and that aggregation into a fibrillar product was nearly complete in 21 h. A 
comparison with the aggregation kinetics of 30μM SOD1 in the absence of dialysis (Fig. 3A) 
shows that the monomeric species appearing under dialysis conditions is the apo-monomer. 
These findings constitute direct evidence that aggregation occurs via an apo-monomer 
intermediate. The finding that the apo-monomer accumulated before aggregation shows that 
the final assembly step is rate-limiting in the reaction Eq. (1). The mechanism in Eq. (1) is 
minimal since the final step leading to fibril formation is likely to be a complex multi-step 
process, possibly involving higher-order nuclei and oligomers (40, 41). kagg is an apparent-
second order rate constant that is a convolution of these underlying higher-order reactions. 
Also, kagg ≈103 M-1s-1 is significantly smaller than that expected for a diffusion-controlled 
reaction, kdiff =106-109 M-1s-1, further suggesting that additional steps that reduce the effective 
concentration of the aggregating species, such as a rate-limiting conformational change in the 
monomer or formation of oligomeric nuclei, occur downstream of the apo-monomer formation.  
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The monomer intermediate in the proposed mechanism was recently observed for 
oxidized-SOD1 aggregation (42) and for the A4V FALS mutant (43). Also, mutants that cause 
monomerization of the homotetrameric protein TTR (44) were found to aggregate rapidly and 
were cytotoxic. The dissociation of multimeric proteins into their monomeric subunits, 
followed by misfolding and oligomerization, may be a general theme in the amyloidosis of 
proteins.  
 
The thermodynamics and kinetics of dimer dissociation and SOD1 stability. 
The low value of Kd ≈1.6×10-10 M at pH 7.8 reported here is consistent with previous 
studies  showing the remarkable stability of the SOD1 dimer. The dimer retains its native 32 
kDa molecular weight in 8 M urea for 72 hours at 25oC (45) and is active in 4% SDS (46). This 
stability was also seen in pulse-chase studies showing that the protein has a relatively long (20-
78 h) half-life in cells ((47), (48), (12)). The Kd ≈1.6×10-10M (pH 7.8, 370C) corresponds to a 
free energy, ΔGd ≈ -13.5 kcal/mol, for the dimer dissociation reaction: 2 .D M   Consistent 
with our estimate, a three-state fit to SOD1 unfolding (32) of the homologous human SOD1 
(pH 7.4, 200C) gave: 2D M U    ; ΔGd ≈ -12.5 kcal/mol and ΔGm ≈ -8 kcal/mol, where U is 
the unfolded state and ΔGm is the free energy of unfolding of both monomers. The total 
stability of SOD1 (ΔGd+ΔGm) is approximately 20.5 kcal/mol (32) and the dimer dissociation 
free energy represents the largest contribution to the stability of the protein. Therefore, 
conditions that lead to aggregation must destabilize the dimer and/or reduce the dissociation 
barrier. In accord with this, we found that the rate and equilibrium constants for dimer 
dissociation are enhanced 30- and 6×103-fold at pH 3.5 compared to pH 7.8. These values 
imply that low pH reduces the dimer dissociation barrier by 2.0 kcal/mol, while the dimer 
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stability is reduced by 5.2 (=13.5-8.3) kcal/mol (Fig. 4). Thus, the rarity and the late age-of-
onset of ALS may occur because under physiological conditions, the Kd and koff are 6,000- and 
30-fold smaller, and the H+-concentration expected to induce metal loss is 10,000-fold smaller, 
compared to pH 3.5. The effect of factors related to aging, such as the decreased efficacy of 
chaperone-mediated proteosomal degradation (23), is likely to increase the demetallation 
and/or the dimer dissociation in vivo.  
 
A model for the effect of FALS mutations on SOD1 aggregation 
There is no discernable pattern in the primary, secondary or tertiary structure of FALS-
associated SOD1 mutants, suggesting that they affect a global property of the protein. We 
postulate that mutations affect one or more steps in the multi-step pathway for SOD1 
aggregation, and this suggests a unified framework to account for the effect of FALS mutants 
on SOD1 aggregation (Fig. 4). Dimer dissociation generates a monomeric form of SOD1, 
which loses its metal(s) to generate the aggregation-competent species Mapo. We have 
computationally estimated (Khare et al., unpublished results) that 70 of 75 known FALS-
associated point mutants in SOD1 decrease the dimer stability and/or increase dissociation 
propensity, and propose that mutant forms of SOD1 result in FALS because of one or more of 
the following: (1) mutations destabilize the SOD1 dimer resulting in higher than normal 
concentrations of Mholo and consequently Mapo; (2) mutations enhance the loss of metals from 
Mholo, possibly by affecting the interaction with the copper chaperone CCS, resulting in higher 
than normal concentrations of Mapo; (3) SOD1 mutations reduce the barrier for fibril formation. 
In all cases, the probability for forming protein aggregates is significantly increased. Important 
questions concerning the role, if any, of aggregates in the cell-specific biological origin of 
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FALS i.e. why the aggregates are found only in motor neurons and the origin of cytotoxicity in 
the disease, remain a formidable challenge.   
 
 45
2.6 References  
 
1.  Cleveland, D. W. & Rothstein, J. D. (2001) Nature Reviews Neuroscience 2, 806-819. 
2. Ratovitski, T., Corson, L. B., Strain, J., Wong, P., Cleveland, D. W., Culotta, V. C. & 
Borchelt, D. (2000) Brain Pathology 10, 725. 
3. Beckman, J. S., Estevez, A. G. & Crow, J. R. (2001) Trends in Neurosciences 24, S15-
S20. 
4. Rowland, L. P. & Shneider, N. A. (2001) New England Journal of Medicine 344, 1688-
1700. 
5. Siddique, T., Nijhawan, D. & Hentati, A. (1996) Neurology 47, S27-S34. 
6. Siddique, T., Deng, H. X., Hentati, A., Tandon, R., PericakVance, M. A., Laing, N. G., 
Roos, R. P., Cayabyab, A., Gerzfeldt, B., Hung, W. Y. et al. (1993) Annals of Neurology 34, 
303-304. 
7. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., 
Donaldson, D., Goto, J., Oregan, J. P., Deng, H. X. et al. (1993) Nature 362, 59-62. 
8. Gurney, M. E., Pu, H. F., Chiu, A. Y., Dalcanto, M. C., Polchow, C. Y., Alexander, D. D., 
Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H. X. et al. (1994) Science 264, 1772-1775. 
9. Gaudette, M., Hirano, M. & Siddique, T. (2000) Amyotrophic Lateral Sclerosis and Other 
Motor Neuron Disorders 1, 83-89. 
10. Rakhit, R., Cunningham, P., Furtos-Matei, A., Dahan, S., Qi, X. F., Crow, J. P., 
Cashman, N. R., Kondejewski, L. H. & Chakrabartty, A. (2002) J. Biol. Chem. 277, 47551-
47556. 
11. Valentine, J. S. & Hart, P. J. (2003) Proceedings of the National Academy of Sciences of 
the United States of America 100, 3617-3622. 
12. Johnston, J. A., Dalton, M. J., Gurney, M. E. & Kopito, R. R. (2000) Proceedings of the 
National Academy of Sciences of the United States of America 97, 12571-12576. 
13. Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., 
Reaume, A. G., Scott, R. W. & Cleveland, D. W. (1998) Science 281, 1851-1854. 
14. Durham, H. D., Roy, J., Dong, L. & Figlewicz, D. A. (1997) Journal of Neuropathology 
and Experimental Neurology 56, 523-530. 
15. Wang, J., Xu, G. & Borchelt, D. R. (2002) Neurobiology of Disease 9, 139-148. 
 46
16. Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. 
F., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H. et al. (1996) Nature Genetics 13, 
43-47. 
17. Wang, J., Xu, G. L., Gonzales, V., Coonfield, M., Fromholt, D., Copeland, N. G., 
Jenkins, N. A. & Borchelt, D. R. (2002) Neurobiology of Disease 10, 128-138. 
18. Shibata, N., Hirano, A., Kobayashi, M., Sasaki, S., Kato, T., Matsumoto, S., Shiozawa, 
Z., Komiri, T., Ikemoto, A., Umahara, T. et al. (1994) Neuroscience Letters 179, 149-152. 
19. Matsumoto, S., Kusaka, H., Ito, H., Shibata, N., Asayama, T. & Imai, T. (1996) Clinical 
Neuropathology 15, 41-46. 
20. Shibata, N., Asayama, K., Hirano, A. & Kobayashi, M. (1996) Developmental 
Neuroscience 18, 492-498. 
21. Khare, S. D., Ding, F. & Dokholyan, N. V. (2003) Journal of Molecular Biology 334, 
515-525. 
22. Elam, J. S., Taylor, A. B., Strange, R., Antonyuk, S., Doucette, P. A., Rodriguez, J. A., 
Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O. et al. (2003) Nature Structural 
Biology 10, 461-467. 
23. Okado-Matsumoto, A. & Fridovich, I. (2002) Proceedings of the National Academy of 
Sciences of the United States of America 99, 9010-9014. 
24. DiDonato, M., Craig, L., Huff, M. E., Thayer, M. M., Cardoso, R. M. F., Kassmann, C. 
J., Lo, T. P., Bruns, C. K., Powers, E. T., Kelly, J. W. et al. (2003) Journal of Molecular 
Biology 332, 601-615. 
25. Stathopulos, P. B., Rumfeldt, J. A. O., Scholz, G. A., Irani, R. A., Frey, H. E., Hallewell, 
R. A., Lepock, J. R. & Meiering, E. M. (2003) PNAS 1237797100. 
26. Lindberg, M. J., Tibell, L. & Oliveberg, M. (2002) PNAS 262527099. 
27. Rodriguez, J. A., Valentine, O. S., Eggers, D. K., Roe, J. A., Tiwari, A., Brown, R. H. & 
Hayward, L. J. (2002) J. Biol. Chem. 277, 15932-15937. 
28. Inouye, K., Osaki, A. & Tonomura, B. (1994) Journal of Biochemistry 115, 507-515. 
29. Caplow, M. & Fee, L. (2001) Molecular Biology of the Cell 12, 430A. 
30. Mccord, J. M. & Fridovich, I. (1969) J. Biol. Chem. 244, 6049-6055. 
31. Pantoliano, M. W., Valentine, J. S., Mammone, R. J. & Scholler, D. M. (1982) Journal of 
the American Chemical Society 104, 1717-1723. 
32. Stroppolo, M. E., Malvezzi-Campeggi, F., Mei, G., Rosato, N. & Desideri, A. (2000) 
Archives of Biochemistry and Biophysics 377, 215-218. 
 47
33. Lepock, J. R., Frey, H. E. & Hallewell, R. A. (1990) J. Biol. Chem. 265, 21612-21618. 
34. Rodriguez, J. A., Valentine, J. S., Eggers, D. K., Roe, J. A., Brown, R. H. & Hayward, L. 
J. (2001) Journal of Inorganic Biochemistry 86, 403. 
35. Liu, K., Cho, H. S., Lashuel, H. A., Kelly, J. W. & Wemmer, D. E. (2000) Nature 
Structural Biology 7, 754-757. 
36. McParland, V. J., Kalverda, A. P., Homans, S. W. & Radford, S. E. (2002) Nature 
Structural Biology 9, 326-331. 
37. Swietnicki, W., Petersen, R., Gambetti, P. & Surewicz, W. K. (1997) J. Biol. Chem. 272, 
27517-27520. 
38. Blanch, E. W., Morozova-Roche, L. A., Cochran, D. A. E., Doig, A. J., Hecht, L. & 
Barron, L. D. (2000) Journal of Molecular Biology 301, 553-563. 
39. Goto, J. J., Zhu, H. N., Sanchez, R. J., Nersissian, A., Gralla, E. B., Valentine, J. S. & 
Cabelli, D. E. (2000) J. Biol. Chem. 275, 1007-1014. 
40. Lomakin, A., Teplow, D. B., Kirschner, D. A. & Benedek, G. B. (1997) PNAS 94, 7942-
7947. 
41. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., 
Benedek, G. B., Selkoe, D. J. & Teplow, D. B. (1999) J. Biol. Chem. 274, 25945-25952. 
42. Rakhit, R., Crow, J. P., Lepock, J. R., Kondejewski, L. H., Cashman, N. R. & 
Chakrabartty, A. (2004) J. Biol. Chem. 279, 15499-15504. 
43. Ray, S. S., Nowak, R. J., Strokovich, K., Brown, R. H., Walz, T. & Lansbury, P. T. 
(2004) Biochemistry 43, 4899-4905. 
44. Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W. & Buxbaum, J. N. (2004) 
Proceedings of the National Academy of Sciences of the United States of America 101, 2817-
2822. 
45. Malinowski, D. P. & Fridovich, I. (1979) Biochemistry 18, 5055-5060. 
46. Forman, H. J. & Fridovich, I. (1973) J. Biol. Chem. 248, 2645-26499. 
47. Borchelt, D. R., Guarnieri, M., Wong, P. C., Lee, M. K., Slunt, H. S., Xu, Z. S., Sisodia, 
S. S., Price, D. L. & Cleveland, D. W. (1995) J. Biol. Chem. 270, 3234-3238. 
48. Nakano, R., Inuzuka, T., Kikugawa, K., Takahashi, H., Sakimura, K., Fujii, J., Taniguchi, 
N. & Tsuji, S. (1996) Neuroscience Letters 211, 129-131. 
 
 
 48
  
 
      
  Table 2.1 Measurement of the Kd for SOD1 dimer dissociation using AUC. 
 
 
 Conditions 
 Concentration pH/incubation 
Mw, Da Comment 
         30μM pH 7.8 36180 Dimeric 
30μM pH 3.5+ EDTA (40C)a 16417 Monomeric 
30μM pH 3.5 29402 Kd =0.90μM 
20μM pH 3.5 27481 Kd =1.3μM 
10μM pH 3.5 27425 Kd =0.82μM 
30μM pH 3.5+ 24 h 30269 Kd =1.29μM 
10μM pH 3.5+ 24 h 29969 Kd =1.29μM 
 
 
 
 
 
 
 
 
 
 
 
 a Low temperature was used with EDTA in order to avoid aggregation of the apo-monomer. 
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Figure 2.1: Size exclusion profiles of SOD1 at pH 7.8. A: The Calibration curve for the 
column obtained by using with globular protein standards at pH 7.8 was: log (Mw/1000) = 
4.56-1.526·(Ve/V0), where Mw is the molecular weight, Ve is the elution volume and V0 is the 
void volume (7.8 ml) of the column. SOD dimer (32kDa) and monomer (16kDa) are 
expected to elute at 15.5 and 17.0 ml respectively. B: Elution profile at 30μM: SOD1 elutes 
at 15.6 ml and is therefore dimeric. C: Immunostaining dot-blot profile of a 5nM SOD1 
sample after 24h of incubation. The peaks are Gaussian fits and correspond to the dimer and 
monomer respectively.   
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Figure 2.2: The dimer dissociation rates of SOD1 measured by SPR. 
A: Scheme for SPR measurement of SOD1 dimer dissociation rate. The rate constant at pH 3.5 
was calculated as 1.07×10-3 s-1 (B) and 3.13×10-5 s-1 at pH 7.8 (C), by fitting to a single 
exponential (dotted lines). The initial rate was followed in the pH range 2.5 to 12.7. D: For 
dissociation at pH 6.6, the rate constant was found to be 2.75×10-5 for bovine SOD1 and 
1.53×10-5 for human SOD1 (inset). E: The koff dependence on pH follows a titration curve with 
apparent pKa values of <2.5 and >12.5 at the acidic and basic ends of the pH range 
respectively. The lines have slopes of 1 and -1 (Eq. (2)).  
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Figure 2.3: Kinetics of aggregation of SOD1.  
 A: Aggregation at 30μM. SOD1 elution profiles were obtained at initial time and at 24 and 48 
hours by immunostaining dot-blots and UV-absorbance (solid lines). The profiles were 
normalized according to the fraction with the highest signal intensity and the monomer is more 
pronounced in the dot-blot elution profile. Aggregate is defined as the protein not eluting as 
dimer or monomer. B: Aggregation at 1μM. SOD1 was detected by immunobloting column 
fractions with Gaussian fits to the spot-intensity profile. C: Dot blots showing the elution 
profile at 30μM and 1μM before and after incubation. The fractions corresponding to the dimer 
and monomer at 30μM were diluted 30-fold to ensure linearity of signal. D: Time course of 
30μM SOD1 under dialysis conditions. The inset shows an image of the fibrilar product after 
21 h, obtained by negative staining electron microscopy. E: Fit of the model in Eq. (3), to the 
results obtained in D. The continuous curves are obtained from numerical simulations with the 
optimized rate constants. F: Predicted aggregation profiles with 30 and 1 μM using the 
parameters derived in E. The predicted fraction of aggregates in 30 and 1μM SOD1 after 48 h 
was 14% and 63% respectively, in close agreement with the experimentally measured values in 
A and B. 
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 igure 2.4: A scheme for the aggregation of SOD1.The more rapid aggregation at pH 3.5 
of Zn 
is the 
 
 
F
compared to pH 7.8 results from the increased Kd and koff values at pH 3.5. Exposure to low 
pH decreases the stability of SOD1 by 5.2 (=13.5-8.3) kcal/mol, while the dissociation 
barrier is reduced by approximately 2 kcal/mol. At pH 3.5, the dissociation free energy 
from SOD1 monomer, Mholo, is approximately 9.6 kcal/mol. In the minimal reaction 
sequence (Eq. (1)), the apo-monomers, Mapo, aggregate to form insoluble fibrils; this 
rate-limiting step for aggregation.  
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2.7 Supplementary Material 
 S1: SOD1 dimer dissociation equilibrium detected by Size Exclusion chromatography. 
   We confirmed that chemical modification by biotinylation of SOD1 does not affect its 
chromatographic or aggregation behavior (Fig. S1). 
S2: Dot blotting.  
Column fractions were analyzed by a dot-blot assay, with Avidin-AP, as previously 
described (1) and/or by immunostaining with anti-SOD1 antibody. At high (>1μM) protein 
concentrations, column fractions were diluted before blotting. For example, for a 30μM protein 
sample, 5μl of the column fraction (volume 250μl) was diluted into a volume of 300μl with the 
flow buffer, and 100μl of the diluted sample was blotted.  For immunostaining, the membrane 
was blocked for 1h with 5% BSA, then incubated for 1h with rabbit anti-SOD1 (Abcam, 
diluted 4000-fold in PBS-Tween, 3%BSA), followed by another hour of anti-rabbit-AP 
secondary antibody (Sigma, diluted 40,000-fold in PBS-Tween, 1%BSA). After two 10 min. 
washes with PBS-Tween (0.1%) and one 10 min. wash with Tris-buffered saline, the 
membrane was treated with Amersham Pharmacia ECF reagent for 5-20 mins. The resulting 
signal was detected by a phosphorimager and quantitated with the software ImageQuant®. 
Background correction was applied by local averaging of the spot intensities and was used as 
an estimate of the baseline.  It was found that while the relative intensity of spots on the dot-
blot for a given set of column fractions was highly reproducible, their absolute values varied 
from blot to blot. Therefore, for comparison of dot-blot elution profiles obtained at different 
time-points, the spot intensities were normalized by the maximum value detected on a given 
blot.   
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 S3: Estimation of rate constants and numerical integration. 
ere estimated from the data in    The constants mk
− , mk
+ and kagg in Eq. (1) and Eq. (3) w
Figs. 3A-3E. (i) mk
− : The changes in SOD1 dimer and monomer concentrations under dialysis 
conditions were used to estimate km
− = 1.2×10-4. As shown in Fig. 3E, in the initial 6300 s of the 
reaction (900 s to 7200 s), Dholo ecreased from 25 to 21μM. Based on Kd=1μM, Mholo is 
expected to concomitantly decrease from 5 to 4.5μM, whereas the observed total monomer 
(Mholo+Mapo) increased from 5 to 8.1μM. Therefore, Mapo=8.1-4.5=3.6μM was formed during 
this period from Mholo=5μM in a first-order process: 6 63.6 10 5 10 6300mk
− − −× = ⋅ × ⋅ . (ii) kagg: The 
apparent second-order rate constant for aggregation, k stimated from 
the observed 9μM aggregation in 10800 s (7200 s to 18000 s; Fig. 3E), from a nearly constant 
Mapo=3.6μM during this period: 6 6 29 10 0.5 (3.6 10 ) 10800aggk
− −
 d
agg =0.12×103 M-1 s-1, was e
× =
aggregation was m
⋅ ⋅ × ⋅ . (iii) mk + : The value 
k + =5.2×104 M-1s-1 was obtained on (Figs. 3A-B) that 
re rapid with 1μM SOD1 than with 30μM SOD1. With 1μM SOD1, there 
was 0.6μM aggregation in 24 h, and based on kagg=0.12×103 M-1 s-1, it was calculated that this 
occurred from an apo-monomer concentration Mapo=0.28μM. This means that the equilibrium 
composition of 1μM SOD1 was Dholo=0.39μM, Mholo=0.33μM, and Mapo=0.28μM, yielding an 
equilibrium constant for Zn-loss 
m by taking into account the observati
o
apo
m
holo
M Zn
K
M
⋅= =2.3×10-7 M; this value and k − = 1.2 ×10-4 s-1 
Material S3).   
The dif
m
were used to estimate . These values were used for numerical simu entary 
ferential master equations corresponding to the aggregation reaction under 
dialysis conditions are:  
mk
+ lation (Supplem
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where the symbols are as defined in Eq. (3). In the absence of dialysis, the rate of loss of 
Zn, . These equations were solved numerically and a time step of 10-2 was sufficient for 
der aggregation-promoting conditions is reversible.  
The reversibility of dimer dissociation at pH 3.5 was evaluated by SEC. A SOD1 
(Fig. 
S2B, b
We propose that the salt-linkage governing dimer dissociation rate is between Arg79 
onding to hSOD1) based on the observations that: (i) a 
structure-based alignment of 76 SOD1 sequences obtained from the FSSP database (2) showed 
0Zn
• =
the convergence of the solution. 
 
S4: SOD1 dimer dissociation un
sample at 6.5μM eluted as a mixture of approximately 73% dimer and 27% monomer 
lack curve). When this sample was concentrated approximately 4-fold (final 
concentration 24.1μM), it eluted as a mixture of approximately 87% dimer and 13% monomer 
(Fig. S2B, blue curve). The fraction of protein eluting as monomer reduced 14% upon 
concentration, showing that the dimer was re-formed from the monomer. Thus, SOD1 dimer 
dissociation at pH 3.5 is reversible.   
 
S5: Arg79-Asp101 salt-linkage. 
and Asp101 (numbering corresp
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that thi
logy of the Cell 12, 430A. 
 2.  Holm, L. & Sander, C. (1996) Nucl. Acids. Res. 24, 206-209. 
r Biology 334, 
515-525. 
 4.  Elam, J. S., Taylor, A. B., Strange, R., Antonyuk, S., Doucette, P. A., Rodriguez, J. A., 
Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O. et al. (2003) Nature 
Structural Biology 10, 461-467. 
 
s salt-linkage Arg79-Asp101 is 100% evolutionarily conserved in the eukaryotic SOD1 
fold (Fig. S3), while being absent in prokaryotic SOD1, which has a structurally distinct dimer 
interface,  (ii) Arg79 and Asp101 are located in the Zn-loop and an edge-strand of the β-barrel 
of SOD1 respectively and their interaction is crucial for the stability and the folding kinetics of 
SOD1 (3). It is likely that the titration of the Arg79-Asp101 salt-linkage promotes greater 
disorder in the Zn-binding region, thereby disrupting its interactions with the β-barrel and the 
disorder is propagated in the molecule leading to dimer dissociation. The mutation of Asp101 
to Gly or Asn is implicated in FALS (http://www.alsod.org) and the disordered Zn-loop of 
metal-deficient SOD1 has previously been found to be a site for SOD1 oligomerization (4). 
Therefore, we propose that salt-linkages in SOD1 are crucial for maintaining SOD1 dimer 
structural integrity, and that the disruption of these charge-charge interactions promotes 
misfolding into an aggregation-competent state.  
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igure S1: Size exclusion profiles of SOD1 and biotinylated SOD1 A: Size exclusion 
rofiles of SOD1 sample (30μM, pH 3.5) a 1:4 mixture of the biontinylated and unmodified 
rotein (bSOD1-SOD1), obtained by UV-absorbance and two dot-blotting methods: antibody 
 SOD1, and biotin detection; a typical dot-blot for this sample, stained by anti-SOD1 
ntibody, is shown in the inset. B: Size exclusion profiles of pure bSOD1 and a bSOD1-
OD1 under identical conditions (5μM, pH 3.5, 20 minute incubation) showing that 
iotinylated SOD1 has identical chromatographic properties as the unmodified SOD1. 
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as not 
available. B. The reversibility of SOD1 dimer dissociation.  The elution profiles correspond 
to 6.5μM SOD1 (solid black curve), and 24.1μM SOD1 (solid blue curve) which was 
obtained by concentrating the 6.5μM sample. The fraction of monomer reduced upon 
concentration, indicating that dimer was formed from the monomer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2: A. Column calibration at pH 3.5. 30μM SOD1 at pH 3.5 eluted at 16.5 ml and 
17.3 ml, before and after incubation with 10mM EDTA. These samples were known to be 
primarily dimeric and primarily monomeric respectively, from AUC (Table I). Calibration at 
pH 3.5 was done as above because a set of globular protein standards at pH 3.5 w
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76 eukaryotic SOD1 sequences obtained from the FSSP database showing the conserved salt-
yellow and grey backgrounds, respectively.  
 
 
 
 
 
 
Figure S3: Sequence alignment of SOD1 sequences. A portion of the sequence alignment of 
linkage between Arg79 and Asp101. Positions with 100% and >50% conservation have 
 
 60
  
 
CHAPTER 3 
 
ESTIMATION OF THE EFFECT OF MUTATION ON SOD1 STABILITY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was submitted as a part of a manuscript to The Journal of Biological Chemistry, 
and is formatted in the journal style. 
3.1 Abstract 
Mutations in the dimeric enzyme Cu, Zn superoxide dismutase (SOD1) leading to its 
aggregation are implicated in the toxicity in Familial Amyotrophic Lateral Sclerosis (FALS). 
We and others have previously shown that aggregation occurs by a pathway involving dimer 
dissociation, metal-loss from monomers and multimeric assembly of apo-SOD1 monomers. 
We postulate that FALS mutations cause enhanced aggregation by affecting one or more 
steps in the pathway, and computationally test this postulate for 75 known mis-sense FALS 
mutants of SOD1. Based on an extensive thermodynamic analysis of the stability of apo-
dimer and apo-monomer forms of these mutants, we classify the mutations into the following 
groups: 70 out of 75 mutations in SOD1 lead to (i) decreased dimer stability, and/or (ii) 
increased dimer dissociation, compared to wild type, and 4 mutations lead to (iii) decreased 
monomer stability compared to wild type. Our results suggest that enhanced aggregation of 
mutant SOD1 in FALS occurs due to an increased population of mutant SOD1 apo-
monomers compared to wild type. 
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3.2 Introduction 
Point mutations in the cytoplasmic homodimeric enzyme Cu, Zn superoxide 
dismutase have been identified as the primary cause of approximately 20% cases of the 
disease Familial ALS (1, 2). More than 90 distinct and structurally diverse FALS mutations 
are known (3). The sporadic form of ALS (SALS), which is not associated with any heritable 
defect, constitutes 90% of all ALS cases and is symptomatically identical to SOD1-linked 
FALS. It is likely that understanding the molecular basis of SOD1-linked FALS will also 
provide insights for understanding SALS.  
There is increasing evidence that the FALS does not arise due to a reduction in 
mutant SOD1 activity, and the motor neuron-specific toxic gain-of-function of the mutants is 
associated with intracellular aggregation, trafficking and/or degradation of misfolded SOD1. 
The mutation-induced destabilization of the native state of SOD1 may lead to a relatively 
higher population of misfolded or partially folded protein molecules that may (i) assemble 
into structured fibrils, (ii) interfere with mitochondrial transport, and/or (iii) saturate the 
protein degradation machinery, thereby leading to toxicity. Thus, the misfolding-induced 
aggregation of mutant SOD1 leading to the appearance of inclusion bodies is correlated with 
toxicity, and the inhibition of aggregation by over-expression of chaperones leads to 
increased cell viability.   
 The molecular mechanism of misfolding and aggregation of SOD1 is not well-
understood. We and others have previously provided evidence that the aggregation of SOD1 
occurs via a pathway involving dissociation of the dimer and metal-loss, followed by 
multimeric assembly of the apo-monomeric SOD1. Mutations are likely to lead to enhanced 
aggregation by affecting one or more steps in the pathway. In vivo, FALS mutant SOD1s 
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have decreased solubility and half-life compared to wild type, indicating that they form less 
stable dimers. Also, SOD1 solvent denaturation occurs via a monomeric intermediate (4, 5), 
this monomeric intermediate was also detected in the oxidation-induced aggregation of wild 
type SOD1, and preventing dimer dissociation by engineering an inter-subunit disulfide bond 
abolished the aggregation of the A4V FALS SOD1 mutant. Evidence that the apo-form of 
mutant SOD1 is involved in FALS-linked pathology is (i) the in vitro stability of the mutant 
apo-dimers was correlated with the mean survival time of FALS patients carrying the 
mutation (6), (ii) treatment of ALS patients with chelators such as penicillamine, EDTA, and 
thioctic acid was found to sometimes accelerate the disease, (iii) the in vitro aggregation rate 
of A4V and H43R SOD1 was enhanced in the presence of EDTA, and (iii) some recombinant 
mutant SOD1s were found to have smaller metal content and stability than wild type. Taken 
together, these studies suggest a general framework for the effect of mutation on FALS-
linked aggregation of SOD1, in which mutations cause enhanced aggregation by decreasing 
apo-SOD1 dimer and monomer stability and/or increasing dimer dissociation, compared to 
the wild type. An exhaustive analysis of FALS mutants is required to test this general 
framework. In spite of the recent significant advances(6-8), the challenging task of 
uncovering the effect of mutation on dimer-monomer equilibrium of apo-SOD1 is likely to 
remain experimentally unfeasible on the large scale required to ascertain the generality of the 
suggested framework.     
Here, we perform exhaustive in silico mutagenesis of SOD1 and evaluate the dimer 
stabilities and dissociation propensities for 75 FALS-associated point mutants in SOD1 using 
molecular dynamic (MD) simulations and an implicit-solvation based scoring function. The 
effect of mutation on SOD1 dimer stability is evaluated as the difference in the calculated 
 64
conformational free energy between mutant and wild type SOD1, and the dissociation 
propensity is evaluated as the difference between the conformational free energies of the 
SOD1 dimer and two monomers. Based on these calculations, we classify mutants into four 
groups depending upon how mutation affects dimer stability and dimer dissociation. We find 
that 70 out of 75 FALS mutants decrease dimer stability and/or increase dimer dissociation, 
while four of the remaining five lead to decreased monomer stability, suggesting that FALS-
linked aggregation may be mediated by the apo-state of mutant SOD1. 
 
3.3 Methods 
Generating mutant SOD1 structures 
The available structures of mutant SOD1 molecules show remarkable similarity and 
are almost identical to the wild-type (RMSD≤1.25Å); the difference between wild-type and 
mutant SOD1 molecules is largely due to side-chain packing(9-12). Thus, we generate 
mutant structures by in silico mutation using the package Sybyl (Tripos Inc.) and the wild-
type SOD1 structure (PDB accession code: 1SPD) keeping the backbone co-ordinates fixed 
and replacing the appropriate side-chains. This is followed by 200 steps of steepest descent 
energy minimization in the vicinity of mutation to remove steric clashes, while the rest of the 
protein is rigid. 
 
Estimating Conformational Free Energy 
We determine the conformational free energy of a structure by the Explicit Solvent 
Implicit Solvent (ES/IS) method as described by Vorobjev et al.(13-16). Applied to SOD1, 
the method consists of a short molecular dynamics simulation (196 ps) of SOD1 (wild-type 
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or mutant) with explicit solvent (ES) to obtain microstates of the system. The conformational 
free energy of the SOD1 structure is written as a sum of six contributions: 
 , , ,m sh m coul conf cav s vdw pol
G U U TS G G G= + − + + + , (1) 
where K  denotes average over the MD trajectory,  is the intra-protein conformational 
energy which can be written as the sum of short-range, , and coulombic, , terms, 
 is the determined conformational entropy, and T is the absolute temperature. The 
solvation free energy, 
mU
,m shU ,m coulU
confS
solG , is a sum of the last three terms : the free energy of creating the 
empty protein-sized cavity in the solvent , the free energy of inserting the protein 
molecule into the protein-sized cavity 
cavG
,s vdwG , and the free energy of solvent polarization . polG
mU  and ,s vdwG  is accumulated as averages during the molecular dynamics simulation. 
 is calculated from the position covariance matrix of the protein during the dynamics 
trajectory in the quasi-harmonic approximation. and  is calculated with models in 
which the solvent is treated implicitly, as described by Vorobjev and Hermans(16). Thus, this 
gives a physically realistic energy function that effectively discriminates between wild-type 
and mutant SOD1 structures. 
confS
cavG polG
Estimation of the effect of a mutation on SOD1 stability requires knowledge of the 
free energy of the reference (unfolded) states of the wild type  and mutant  
molecules. The stability of the wild type or a mutant SOD1 is then determined by the 
following: 
WT
UG
X
UG
 
WT WT WT
N UG G GΔ = − ,                                                                    (2) 
and 
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X X
N UG G GΔ = − X .                                                                                      (3) 
We thus determine the change in SOD1 stability due to a mutation: 
 ( ) ( )X X WT WT X WT XN N U UG G G G G G GΔΔ = Δ − Δ = − + + −                                             (4)
 
We assume that the reference (unfolded) state can be modeled as a fully solvated chain. We 
determine these  by computing the conformational free energy GU of the small peptides Ace-
(Ala)2-Gly-Ala-x-Ala-Gly-(Ala)2-NMet using the ES/IS method, where x denotes any of 20 
amino acids (Supplementary material Table SI). Thus, we calculate the conformational free 
energy difference between wild-type and mutant SOD1 for monomeric , dimeric 
. 
X
mGΔΔ
X
dGΔΔ
The dimer dissociation is characterized by comparing the free energies of monomers 
and the dimer:  
( 2dissoc dim monoG G GΔ ≈ − − )         (5) 
where is the free energy of dimer dissociation,  and are the ES/IS free 
energies of the dimer and monomer respectively. 
dissocGΔ dimG monoG
All molecular dynamic (MD) calculations are performed using the Sigma molecular 
dynamics program(17) and the CEDAR force field using a protocol involving relaxation and 
production, as described elsewhere(18)  
 
Scaling of free energy values and error-bars 
We scale the free-energy values obtained according to experimental values(5) of the 
measured free energy of unfolding of SOD1. The free energy of dimer dissociation has been 
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measured to be 12.5 kcal/mol (5) for the wild-type. We estimate it to be 93.8 kcal/mol from 
our calculations. This difference is likely to arise due to (i) systematic errors in the force-
field, (ii) limited sampling (iii) the difficulties in modeling the unfolded state. The 
differences in the stabilities are relative to the wild type and we expect that these systematic 
errors will be compensated. Therefore, we scale the calculated free energies by a factor of 
12.5/93.8=0.13. The uncertainty (error-bar) in the estimated free energy is ideally obtained 
by performing multiple simulations and calculating the dispersion of the average values thus 
obtained. For the D90A mutant, the average free energies obtained in two independent 
simulations are -7353.5 and -7332.0 kcal/mol (difference = 21.5 kcal/mol). The (unscaled) 
difference between the D90A mutant and wild type is 175.8 kcal/mol, and therefore we 
estimate the values reported have an intrinsic uncertainty of approximately 15%.  
 
3.4 Results & Discussion 
MD trajectories 
Molecular dynamic simulations of mutant SOD1 structures generated from the wild 
type are performed for 196 ps and snap shots are recorded every 2 ps yielding a total of 98 
snapshots, averaged over which the conformational free energy of the mutant is calculated. 
All the SOD1 MD trajectories are stable in our simulations and sample conformations that 
are near-native (RMSD < 2.5 Ǻ). For four representative mutant dimers and monomers, 
RMSD versus time is shown in Fig 1(a). We find that the monomers have a larger RMSD, 
which is expected since monomerization exposes a large hydrophobic patch on the surface of 
SOD1 to the solvent. However, both the dimers and monomers are stable on the time-scale of 
the simulation (200 ps). This is in accord with the observation that the SOD1 unfolding 
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occurs via a monomeric intermediate, and the stability of the monomer is ~4 kcal/mol, thus 
the monomers are expected to be stable on a picosecond timescale. 
 
Conformational free energy calculations and classification of mutants 
Based on a free-energy cycle thermodynamic analysis (Methods) we estimate the 
change in free energy change (ΔΔGdim= - ) for unfolding between the mutant and 
Wild-type dimer structures. ΔΔG
dim
mutGΔ dimWTGΔ
dim is a measure of the tendency of the mutant dimer to 
unfold relative to the wild type. The effect of mutation on the stability can be construed as 
arising from both effects on intra-protein interactions, and protein-water interactions 
(solvation). We find that in mutations such as D90A and G93A (Fig. 1(b)), the destabilizing 
effect of mutation is due to the decreased solvation energy relative to wild type(shown as red 
curves in Fig 1(b)); the intra-protein interactions (in vacuum) are not significantly affected. 
For other mutants such as H43R and I112T, which stabilize the dimer, the intra-protein 
interaction energy is higher than the wild type, whereas the solvation free energy is lower or 
of similar magnitude (Fig. 1(b)). This is in accord with the experimental finding that SOD1 
FALS mutants have lower solubility in vivo than the wild type protein. We find that the 
differences between mutant and wild type dimers are statistically significant and we obtain 
distinct distributions in the Kolomogorov-Smirnov test (Fig. 1(c)).  
We evaluate the tendency of the mutant SOD1 to dissociate into its monomeric 
subunits, which we estimate by change in dissociation free energy change (ΔΔGdissoc) 
between mutant and wild type. The more negative this value, the higher the dissociation 
tendency and the higher is the chance that the mutant forms the monomeric state. This apo-
monomer, in turn, is likely to form misfolded/unfolded structures that aggregate.  Thus, we 
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characterize each mutant by its ΔΔGdim and ΔΔGdissoc values (Fig. 1(d)) and classify the 
mutants into four different classes based on their effect on dimer stability and dissociation 
relative to wild type (Fig. 1(d) and  Supplementary material Table SII): Class I (lower dimer 
stability, increased dimer dissociation, e.g. D90A), Class II (higher dimer stability, increased 
dimer dissociation e.g. H43R),  Class III (lower dimer stability, decreased dimer dissociation 
e.g. G93A), and Class IV (higher dimer stability, decreased dimer dissociation e.g. I112T), 
mutants respectively. In total, all but 15 out of the 75 mutants destabilize the dimer, while all 
but 10 are more prone to dissociate than the wild type. 5 of the 75 mutants marginally 
stabilize the dimer as well as increase dimer dissociation propensity, but the monomers of 
these mutants have lower stability than the wild type monomer. Therefore, we conclude that 
FALS mutations in SOD1 may induce aggregation by one or more of the following: (i) 
decreasing dimer stability, (ii) decreasing monomer stability, and (iii) increasing dimer 
dissociation propensity. A mutation belonging to each class, affects the dimer-monomer 
equilibrium such that the overall equilibrium is shifted towards the apo-monomer, and thus 
increases the population of the aggregation-prone species. 
 
Comparison with experiments 
We compare our calculations with the experiments of Rodriguez et al. (Fig. 2) and 
Lindeberg et al. Rodriguez et al. report 4 peaks in the DSC scans of the SOD1 mutants, and 
the peak with the lowest melting temperature (Tm) corresponds to the metal-free SOD1 
species.  We compare trends in the calculated ΔΔGdim values with the ΔTm values of the 
corresponding 15 FALS mutants and find excellent agreement. We correctly identify the 
mutations that do not have any effect on stability (H48Q), as well as those which have a large 
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effect on stability, thus covering a range of stability values. Similarly, for the data of 
Lindeberg et al., we find good qualitative agreement between the estimated free energy 
values, and the change in mid-point concentration of urea, for the melting curve obtained in 
their experiments. This indicates that the simulation is successful in estimating the 
thermodynamic effect of mutation. Our simulations rely on the assumption that there is no 
major structure change upon mutation, and in accord with this assumption, we find that the 
simulated structures are within 1.8 Å RMSD, of the experimentally determined FALS 
mutants (Fig. 3). Thus, our simulations agree with experimental data in terms of both the 
thermodynamic and the structural effects of mutation.    
 
3.5 Conclusions 
We demonstrate that the effect of mutations on SOD1 can be characterized in terms 
of the relative stabilities and dimer dissociation constants of mutant proteins compared to 
wild type. We characterize all the known SOD1 point mutants into classes based on this 
scheme. We find that 70 out of 75 mutants modulate aggregation propensity by affecting the 
stability and/or dimer dissociation in a way that makes either the mutant dimer less stable 
and/or more prone to dissociate. A graph theoretic analysis of SOD1 interactions reveals that 
perturbations in the protein caused by mutations are likely to be effectively transmitted to 
both the dimer interface and metal-coordinating centers. Thus, dimer dissociation and/or 
metal-loss may provide the intervention points to prevent the aggregation and consequent 
toxicity of SOD1.  
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 (d) 
Figure 3.1 Conformational free energies of 75 FALS point mutants. (a) The Cα-RMSD 
vs. time for four representative mutant trajectories. The dimer is in black and monomer in 
red. (d) The internal energy, solvation free energy and total conformational free energy for 
the four mutants in (a). For comparison, the wild type energies are shown in red. (c) 
Distributions of free energy values obtained in the Kolmogorov-Smirnov test, showing that 
the differences observed between the wild type (solid) and mutant (dashed) are significant. 
The differences between mutant and wild type dimers are statistically significant 42.  (d) The 
effect of mutation on SOD1 dimer stability and dissociation for all 75 FALS mutants 
considered in this study. 70 out of 75 mutations lower dimer stability and/or increase dimer 
dissociation, whereas 5 out of 75 lead to marginally higher stability and decreased dimer 
dissociation. 
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Figure 3.2 Comparison of calculated free energies with experiments (a) Comparison of 
calculated ΔΔG with change in melting temperature (ΔTm) for 15 FALS mutants. ΔTm is 
obtained from Rodriguez et al 43. (b) Comparison of calculated ΔΔG with change in mid-
point Urea concentration during solvent denaturation (ΔMPapo) for 4 FALS mutants. ΔMPapo 
is obtained from Lindberg et al 26.          
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Figure 3.3 Superimposition of SOD1 structures. Structural identity is seen between solved 
crystal structures of A4V (1UXM, pink) and the modeled structure (yellow). The site of 
mutation, Ala4, is shown in green. 
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3.7 Supplementary Material 
Table 3.S.1 Free energies of the unfolded state Free energies of peptides 
(Ace-(Ala)2-Gly-Ala-x-Ala-Gly-(Ala)2-NMet ) relative to x=Gly 
x Um, sh Um, coul Gcav Gs,vdw Gpol Gsolv TSconf G 
Ala 31 0.8 43.2 -35.2 -39.3 -31.3 -18.70 3.76 
Arg 39 -14 49.4 -37.7 -96.3 -84.7 -19.77 -57.50 
Asn 33.1 -40.9 45.5 -35.2 -46.2 -35.9 -18.10 -39.92 
Asp 58 -9.7 46.1 -29.1 -122.8 -105.8 -21.42 -56.94 
Cys 55.5 -2.5 45.5 -37 -39 -30.5 -18.63 25.836 
Gln 35.1 -36.4 47.4 -35.9 -50.9 -39.4 -18.92 -37.65 
Glu 34.6 -5.4 45.8 -29.7 -127.5 -111.4 -23.77 -84.00 
Gly 31.6 -2.8 43.3 -36 -38.2 -30.9 -19.77 0 
His 32.9 -17.3 46.8 -38.2 -46.2 -37.5 -19.03 -18.95 
Ile 38.5 -5.2 45.8 -38.3 -34.9 -27.4 -18.17 9.69 
Leu 36.6 -5.6 46.6 -38.9 -34.3 -26.6 -20.39 5.97 
Lys 67 1 48.9 -31.1 -133.2 -115.3 -20.50 -45.83 
Met 34 -6.1 47.8 -40.2 -34.5 -26.9 -19.32 3.64 
Phe 35 -0.3 47.1 -41.5 -38.9 -33.2 -19.61 3.86 
Pro 44.4 -0.6 45.7 -38.6 -38.5 -31.4 -22.36 12.0 
Ser 32.7 -3.7 44.1 -32.8 -46.5 -35.2 -21.37 -5.60 
Thr 35 -7.5 45.9 -36 -43.3 -33.4 -22.60 -6.53 
Trp 36.2 -2.9 50.1 -44.9 -41.4 -36.2 -19.38 -0.31 
Tyr 35.2 -9.9 48.7 -40.1 -41 -32.3 -19.31 -4.34 
Val 62.1 -4 46.3 -36.9 -37.4 -28 -20.09 31.97 
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Table 3.S.2: Conformational Free Energies of SOD1 mutants   
Res(wild type) Pos Res(Mut) ΔΔG(dim-s) ΔΔG(dissoc-s) 
Class I     
Wild type   0 0 
A 4 S 9.737 -2.73 
A 4 T 11.128 -3.068 
A 4 V 13.468 -10.985 
V 7 E 9.529 -29.471 
L 8 V 2.73 -4.94 
G 12 R 6.201 -17.446 
V 14 G 14.69 -9.126 
V 14 M 2.197 5.005 
G 16 A 9.373 -18.72 
G 16 S 2.236 10.816 
E 21 G 11.323 -4.199 
G 37 R 6.461 -19.994 
L 38 R 1.924 -14.287 
L 38 V 7.189 -4.953 
G 41 S 6.435 -12.311 
H 46 R 3.965 -16.003 
H 48 Q 0.754 -10.66 
E 49 K 7.397 -22.932 
N 65 S 13.286 -4.134 
D 76 V 20.007 -9.204 
D 76 Y 24.908 -8.723 
L 84 F 4.329 -13.546 
L 84 V 15.535 -26.299 
G 85 R 13.182 -4.719 
N 86 S 14.833 -8.931 
A 89 V 13.078 -14.027 
D 90 A 22.854 -13.936 
D 90 V 23.179 -21.294 
G 93 C 4.914 -2.288 
G 93 R 5.629 -2.756 
G 93 V 13.676 -11.258 
A 95 T 5.837 -6.071 
D 96 N 19.565 -1.976 
D 101 G 26.559 -8.268 
D 101 N 24.635 -24.986 
S 105 L 4.823 -7.137 
L 106 V 7.449 -7.085 
G 108 V 5.252 -6.422 
D 109 N 21.346 -24.973 
I 112 M 8.359 -22.802 
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I 113 F 3.315 -5.915 
I 113 T 2.652 -11.336 
G 114 A 12.948 -15.873 
R 115 G 20.943 -11.544 
D 124 V 16.198 -15.509 
D 125 H 15.21 -16.77 
L 126 S 5.564 -17.524 
S 134 N 2.262 0.39 
L 144 F 1.183 -4.472 
A 145 G 8.268 -10.517 
A 145 T 24.622 -19.084 
C 146 R 7.748 -22.191 
V 148 G 5.733 -4.147 
V 148 I 5.161 -16.146 
I 149 T 1.703 -7.189 
Res(wild type) Pos Res(Mut) ΔΔG(dim-s) ΔΔG(dissoc-s) 
Class II     
L 8 Q -0.611 -2.73 
G 41 D -1.001 -18.564 
H 43 R -6.812 -4.602 
L 67 R -3.419 -5.694 
H 80 R -4.732 -5.59 
V 97 M -0.416 -10.79 
I 104 F -1.131 -0.949 
N 139 K -2.327 -4.966 
L 144 S -2.288 -10.426 
Res(wild type) Pos Res(Mut) ΔΔG(dim-s) ΔΔG(dissoc-s) 
Class III     
G 10 V 5.941 7.995 
G 72 S 8.684 1.378 
G 93 A 9.906 2.795 
E 100 G 24.726 8.736 
I 151 T 0.975 9.633 
     
Res(wild type) Pos Res(Mut) ΔΔG(dim-s) ΔΔG(dissoc-s) 
Class IV     
E 21 K -4.55 7.163 
G 93 D -9.815 7.358 
G 93 S -2.561 8.775 
E 100 K -9.737 20.358 
I 112 T -14.274 21.086 
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CHAPTER 4 
 
SEQUENCE AND STRUCTURAL DETERMINANTS OF SOD1 AGGREGATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as a manuscript in the Proteins: Structure, Function, 
Bioinformatics and is formatted in the journal style. 
4.1 Abstract 
Diverse point mutations in the enzyme Cu, Zn superoxide dismutase (SOD1) are linked to its 
aggregation in the familial form of the disease Amyotrophic Lateral Sclerosis. The disease-
associated mutations are known to destabilize the protein, but the structural basis of the 
aggregation of the destabilized protein and the structure of aggregates are not well 
understood. Here, we investigate in silico the sequence and structural determinants of SOD1 
aggregation: (a) we identify sequence fragments in SOD1 that have a high aggregation 
propensity, using only the sequence of SOD1, and (b) we perform molecular dynamics 
simulations of the SOD1 dimer folding and misfolding. In both cases, we identify identical 
regions of the protein as having high propensity to form intermolecular interactions. These 
regions correspond to the two cross-over loops and two β-strands in the Greek-key native 
fold of SOD1. Our results suggest that the high aggregation propensity of mutant SOD1 may 
result from a synergy of two factors: the presence of highly amyloidogenic sequence 
fragments (“hot-spots”), and the presence of these fragments in regions of the protein that are 
structurally most likely to form inter-molecular contacts under destabilizing conditions. 
Therefore, we postulate that the balance between the self-association of aggregation-prone 
sequences and the specific structural context of these sequences in the native state determines 
the aggregation propensity of proteins.    
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4.2 Introduction 
The formation of protein aggregates is associated with cytotoxicity in more than 20 
diverse human pathologies including amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s 
and prion diseases1-3. Compelling experimental evidence suggests that specific, contiguous 
sequence fragments in proteins are responsible for nucleating the conversion of native 
proteins to amyloids4,5. Peptides corresponding to sequence fragments of amyloid-forming 
polypeptides such as the amyloid β peptide, yeast and human prion proteins, calcitonin, 
insulin, transthyretin, β2 microglobulin, and tau protein, have been shown to form amyloid 
fibrils in vitro (Ref.6 and references therein). Mutations found to diminish (or enhance) the 
aggregation of isolated peptide fragments also diminish (or enhance) the aggregation of the 
entire polypeptide chains7. Furthermore, the insertion of amyloidogenic fragments of human 
β2-microglobulin and the PI-SH3 domain into their respective non-aggregating homologs, 
mouse β2-microglobulin and the Src-SH3 domain respectively, causes the engineered 
homologs to readily aggregate, suggesting that the amyloidogenic sequence fragments may 
be necessary and sufficient for aggregation 8,9.  
It is widely believed that protein aggregation requires partial or complete unfolding of 
the native state6,10. Unfolding may result in the exposure of amyloidogenic sequence 
fragments which, in turn, leads to oligomerization. It has been argued that natural selection 
has led to amyloidogenic sequence fragments being protected in the native states of protein 
structures found in nature 1,11. Therefore, the ability of amyloidogenic sequences to induce 
aggregation is modulated by the global stability and the structure of proteins. In the 
aggregated state, these amyloidogenic sequence fragments have been found to be arranged as 
parallel β-strands in a sheet in which the amino acid sequence is in exact register. Protein 
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aggregation propensity is then, the interplay between the stability of the native structure, 
which prevents protein aggregation, and the self-association of amyloidogenic sequence 
fragments from different polypeptide chains into in-register structures, which promotes 
protein aggregation. Consequently, mutations associated with familial forms of 
neurodegenerative diseases may promote aggregation by either destabilizing the native state 
and/or increasing the self association propensities of exposed sequence fragments under 
destabilizing conditions. However, the molecular basis underlying protein aggregation and 
the effect of mutation on aggregation is not well-understood. To understand the physical 
basis of protein aggregation, we address the following questions: (i) which sequence 
fragments in a protein have high amyloidogenicity, and (ii) how is the association of these 
fragments modulated by the native structure and stability of the protein during its 
misfolding?  
To address these questions, we develop an in silico method to identify sequence 
fragments and structural regions that have high amyloidogenic propensity. We apply our 
method for determination of the sequence and structural aggregation propensities to the 
homodimeric enzyme Cu, Zn superoxide dismutase (SOD1). The mutation-induced 
aggregation of SOD1 has been implicated in the familial form of the disease amyotrophic 
lateral sclerosis (FALS)3. In its native state, each SOD1 monomer adopts the classic Greek-
key fold 12 – two β-sheets, composed of four β-stands each, and connected by two cross-over 
loops (Fig. 1(a)). More than 90 FALS-associated point-mutations are scattered throughout 
the structure of SOD1. A subset of these mutations is known to destabilize SOD1, both in 
vitro and in vivo13-15. It was previously demonstrated that in vitro SOD1 aggregation involves 
dissociation of the dimer, the loss of metal ions, and assembly of misfolded apo-monomers 
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into aggregates 16-18. The first step in the SOD1 aggregation possibly occurs via the non-
native dimerization of apo-monomers. The domain swapping mechanism 19-21 was suggested 
as a plausible mechanism for the formation of aberrant dimers22. Domain swapping (Fig. 
1(b)) is known to occur in amyloid fibril-forming proteins22,23.  
To determine sequence determinants of SOD1 aggregation, we identify sequence 
fragments that have a high tendency to self-associate into in-register β-strands, based purely 
on the sequence of SOD1. To determine the structural determinants of SOD1 aggregation, we 
study the folding and misfolding of the SOD1 dimer, based purely on the geometry of the 
dimer. Both these complementary approaches identify the same amyloidogenic regions in the 
protein – corresponding to two β-strands and to the two cross-over loops in SOD1 (Fig. 1(a)) 
– indicating that the high aggregation propensity of SOD1 is a due to both amyloidogenic 
sequence “hot-spots” and their  structural context. Our results suggest that aggregation of 
proteins requires both highly amyloidogenic sequence fragments and the presence of these 
fragments in specific aggregation-prone structural elements of the protein. 
 
4.3 Methods 
Preparation of peptide fragment structures  
We obtain a total of 147 fragments of seven consecutive residues for the 153 residues in 
a SOD1 monomer. For each fragment, we construct the following five conformations: 
monomer, β-strand dimer (parallel and anti-parallel), and β-strand tetramer (parallel and anti-
parallel). For constructing the dimer and tetramer, we mount the sequence of each fragment 
on idealized parallel and anti-parallel β-sheet structures using the package SCWRL. These 
template structures are constructed using the packages MOE (Schröedinger Inc.) and have 
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ideal parallel or anti-parallel β-sheet geometry. We cap the strands at the N- and C-termini by 
acetyl and N-methyl groups respectively, using the package SYBYL (Tripos, St. Louis, MO). 
For constructing the monomer, the sequence of each fragment is mounted on a random coil 
conformation generated using SYBYL. 
 
MD simulations and free energy calculations 
For each fragment, we perform all-atom MD simulations of each conformation and 
calculate the conformational free energy. For each MD trajectory, the simulation time is 496 
picoseconds (ps) in explicit solvent (SPC water model 54) using the SigmaX2.2 MD program. 
Conformational free energy is calculated using the ES/IS method 55 for every snapshot. 
Following the procedure for free energy calculations described in Ref. 56, each MD 
simulation consists of relaxation of the peptide(s) and water, followed by a production run of 
496 picoseconds, where snapshots are collected at intervals of 1 ps. The conformational free 
energy is 
 ,       (1) conf solvG E TS G=< > − + < Δ >
where <…> represents the average over the MD trajectory, E is the internal energy of the 
peptides in vacuum, T is the absolute temperature (set to 300 K), Sconf is the configurational 
entropy, and ΔGsolv is the solvation free energy, calculated using an implicit solvation model 
described by Vorobjev and Hermans 57.  
For each fragment i, the difference between the average conformational free energies of 
the dimer and two times that of the monomer, , represents the free energy of 
dimerization:  
i
DGΔ
( ) ( ) ( )iMiDiMiDiD GGGGG 22 42 σσ ×+±×−=Δ ,    (2) 
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where iDG , 
i
MG , ( )iDG2σ  and ( )iMG2σ  are the averages and standard deviations of the 
conformational free energies of the dimer and the corresponding monomer, respectively. The 
free energy of tetramerization  is similarly the difference between the average 
conformational free energies of the tetramer and four times that of the monomer. The 
values  and  are measures of the amyloidogenicity of a given sequence fragment. 
i
TGΔ
i
DGΔ iTGΔ
To calculate the per residue amyloidogenicity for the protein sequence, we assume that 
each residue in a given fragment contributes equally to its calculated amyloidogenicity. The 
amyloidogenicity of any residue is its average contribution to the amyloidogenicity of all 
fragments that include this residue. This averaging ensures that the amyloidogenicity of a 
given residue is modulated by its sequence neighbors. The amyloidogenicity, , of the 
residue j is  
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,      (3) 
where the sum of  is over all dimer fragments, n (1≤n≤7), that include a given residue j, 
and the second term in Eq. (3) is the standard deviation. We calculate a similar per-residue 
amyloidogenicity profile for the tetramer structures.  
i
DGΔ
 
Discrete molecular dynamics simulations 
We use a scaled Gō-model, based on the interaction scheme developed by Khare et al. 
36, to model the folding and misfolding of the SOD1 dimer. We assign pair-wise, square-well 
interaction potentials between beads in a simplified polypeptide model according to contacts 
formed in the native state, i.e. two residues are said to be in contact if any of their atoms 
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(excluding hydrogen) are within 4.5 Å in the native state crystal structure (Protein DataBank 
accession code 1SPD). This procedure results in a matrix of contacts Δij, in which each 
element is equal to 1 if residues i and j are in contact, and 0 otherwise (Fig. 1(c)). The contact 
map includes interactions between monomers at the dimer interface. In addition, we allow 
the formation of both intra- and inter-monomer contacts, for example, Ile 18 from chain A, 
which forms a native contact with Ala 4 from chain A, can also interact analogously with Ala 
4 from chain B. Thus, the effective Gō-like energy of the model protein is 
 ,   (4) dim domain-swap *
, , , *
ij ik ij
i j i k i j
E ε ε α ε= ⋅ Δ + ⋅ Δ + ⋅ ⋅ Δ∑ ∑ ∑
where ε is the strength of a contact, Δij, dimikΔ , and *ijΔ are the contact maps corresponding to a 
monomer, the dimer interface, and the domain swapping interactions, respectively. The value 
αdomain-swap in Eq. (4) is used to regulate the degree of inter-monomer overlap, or the effective 
concentration of the protein. When αdomain-swap>1, interactions between residues from 
different monomers are stronger than intra-monomer interactions, resulting in a tendency of 
each chain to penetrate the pervaded volume of the other chain, rather than forming intra-
chain contacts. This scenario corresponds to a polypeptide concentration in the semi-dilute 
regime58. There is an additional translational entropic contribution associated with the 
interactions between amino acids from different protein chains compared to the analogous 
interactions within the protein chain. Therefore, the magnitude of the inter-protein 
interactions may differ from the intra-protein interactions between analogous amino acids 
depending on environmental conditions such as the protein concentration. To capture this 
effect, we study the dynamics of misfolding at different values of the scaling factor αdomain-
swap. 
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4.4 Results 
Sequence determinants of SOD1 amyloidogenesis 
Since the formation of β-sheets is a necessary condition for aggregation1,24,, to 
identify amyloidogenic sequence fragments in SOD1, we use idealized dimer and tetramer β-
strand templates, in both parallel and anti-parallel conformations. We mount overlapping 
heptapeptide sequences from the SOD1 sequences on each template, and calculate the 
conformational free energies of the 147 heptapeptide sequence oligomers using explicit 
solvent 496-ps MD simulations and an implicit solvation energy function (Eq. (1), Fig 2 (a)). 
By subtracting the free energy of two and four monomers from parallel and anti-parallel 
dimers and tetramers, respectively, we obtain the free energies of dimerization and 
tetramerization into these parallel and anti-parallel β-structures (Eq. (2)). We use these values 
to obtain a sequence-profile for amyloidogenicity (Eq. (3), Fig. 2(b) and (c)). The free energy 
contribution per residue ranges from -5.9 to +2.5 kcal/mol for dimerization (Fig. 2(b)), and 
from -18.3 to +6.1 kcal/mol (Fig. 2(c)). Although for a given residue, the magnitude of the 
amyloidogenicity is larger in the tetramer compared to the dimer, we obtain similar free 
energy profiles for parallel, anti-parallel, dimer and tetramer (Fig. 2(b) and (c)) structures. 
Thus, we conclude that the free-energy profiles adequately represent the oligomerization 
propensity of the SOD1 sequence fragments. 
 Based on the sequence amyloidogenicity profile, we identify sequence regions with 
high and low amyloidogenicity. Four regions of the protein have high amyloidogenicity: the 
N- and the C-termini, and the residues 35-45 and 110-120. The residue sequence 35-45 
(IKGLTEGLHGF) is a cross-over loop, and connects the two β-strands, β3 and β4, of the 
sheets in the barrel. The residue sequence 110-120 (HCIGRTLVVH) corresponds to a loop 
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between the strands β6 and β7 (residues 110-114), and the strand β7 (residues 115-120). 
Residues 113-115 are also part of the dimer interface, and in the native dimer structure are 
symmetrically placed such that residues 113 and 114 from both subunits form contacts with 
each other. Thus, we find that specific regions of the SOD1 sequence have a high propensity 
to oligomerize into in-register, parallel and anti-parallel β-strands. 
 
Folding thermodynamics of SOD1 monomer and dimer 
 In the context of the entire polypeptide chain, the oligomerization of the identified 
amyloidogenic “hot-spot” sequences is dependent on the degree to which these sequences are 
exposed in unfolded or partially folded SOD1. To identify the regulation of amyloidogenic 
sequences during the misfolding of SOD1, we first model the folding of SOD1 monomer and 
dimer to reproduce the experimentally observed thermodynamics of folding. Protein folding 
pathways are largely determined by the topology of the native state25-30, and, therefore, the 
native topology of SOD1 determines the specific sub-structures of the protein that are 
exposed in the aggregation-prone partially folded states (i.e. the structural determinants of 
SOD1 aggregation). The principal difficulty in studying the folding of proteins in silico is the 
lack of accurate information about the energetics of interaction between amino-acids. Since 
protein structures have a posteriori information about the amino-acid interactions31, 
simplified native-structure based models such as the Gō model are used to study folding. In 
the Gō model32,33, the energy of the protein is expressed as a sum of pairwise native contact 
energies. A native contact exists between amino acid residues if they are closer to each other 
than a cut-off distance in the native state, and folding process is regarded as the acquisition of 
all native contacts. Typically, in these simplified models of folding, a coarse-grained 
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representation of the protein is used in which each amino acid is represented by one or more 
beads and the protein chain is represented as beads-on-a-string34. For modeling SOD1 
folding, we use a coarse-grained representation of the SOD1 polypeptide chain developed by 
Ding et al. 35 (6-bead model, 4 backbone and 2 side chain beads). We have previously shown 
that a scaled Gō-model of native-state based inter-residue interactions can reproduce the two-
state folding of the SOD1 monomer36 (see Methods). Starting from a stretched conformation, 
we perform equilibrium simulations at constant temperatures, T, ranging from T=0.1 to 1.0 
(Fig. 3(a)). We find that the 6-bead polypeptide model with scaled-Gō interactions 
reproduces the experimentally observed two-state folding thermodynamics of SOD1. For a 
two-state protein, the heat capacity is expected to have a single peak at the folding transition 
temperature, TF. A MD trajectory at T=TF consists of two distinct populations – folded and 
unfolded – at equilibrium with other, characteristic of a two-state protein (Fig 3(a)). At T<TF 
and T>TF, on the other hand, only the folded and the unfolded states, respectively, are 
populated. 
 Next, we model the folding of the SOD1 dimer. In addition to the intra-monomeric 
contacts of the two monomers, the contact map of the dimer contains contacts corresponding 
to the native dimer interface. Starting from two stretched chains, we perform equilibrium 
simulations at constant temperature ranging from T=0.1 to T=1.0. The heat capacity versus 
temperature curve shows the existence of two transitions, corresponding to the temperatures 
T1=0.66 and T2=0.72 (Fig. 3(b)). The MD trajectories at T1 consist of two distinct 
populations, corresponding to the dimer and two folded monomers respectively, whereas at 
T2, the two populations correspond to the folded monomers and unfolded monomers 
respectively (Fig. 3(b)). At low temperatures (T<T1), the native dimer is formed, where as at 
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high temperatures (T>T2), both chains are unfolded. This is in accord with experimental 
studies, in which the folding of the dimer has been shown to be a three-step process16,17,37: 
  2 2D M U⎯⎯→ ⎯⎯→←⎯ ←⎯ ,       (5) 
where D is the dimer, M is the monomer and U is the unfolded state Thus, our simulations 
reproduce the folding thermodynamics of the SOD1 dimer in agreement with the 
experimentally observed thermodynamics.  
 
Structural determinants of SOD1 misfolding and aggregation 
After verifying that the SOD1 monomer and dimer models fold to the correct native 
state with experimentally-observed two-state and three-state thermodynamics respectively, 
we study the misfolding of the SOD1 dimer. In Eq. (4), when αdomain-swap>1, the relatively 
higher strength of inter-monomer domain-swapped interactions (see Methods) compared to 
the intra-monomer interactions mimics an increase in the protein concentration. At high 
concentrations, native structure formation within a monomer competes with the formation of 
domain-swapped19,20 topologies (Fig. 1(b) and (c)). Further, non-specific hydrogen bonds can 
form between the backbones of the two monomers. Under these conditions, we expect to 
observe non-native topologies. We perform dimer simulations over a range of α-values, α = 
0.5, 1, and 1.5, to screen for non-native dimeric forms of SOD. To obtain the aggregation 
propensity of each residue, we calculate the cumulative frequency of inter-monomer contacts 
formed by each residue at the temperatures T=0.65 and T=0.75. For the native dimer, the 
residues on the dimer interface are 5, 7, 9, 50-53, 113-115, and 150-153, in each monomer. 
Since aggregation has been shown to occur in a narrow temperature range around the folding 
transition temperature, we perform simulations with domain-swapped interactions in the 
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range T=0.65 to T=0.75 (the transition temperatures for the native dimer are T1=0.66 and 
T2=0.72).  
 At α=0.5, the folding of the dimer is native-like, as evidenced by frequency profile 
(Fig. 4(a)) where residues that are involved in the native dimer interface form inter-monomer 
contacts with a high frequency at both T=0.65 (red bars) and T=0.75 (green bars). However, 
other residues in the vicinity of the dimer interface residues, such as 3, 55, 107-110 also form 
inter-monomer contacts with a high probability. Thus, although weak domain-swapping 
interactions do not significantly alter the folding of the dimer, several residues, especially 
near the native dimer interface and near residue 110, can induce alternate dimer 
conformations. 
At α=1, we observe significant non-native contact formation, especially at T=0.65, 
which is near the transition temperature T1=0.66 for dimer dissociation. The residues that 
form inter-monomer contacts include the native dimer residues and several other residues, 
especially at the N- and the C-termini, and the regions 25-40 and 100-120. The formation of 
inter-monomer contacts by both the native dimer interface and specific non-native residues 
suggests that the formation of an alternate dimer interface competes with the formation of the 
native dimer interface.  
At α=1.5 and T=0.65, the native dimer interface is not seen as evidenced by a 
disappearance of inter-monomer contacts by native interface residues. Instead, a new set of 
residues, 55-65, 90-100, 110-120 is observed to form the most inter-monomer contacts. Thus, 
at increasing concentrations of the destabilized dimer, simulated by increasing α-values, we 
observe decreased formation of the native dimer interface and an increase in the formation of 
an alternative dimer interface.  
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An examination of the structures with the altered dimer interface shows a diversity of 
conformations. This is expected to be the case if dimer formation is under kinetic control and 
further oligomerization, i.e. the formation of a trimeric or a higher-order species, causes 
thermodynamic stabilization of the oligomers. These observations are in agreement with 
recent computational and experimental studies38,39 suggesting that kinetic effects play an 
important role in the early stages of aggregation. Based on the structures of non-native 
dimers observed in simulation, we propose several plausible, kinetically competing 
aggregation pathways. For example, two representative structures are shown in Fig. 4 (b) and 
4(c). Each of these two non-native dimeric states persists throughout the entire simulation 
time of 1.5×105 time units once it is formed. Fig. 4(b) shows a domain swapping interaction 
to form a native-like beta-barrel using half of the strands from each monomer, while the 
remainder of each monomer undergoes smaller-scale strand-by-strand pairing between the 
chains. Interestingly, residues 35-45 from each monomer associate with each other at the 
interface between the canonical domain-swapped region and the strand-swapped region. 
Domain swapping of this nature results in the apposition of identical, aggregation-prone 
sequences from each monomer. Fig. 4(c) shows a non-native SOD dimer in which the native 
strand pairings form but the monomers do not collapse into the barrel topologies, resulting in 
the formation of a continuous β-sheet. At the interface between the two flattened sheets, 
residues 110-120 from the opposite monomers directly interact in a parallel fashion. The 
residues 35-45 are located on the outside edges of this dimeric β-sheet where they are 
available for propagating the aggregate further. In this alternative model for multimeric β-
sheet association, flattened β-sheets associate via edge-edge interactions mediated by 
fragment 110-120 and propagate unidirectionally by interactions between the fragments 35-
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45. Thus, the dimers exhibit a rich variety of structures in which the residues 35-45 and 110-
120 form key intermolecular contacts. 
 
4.5 Discussion 
Finding aggregation “hot-spots” in SOD1 using peptide fragments  
To obtain the aggregation-propensity of SOD1 sequence fragments, we use the free 
energy of oligomerization of isolated sequence fragments mounted onto idealized β-sheet 
templates, composed of two and four β-strands. In a similar approach, de la Paz et al.24 
mounted hexapeptide sequences on each strand of a six-stranded antiparallel β-sheet template 
to design highly amyloidogenic peptide sequences. Using this simplified design procedure, 
they found that, for short peptide sequences, the formation of β-structures is necessary, but 
not sufficient, for the formation of amyloid fibrils.  
The β-sheet templates we used included both parallel and anti-parallel conformations. 
Although protein and peptide aggregation involves conversion to β-sheets, whether the β-
sheets are parallel or anti-parallel has not been understood6. It has been argued that the early 
oligomers formed during protein and peptide aggregation can be of either topology, although 
for small peptides, anti-parallel topologies are preferably formed40. In recent study of the 
dynamics of peptide dimerization, Hwang et al.38 found that the β-strand peptide dimers 
exhibited both parallel and anti-parallel β-sheets, with an overall preference for anti-parallel 
arrangements. Since both parallel and anti-parallel topologies are likely in the early stages of 
aggregation, we used both topologies for constructing the templates, and also found that anti-
parallel β-sheets have lower free energies for a given sequence (Fig. 2(b) and (c)). We 
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postulate that the lower free energy of the anti-parallel structures is due to less strained 
hydrogen bonds in the anti-parallel structures compared to the parallel structures.  
 We find that the thermodynamic contribution of each residue to the aggregation 
propensity (ΔG ) is greater in the tetramer compared to the dimer (Fig. 2(b) and (c)). This 
finding indicates that the free energy gain upon aggregation increases non-linearly as the size 
of the aggregate increases, i.e. greater stabilization occurs as higher-order oligomers are 
formed. Thus, aggregation may be reversible for smaller oligomers, but as the size and the 
stability of the oligomer of the increases, the disaggregation is less likely. This postulate is in 
agreement with recent findings of the stability of amyloid β dimers, which suggest that 
dimers are only marginally stabilized compared to free monomers41. 
The use of overlapping peptide fragments to determine amyloidogenicity of residues 
ensures that sequence neighbors of a residue modulate its amyloidogenicity. Inclusion of 
local interactions by use of such peptide models is known to be a successful strategy for 
modeling protein structure42. In protein modeling algorithms, for example the ROSETTA 
program developed by Baker and co-workers43,44, the propensity of peptide fragments of a 
protein to adopt specific secondary structures has been used to successfully predict protein 
structures. Our approach of predicting aggregation propensities also similarly relies on 
evaluating the propensities of short peptide fragments to adopt specific structures, and on 
evaluating the effect of neighboring residues on the amyloidogenicity of a given residue. 
 
Dependence of amyloidogenicity on the hydrophobicity, β-sheet propensity, and net 
charge of the sequence 
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 The residue fragments that we identify as amyloidogenic have a high content of 
hydrophobic residues, and strategically placed polar (T, H) and charged residues (K, E, R). 
The charged residues may provide further stabilizing interactions by electrostatic and/or 
hydrogen bonds. Both hydrophobic and charged interactions are known to be critical to 
stabilize aggregates24,45,46. The residue sequence 100-109 (EDSVISLSGD) is also 
amyloidogenic, albeit less than the two highly amyloidogenic fragments 35-45 and 110-120, 
and shows a similar distribution of charged, polar and hydrophobic residues. Residues 
fragments that have comparatively low amyloidogenicity are 18-22 (INFEQ), 52-55 
(DNTA), 84-88 (LGNVT), and 135-140 (TKTNA). These fragments have a high content of 
polar, uncharged amino-acids (N, Q, T). The fragments containing these residues are stable 
in tetrameric and dimeric oligomeric states (Fig. 2 (a)), but the free energy penalty for 
oligomerization is high (Fig. 2(b) and (c)). We argue that this high penalty is a result of more 
favorable interactions of the monomers with water compared to the interactions with other 
peptides in the oligomeric state. 
To understand if the per residue amyloidogenicity is simply a reflection of some 
intrinsic physico-chemical property of the sequence, such as β-strand propensity and 
hydrophobicity, we compare the amyloidogenicity profile with these physico-chemical 
properties. Recently, a number of phenomenological approaches have been developed in 
which these properties and experimental conditions are used as variables to predict 
aggregation rates of polypeptide chains. We use the model developed by Chiti et al.47 in 
which average hydrophobicity, β-sheet propensity, and net charge is calculated for each 
sequence and a linear regression fit to the aggregation rate is obtained. Following Chiti et 
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al.,47 we assume that the free energy of multimer formation calculated in our MD simulations 
is: 
hydrophob hydrophobG C p C p C pβ β ± ±Δ = + + ,     (6) 
where pβ, phydrophob, and p± are the β-sheet propensity, hydrophobicity, and net charge of the 
sequence at pH 7, Cβ, Chydrophob and C± are scaling coefficients, and ΔG is free energy of 
dimer or tetramer formation determined in MD simulations. First, we find that none of the 
individual properties correlate with the free energy of multimer formation (Fig. 5(a)-(c)). 
Second, for each template structure, namely the dimer and the tetramer with parallel and anti-
parallel topology, we perform a linear regression analysis using Eq. (6) to determine the set 
of coefficients Cβ, Chydrophob and C±. We find that in each case the correlation between the ΔG-
values and the sequence properties is poor (Fig. 5(d)-(g)), and conclude that the ΔG of 
multimerization is not sufficiently explained by a linear combination of the β-sheet 
propensity, hydrophobicity, or the net charge of the sequence. Our finding is in agreement 
with the recent work of Serrano and co-workers in which mean-field aggregation-profiles for 
protein sequences calculated using their TANGO algorithm did not correlate with the β-
strand propensity of the sequence 48. 
 
The determinants of SOD1 aggregation in FALS  
 To determine the sequence and structural determinants of SOD1 aggregation, we 
evaluate (1) the propensities of oligomerization of all sequence fragments of SOD1, and (2) 
the structural propensities of different parts of SOD1 to self-associate during misfolding. We 
use no sequence information during the identification of structural regions that are likely to 
self-associate, and vice versa. Since we find identical regions of the SOD1 molecule using 
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these disparate methods, we argue that aggregation of SOD1 is a consequence of both having 
aggregation-prone sequence fragments, and the topological context of these fragments during 
misfolding. 
We have previously shown16 that a minimal mechanism for the aggregation of SOD1 
is  
 2 aggkapoD M metals A⎯⎯→ + ⎯⎯→←⎯ ,   (7) 
where D is the native dimer, Mapo is the apo-monomer and A is the aggregate. The 
mechanism in Eq. (5) is minimal because the second reaction, Mapo Æ A, is likely to be a 
multi-step process. The first step in this process is the non-native dimerization of apo-
monomers, followed by the further addition of misfolded monomers. A common mechanism 
for non-native dimerization and aggregation is domain swapping 20,49. The domain swapping 
of two monomers leads to the formation of structures which are either “open” and lead to 
further elongation of the aggregate, or are “closed” and serve as dead-ends that cannot 
propagate further. It has been shown that domain swapping has a purely topological origin, 
i.e. it is a consequence of the competition between the formation of native contacts, and the 
formation of symmetric inter-monomer contacts 49,50. Therefore, we study the misfolding of 
SOD1 dimer using domain-swapping. 
We propose that FALS mutations induce aggregation by affecting the rate and 
equilibrium constants of dimer dissociation and metal-loss in Eq. (5), and by affecting the 
degree of domain swapping. To qualitatively model the differential effects of mutations, we 
introduce the scaling parameter αdomain-swap, with which we control the relative of strengths of 
intra- and inter-chain interactions. Under a range of these destabilizing conditions, we 
observe the preferential self-association of residues fragments 35-45 or 110-120, suggesting 
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that conversion to the aggregate is a specific process governed by the self-association of 
specific regions of SOD1. We find a number of misfolded dimeric species in which these key 
interactions formed, but there is considerable conformational diversity in the overall structure 
of the misfolded dimers. This conformational diversity was absent in the misfolded dimers of 
the SH3-domain generated using a similar approach, and only two dominant “open” and 
“closed”topologies were found49. Thus, the conformational diversity of the misfolded dimers 
is an intrinsic property of the SOD1 structure. We expect that once the key interactions for 
aggregation are formed, different dimer conformations are stabilized, and therefore, initiate 
aggregation under different experimental conditions. This phenomenon may be responsible 
for the experimentally observed variety of aggregate morphologies as a function of 
environmental conditions, such as denaturants, pH and temperature, that have been used to 
generate the aggregates18,51-53.      
The sequence profile of amyloidogenicity represents an upper bound for the 
aggregation propensity of SOD1 molecule because it is a measure of the intrinsic property of 
the SOD1 sequence to self-associate. However, the degree to which these different sequences 
can self-associate is determined by the structural dynamics during misfolding. The high 
aggregation-propensity of the destabilized mutant SOD1 may be a result of the synergy 
between structural dynamics and sequence propensity, such that highly aggregation-prone 
sequences are also topologically most likely to form inter-chain contacts.  
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 the contact ma r contacts of the two 
onomers, region II corresponds to contacts on the dimer interface, and region IV 
orresponds to the domain-swapped interactions between the two monomers. 
 
 
 
Figure 4.1 Schematic and contact map of SOD1. (a) A schematic of SOD1. The regions 
identified as amyloidogenic are shown in red. These constitute the β-strands 4 and 7 and the 
two cross-over loops which connect the two β-sheets in the SOD1 barrel. (b) A schematic of 
domain-swapped interactions and (c) the domain-swapped contact map used for simulat
In p, regions I and III correspond to the intra-monome
m
c
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erage contribution of each residue to the free energy of all 
agments containing the residue to evaluate the free energy of oligomerization of the 
residue. (b) The free energy of dimerization for each residue (c) The free energy of 
tetramerization for each residue.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Free energies of SOD1 regions obtained in MD simulations. (a) The free 
energy of the 147 overlapping heptamer sequence fragments of SOD1, mounted on various 
template backbones. We use the av
fr
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Figure 4.3. Folding of SOD1 monomer and dimer (a)-(d) Folding of the SOD1 monomer. 
(a) The heat capacity as a function of temperature shows a single peak at the folding 
transition temperature, TF. The histograms of populations at (b) T<<TF , (c) T=TF and (d) 
T>TF show that the folding transition is two state, as found in experiments. (e)-(i) The 
folding of the SOD1 dimer. (e) The heat capacity versus temperature shows two peaks (at 
T1=0.66 and T2=0.72) indicating the existence of multiple transitions. Trajectories and 
population histograms at the two transition temperatures, (f) and (g) at T1, and (h) and (i) at 
2 show that the folding/unfolding of the dimer is a three-state process, involving folded 
dimer, folded monomers and unfolded monomers, as found in experiments. 
 
T
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Figure 4.4. Inter-monomer interactions during misfolding. (a) The cumulative frequency 
of inter-monomer contacts at (a) α=0.5, (b) α=1, and (c) α=1.5 at T=0.65 (black) and T=0.75 
(grey). As the strength of domain swapped interactions increases, the native dimer interface 
is lost and several competing dimeric structures are populated.  
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Figure 4.5. Self-association and domain-swapping. (a) A “phase diagram” summarizing 
the dimer topologies observed as a function of α and T. At low temperatures and α-values, 
native topologies (dimer, monomer) are observed, whereas at higher α-values (α=1.0 and 
1.5), domain-swapping interactions lead to the appearance of modified dimers (MD I and 
MD II). Contact frequency maps corresponding to the inter-monomer contacts in (b) native 
and (c)-(f) modified dimers. Domain-swapping induced by high values of α and T is 
associated with the formation of self-association contacts (between corresponding identical 
elements of the two chains) which lie on the diagonal of the contact map. (c) MD I, for 
example at α=1.0 and T=0.5 is characterized by a small number of inter-monomer contacts in 
isolated elements of the structures, whereas MD II, for example at (d) α=1.5, T=0.4 (e) 
α=1.5, T=0.5 and (f) α=1.0, T=0.8 is characterized by extensive interactions between β-
strands from the two monomers. Topologies observed for both MD I and MD II are diverse. 
Two representative structures of modified are shown in (g) and (h). These structures are 
formed by in-register interactions between residues 110-120 (red) or residues 35-45 (blue). 
We propose that there are multiple mechanisms by which these modified dimers can further 
propagate the aggregate structures and eventually form fibrils.  
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Figure 4.6. The correlation between the free energies of dimerization into anti-parallel 
β-strands obtained in MD simulations with physical-chemical properties of the 
fragment. Correlations of free-energy of association with (a) the average hydrophobicity (b) 
β-sheet propensity (c) net charge at pH 7, of the fragment. A linear combination of the three 
properties also does not correlate well with the free energies calculated from MD simulations 
of fragments mounted on (e) anti-parallel dimeric (f) parallel dimeric (g) anti-parallel 
tetrameric (h) parallel tetrameric template structures. We conclude that the free energy of 
oligomerization calculated in the MD simulation is not sufficiently explained by these 
physico-chemical properties of the sequence.    
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CHAPTER 5 
 
FOLDING AND MISFOLDING OF SOD1 MONOMER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as a manuscript in The Journal of Molecular Biology, and is 
formatted in the journal style. 
5.1 Summary 
 Cu, Zn superoxide dismutase (SOD1) has been implicated in the familial form of the 
neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS). It has been suggested that 
mutant mediated SOD1 misfolding/aggregation is an integral part of the pathology of ALS. We 
study the folding thermodynamics and kinetics of SOD1 using a hybrid molecular dynamics 
approach. We reproduce the experimentally observed SOD1 folding thermodynamics and find 
that the residues which contribute the most to SOD1 thermal stability are also crucial for 
apparent two-state folding kinetics. Surprisingly, we find that these residues are located on the 
surface of the protein and not in the hydrophobic core. Mutations in some of the identified 
residues are found in patients with the disease. We argue that the identified residues may play 
an important role in aggregation. To further characterize the folding of SOD1, we study the 
role of cysteine residues in folding and find that non-native disulfide bond formation may 
significantly alter SOD1 folding dynamics and aggregation propensity. 
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5.2 Introduction 
 ALS is the most common motor neuron disease in human adults that is characterized by 
selective motor neuron death [1-4]. In approximately 10% of the cases of ALS, the disease is 
inherited, thus called Familial ALS (FALS) [1]. Mutations in the cytoplasmic enzyme SOD1 
were identified as the primary cause of approximately 20% of FALS cases [5, 6]. More than 
90 mutations have been identified so far. The FALS mutations are scattered throughout the 
primary sequence and three-dimensional structure of SOD1, which exists as a homo-dimer in 
native state (each monomer is 153 amino acids in length) [7]. One hypothesis to explain the 
toxic gain-of-function of the mutants is that the toxicity is derived from intracellular aggregates 
and/or failure of SOD1 degradation, which is supported by the observation that in both mice 
and cell culture models, death of mutant neurons is preceded by formation of cytoplasmic 
aggregates containing mutant SOD1 [8-10]. In addition, SOD1 knockout mice do not develop 
motor neuron disease [11]. Aggregation or misfolding is therefore a characteristic of SOD1 
mediated FALS. Toxicity may arise through (i) aberrant chemistry due to misfolded mutants 
[12-14], (ii) saturation of essential cellular machinery such as chaperones and proteasome 
components [15, 16], or (iii) oligomeric forms of the aggregate may themselves be toxic to the 
cells, as has been suggested for other neurodegenerative diseases [17]. 
 Aggregation of proteins is mediated by a variety of factors including native state 
stability [18, 19], β-sheet propensity [20], net charge and overall hydrophobicity [21]. In 
addition, folding and aggregation are kinetically competing processes [20, 22, 23]. Thus, it is 
crucial to study the folding thermodynamics and kinetics of SOD1 in order to understand the 
causes of SOD1 misfolding, aggregation and toxicity. A microscopic picture of SOD1 folding 
 117
and/or aggregation dynamics of SOD1 is not available from either theory or experiment. We 
reconstruct the SOD1 folding mechanism from molecular dynamics simulations. 
 Neither the structure of SOD1 aggregates nor the mechanism of aggregation is fully 
understood. Several experimental studies have characterized the folding thermodynamics of 
SOD1 and the associated FALS mutants [24-30]. Lepock et al. [27] and Rodriguez et al. [30] 
measured the stability of mutants in differential scanning calorimetric studies of the 
irreversible unfolding of the distinctly metallated species of the enzyme, and showed that 
mutants are destabilized relative to the wild type. In addition, a crystal structure of the G37R 
mutant [31] shows higher atomic displacement parameters (B-factors) for the side-chains 
compared to the wild type, but the backbone conformation is not significantly different, thus 
indicating greater molecular flexibility in some portions of the structure. It was recently shown 
that for some mutants, the apo-state (without metals) of the mutants is markedly destabilized 
compared to that of the wild-type, while the holo-state (with metals) of both mutants and wild-
type is not significantly affected [32]. It is, therefore, possible that the apo-state of SOD1 – the 
subject of our studies – is implicated in misfolding and aggregation. 
 Most Cu, Zn superoxide dismutases, including human SOD1, have been shown to 
undergo irreversible aggregation on exposure to temperatures higher than their respective 
melting temperatures. The presence of free cysteines, those that do not form disulfide bonds in 
the native state, is known to be involved in this phenomenon. It is well-established that 
improper disulfide bond formation, concomitant with cysteine oxidation, possibly enhanced by 
metals in SOD1, is a cause of heat-denatured aggregation [33]. In the case of bovine SOD1, 
substitution by site-directed mutagenesis of free cysteine residues was found to greatly increase 
the reversibility of denaturation without substantially affecting the conformational stability [25, 
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27]. Yeast SOD1 [34] and E. coli SOD1 [35], neither of which contain free cysteines, show 
partial and full reversibility respectively upon denaturation. However, SOD1 from P. 
leiognathi also denatures irreversibly despite having no free cysteines [36]. Clearly, the 
presence of free cysteines is one of the crucial factors (but not the only factor) responsible for 
irreversible denaturation. One plausible reason for the effect of free cysteines is that the 
formation of improper disulfide bonds makes SOD1 more prone to kinetic traps. Therefore, we 
also study the effect of disulfide bonds on SOD1 folding reversibility. 
 An atomic resolution simulation of the folding process using traditional molecular 
mechanics force-fields is difficult by direct computational approaches because of the vast 
dimensionality of the protein conformational space [37]. Simplified models such as the Gō-
model [38, 39] provide a powerful alternative to study folding because of their ability to 
simulate folding on reasonable time scales and to reproduce the basic thermodynamic and 
kinetic properties of proteins both on- [40-42] and off-lattices [43, 44]. In the Gō model, the 
energy of the protein is expressed as a sum of pair-wise native contact energies. A native 
contact exists between amino acids if they are closer to each other than a cut-off distance in the 
native state. Thus, in the Gō approximation, folding can be construed as a transition from a 
state with no or a small number of native contacts to a state with all native contacts. Despite 
their apparent simplicity, native topology-based approaches have yielded results in agreement 
with experiments, in particular for small proteins (< 100 amino acids) [45, 46] reflecting the 
underlying simplicity in the folding of these proteins. However, a Gō model of longer proteins 
may lead to discrepancy in protein folding dynamics between simulation and experiment 
because sequence-specific interactions may significantly alter the protein folding dynamics. 
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Thus, we develop methodology to incorporate sequence specific information of the relative 
contribution of various amino-acids into the Gō model of SOD1. 
 
5.3 Results 
 We perform DMD simulations using the unscaled Gō model, to determine the 
thermodynamic properties of a model of SOD1 (as described in Methods). The temperature 
dependence of average potential energy is shown in Fig. 1a. There is a sigmoidal increase in 
the potential energy with increasing temperature. At low temperatures, SOD1 is present 
mostly in its native state, as evidenced by the small (2.83Å) root-mean-square deviation, 
RMSD, from the native state (Fig. 1b), and the small fluctuations in the radius of gyration, 
Rg, around its native state value (14.2 Å) (data not shown). At high temperatures, SOD1 is 
unfolded with the RM SD from the native state being greater than 40 Å, demonstrating the 
loss of any structural similarity with the native state. Also, Rg is approximately three times its 
value in the native state (data not shown), indicating that the average distance between any 
two amino acids is approximately three times that in the native state. 
 In a typical trajectory (Fig. 2a) at the temperature corresponding to the mid-point of 
the abrupt change in potential energy (Fig. 1a) dependence on temperature (defined as the 
folding transition temperature TF ), we observe three distinct states: folded, unfolded and 
intermediate. A histogram of potential energies of protein conformations near TF is, therefore, 
tri-modal (Fig. 2c), instead of the expected bi-modal for a two-state protein, indicating the 
presence of a folding intermediate. The detection of the intermediate state is in contrast with 
the experimental observation of the two-state folding dynamics of the SOD1 monomer [28]. 
Thus, the unscaled Gō model for SOD1 does not accurately reproduce the folding dynamics 
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of SOD1. Next, we calculate the pair-wise interaction energies in the native state of SOD1 
monomer and then employ the scaled Gō model, to uncover SOD1 folding thermodynamics 
and kinetics. 
 
A few contacts make a large thermodynamic contribution to SOD1 native state 
stability.  
 We decompose the stability of SOD1 into pair-wise contributions (as described in 
Methods) that are plotted in the lower triangle in Fig. 3 (the energy map). In the energy map, 
some contacts, corresponding to both short-range and long- range interactions, have 
significantly stronger CHARMM interaction energies (from three to five times) than average. 
We find that there are 16 long-range interactions that have large (about five times larger than 
the average) interaction energies: Lys3-Glu21, Lys3- Glu153, Lys30-Glu100, Ser34-Asp96, 
Lys36-Asp92, Glu40-Lys91, Glu49-Arg115, Arg69- Glu77, His71-Asp83, Arg79-Asp83, 
Arg79-Asp101, His80-Asp83, Asp101-Val103, Glu121- Ser142, Asp125-Lys128, Glu133-
Lys136. The residues involved in the strong long-range contacts are highlighted in Fig. 4 and 
are involved in contacts between oppositely charged amino acid pairs on the surface of the 
protein. Out of the 16 identified interactions, 6 have been found to be directly disrupted in 
patients with FALS as a result of point mutations (listed in Table I) in the residues making 
these contacts 1 . In most cases, the mutations correspond to the change of a charged amino 
acid for an oppositely charged or a neutral one, suggesting an important role these key 
contacts play in SOD1 folding. 
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Scaling thermodynamically important contacts modulates folding kinetics in the Gō 
model.   
 We test the importance of the identified amino acids in DMD simulations by scaling 
their contact strength in the Gō potential. We increase the depth of the interaction well of the 
identified key contacts to five times their original value in the unscaled Gō model (b = 5). 
Using this scaled Gō model, we perform DMD simulations to calculate the thermodynamic 
properties of the SOD1. We find that the potential energy, RM SD and Rg (data not shown) 
exhibit the same sigmoidal trend as for the unscaled Gō model, but the folding transition 
temperature increases to approximately 1.1 from its earlier value of 1.0. Remarkably, a 
typical trajectory near the folding transition temperature (TF = 1.15) shows (Fig. 2b) that the 
intermediate state is no longer populated and the protein only exists in either the folded or the 
unfolded state (Fig. 2b and d) near TF . Thus, by strengthening these key contacts we 
reproduce the experimentally observed two-state folding of SOD1 monomer [28, 29]. As 
control, we randomly select several combinations of sixteen contacts and scale them by the 
same procedure. In such control simulations, we do not observe such effect on the folding 
kinetics (Fig. 2b), thus demonstrating that the effect of strengthening the identified contacts 
is specific. Importantly, this result uncovers a crucial connection between the folding 
thermodynamics and kinetics of SOD1: in our model, the residues that contribute the most to 
the SOD1 thermodynamic stability of the native state are also crucial for keeping the folding 
kinetics two-state. Improper disulfide bonds cause kinetic trapping of SOD1. Human SOD1 
is known to aggregate irreversibly on heat denaturation [30] in vitro. One of the reasons for 
the irreversibility is improper disulfide bond formation between free cysteines. There are four 
cysteine residues in the SOD1 monomer, at positions 6, 57, 111 and 146 of which residues 57 
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and 146 form a disulfide linkage in the native state. We study the effect of non-native 
disulfide bond formation by starting from a fully unfolded conformation, generated at T=2.3 
(>>TF), and cooling the system to low temperature T=0.4 (<TF) slowly, while allowing the 
possibility of interactions between any of the four cysteines to form improper disulfide 
bond(s). We model disulfide bonds by an attractive potential (b = 2, γ = −1 in Eq. (2)). As a 
control, we repeat the annealing procedure without these non-native disulfide bonds (b = 1, γ 
= 1 in Eq. (2)). We observe that out of 20 trajectories with improper disulfide interactions, 4 
result in SOD1 structures that are trapped in non-native conformations while all of the 20 
control trajectories fold to the correct native structure on the same time scale, implying that 
occurrence of improper disulfide linkage increases the number of kinetic traps for the SOD1 
chain en route to its native state. The above observation is statistically significant (the 
probability of observing this result by chance: p-value < 0.01). The increased number of 
kinetic traps makes intermediate states more populated and interaction of these intermediate 
states may make SOD1 prone to aggregation. We conclude that free cysteine residues play an 
important part in the kinetics of folding, and possibly, aggregation. 
 
5.4 Discussion 
 Experimental evidence suggests that the unfolding of dimeric superoxide dismutase 
occurs in a three state equilibrium [28, 29]. 
     (1)   D M⎯⎯→ U2 ⎯⎯→←⎯
where D, M and U are SOD1 dimer, monomer and unfolded state respectively. In order to 
understand the effect of mutations on SOD1 folding, it is important to study the effect of 
mutation on both processes in Eq. (1). Here, we study the second process (MÅÆU ) and 
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report thermodynamically and kinetically important residues for SOD1 monomer folding. 
Using our hybrid method, which incorporates molecular mechanics energetics into the Gō 
model, we identify the key residues involved in the folding of the protein. Surprisingly, the 
key residues are found on the surface of the protein and not in its hydrophobic core (Fig. 4). 
By comparing the identified residues with a comprehensive list of mutations associated with 
FALS (http://www.alsod.org), we find that, 6 out of the 16 contacts identified in our 
simulations are found to be implicated in the disease. In Table I, we list those FALS 
mutations that disrupt contacts identified from our simulations. We find that these mutations 
replace a charged residue in the wild-type protein to a neutral or oppositely charged residue 
in the mutant, thereby disrupting the electrostatic interaction. The presence of mutations 
disrupting these contacts further underscores the importance of these key contacts and 
indicates that the disruption of even one of these contacts may potentially result in protein 
misfolding. There have been no experimental studies characterizing SOD1 monomer folding 
kinetics. However, other members of the immunoglobulin-like (Ig-like) superfold family 
[47], to which SOD1 belongs, are experimentally well-characterized. Clarke and colleagues 
have established that the folding of pathways of Ig-like proteins share some common features 
[48]. They observe that for five structurally similar Ig-like proteins, the folding rates are 
correlated with thermal stabilities, suggesting a similar folding pathway for all members of 
the family. Thus, for Ig-like proteins, the kinetic importance of residues in folding (Φ-values 
[49]) is largely determined by the topology of the fold. We, therefore, expect that the residues 
important for SOD1 folding are in structurally equivalent positions to other members of the 
Ig-like super-fold family, whose folding kinetics is experimentally well-studied [48]. We 
choose Tnf3, the fibronectin type III domain of human tenascin, for which, based on Φ-
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values, eight residues in the hydrophobic core were identified as part of the folding nucleus 
[50]. We identify residues in SOD1 that are structurally equivalent to the nucleus residues in 
Tnf3 by performing a structural alignment of the two proteins using DALI [51] and list these 
residues in Table II. We discover that two of the residues corresponding to this putative 
nucleus correspond to the strongly interacting key residues identified by our simulations, 
while three others are nearest neighbors of other residues we identify. This is significant 
because (i) mutations in the nucleus residues, being in proximity to the identified key 
residues, may disrupt the network of interactions of key residues and affect folding kinetics 
and (ii) in the Gō model entropic contributions are included as effective energetic 
interactions. Therefore, the identified key residues may be kinetically crucial because of the 
entropic contribution of the corresponding region of the structure (which is reflected by high 
Φ-values of the neighboring nucleus residues). Therefore, kinetic evidence further supports 
our hypothesis that residues important for SOD1 native thermodynamics are important for 
folding kinetics. Richardson and Richardson have pointed out [52] that the interactions 
between edges of β-strands are crucial to regulate protein aggregation propensity. Naturally 
occurring β-sheet proteins prevent aggregation by protecting the edges of β strands through a 
multitude of fold- specific mechanisms. In particular, for Ig-like β-sandwiches, strategically 
placed side-chain charges at the edges and loop-crossing are dominant mechanisms which 
shield the edges of the sheets. A recently solved crystal structure of mutant apo-SOD1 
supramolecular assembly [53] identified three regions of the SOD1 structure where non-
native gain of interaction was observed leading to amyloid like arrangement of SOD1 in 
crystals: the cleft between strands S5 and S6 (residues 83-100), the zinc loop (residues 65-
78) and the electrostatic loop (residues 125-142). It was noted that disorder in the zinc and 
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electrostatic loops promoted non-native interactions with the S5-S6 cleft, which is the 
interface between the two β-sheets of SOD1 and hence a likely site for edge-to-edge 
aggregation [52]. We find that most of the key contacts for proper folding are made by 
residues in the three regions identified above. In particular, we see that contacts on both the 
edge-strands S5 and S6 play a crucial role in folding kinetics. The contacts made by residues 
Asp92, Asp96 and Lys91 which form the turn in the S5-S6 hairpin are crucial to seal the 
interface between the two β-sheets and likely prevent gain of non-native interactions, as 
shown in Fig. 5. Thus, our simulations constitute another piece in the growing body of 
evidence which implicates edge protection as the dominant mechanism by which natural 
proteins avoid aggregation. We postulate that the disruption of key interactions is a plausible 
scenario for mutant mediated aggregation of SOD1. The re-organization of the S5-S6 edge 
may be the dominant feature which distinguishes the aggregation-prone misfolded state of 
SOD1, from the native state. The disruption of charge-charge interactions of the side-chains 
of the identified key residues, which stabilize the β-barrel architecture of SOD1, might 
expose the edges of β-strand main- chain to interact with other structures, thus leading to 
aggregation. Wang and Hecht [54] have shown that strategically designed mutations in β-
strand overhangs disfavor aggregation of normally aggregating proteins, further supporting 
our hypothesis. 
 We show that the presence of oxidizable cysteines enhances the kinetic trapping 
during folding. In the presence of metals, cysteine oxidation is enhanced suggesting a 
plausible cause for the misfolding of SOD1. However, it has recently been suggested [32] 
that misfolding of SOD1 likely takes place in the apo-enzyme state, when the metals have not 
yet been delivered to SOD1. In the reducing environment of the cell, cysteine-mediated 
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misfolding/aggregation of the apo-enzyme is, therefore, not a likely mechanism of SOD 
misfolding/aggregation. However, our observations do suggest a generic mechanism for 
SOD1 misfolding especially for mutations that do not affect the native state conformational 
stability [30]. In the scenario similar to the one we have presented for free cysteines, other 
mutations may affect the folding kinetics of SOD1 by introducing non-native interactions 
along the folding pathway, leading to kinetic trapping without substantially affecting the 
native state stability. 
 
5.5 Methods 
The unscaled Gō model. We use the Discrete Molecular Dynamics (DMD) algorithm [43, 
55, 56] to study the folding thermodynamics of SOD1. DMD has recently been used to study 
the folding kinetics [45, 46, 57, 58] and aggregation of proteins [20, 59]. We model the 
SOD1 chain by the beads-on-a-string model developed by Ding et al. [46] with beads 
corresponding to all Cα and Cβ atoms and constraints between neighboring beads to mimic 
real protein flexibility. We study the folding of one monomer derived from the crystal 
structure of SOD1 (Protein data bank access code: 1SPD). We use the Gō potential [38] to 
model the interaction energy, Vij , between Cβ atoms (Cα for Gly) i and j of SOD1: 
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where |ri − rj| is the distance between atoms i and j. The parameters r0  and r1 are the hard-core 
diameter (set to 3.25 Å) and the cut-off distance (7.5 Å) between Cβ atoms (Cα for glycine) 
in the native state respectively. We assign attractive interaction for native contacts (γ = −1), 
defined to exist between pairs of residues whose Cβ  atoms (Cα  for glycine) are closer than 
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7.5  Å in the native state, and repulsive interaction (γ = 1) for non-native contacts, defined to 
exist between Cβ atoms (Cα for glycine) which are farther than 7.5 Å in the native state. 
 The depth of the attractive square-well uij  in Eq. (2) determines the strength of the 
attractive interaction between two amino acids. First, we consider the case where all contacts 
are equally strong, i.e. the depth of each attractive well is u. We call this case the unscaled 
Gō model and use it to perform DMD simulations of SOD1. We find that our model 
undergoes a collapse transition to its native state through a meta-stable intermediate (see 
Results) in contrast with the experimental observation of two-state folding dynamics of 
SOD1 monomer [28, 29]. A possible reason for the existence of meta-stable intermediates is 
that in the unscaled Gō model, all native contacts have equal strength. While such an 
approximation holds for smaller proteins (such as Src SH3 [45]) with relatively low number 
of contacts (162), SOD1 monomer has 495 native contacts and the assumption of equal 
contact strength overestimates the population of intermediate species. Thus, in order to 
include sequence specificity of native interactions, we increase the strength of few specific 
native contacts according to an all-atom model of SOD1 described below by making the 
depth of the attractive well of some chosen native contacts buij , where b is a scale factor. We 
call this the scaled Gō model. By scaling Gō potential according to an all atom model of the 
protein, we effectively include the sequence information. 
The scaled Gō model. To determine the relative strength of each individual native contact in 
SOD1, we use an effective energy function to decompose the total energy of the protein as a 
sum of pairwise terms [60]:       
      (3) 
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i j i
E E
>
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where the summation is taken is over all pairs of residues of SOD1 and Eij is the energy of 
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interaction between residues i and j. To determine the terms Eij , we perform simulations with 
the molecular mechanics force field CHARMM [61] to construct an all atom model of the 
SOD1 monomer in the native state, starting from its crystal structure (PDB accession 
code:1SPD). Recently, higher resolution crystal structures of apo-SOD1 have appeared in the 
literature [62], but our results are not qualitatively affected by starting with the higher 
resolution structure.  We add hydrogen atoms and remove any steric clashes occurring in the 
structure by energy minimization. The interactions which contribute the most to the relative 
contact interaction strength are the non-bonded interactions and the solvent-induced 
interaction screening [60]:      
     (4) 
 We compute Enon ennard-Jones and electrostatic int
E G−E =
nded as the sum of the 
energies. The solvation free energy, Gij , measures the screening of the pairwise interaction 
due to polarization of the solvent. We calculate Gij using an implicit description of the solvent 
[63]. We approximate the solvent as a continuous dielectric medium with a dielectric 
constant (ε = 80) of water and the protein as a continuous medium with dielectric constant (ε 
= 1) of vacuum. We compute the solvation energy by solving the Poisson-Boltzmann 
equation using the finite difference method [64] available in CHARMM. Following Dominy 
et al. [65], in order to decompose the solvation energy into pairwise contributions, we 
eliminate all charges in the protein except those corresponding to residue i and calculate its 
“self ” solvation energy Ui . Similarly, we compute Uj  and Uij  when charges corresponding to 
both i and j are present.  Then, the solvent mediated screening of the interaction is: 
       (5)  
+
ij ij i j[ ]G U U U= − +
 129
 So, we calculate the effective pairwise energy contribution of a contact in the folded 
 ∆Eij = Eij (1 − pij ),   (6)  
ing the 
.6 Conclusions 
he folding thermodynamic and kinetic analysis of SOD1 using a hybrid 
state. The Eij values that we thus obtain correspond to the folded state of the protein. In order 
to calculate the pairwise contribution of residues to the stability, we subtract the value of the 
contact energy in the unfolded state from the Eij values obtained above. The unfolded state is 
an ensemble of conformations. It has been noted that there is considerable native like 
structure in the unfolded state [66-68], meaning that the average environment of a contact is 
likely the same as in the folded state, but this contact is formed less frequently. Therefore, we 
model the unfolded state by simulating the unscaled Gō model near TF and estimating the 
frequency of native contact formation. The total contribution of a given contact to the 
stability can be written as: 
    
where Eij is the contact energy in the folded state and pij is the probability of form
contact in the unfolded state. The energy and contact maps are plotted in Fig. 3. 
 
5
 We present t
molecular dynamics method. We show that our simple model qualitatively reproduces the 
folding of SOD1 observed in experiments. We find that interactions at the edges of SOD1 β 
sheets and the zinc, electrostatic and cross-over loops are the key interactions that modulate 
the folding of SOD1 suggesting that mutants destabilizing these interactions may make the 
enzyme more prone to aggregation. In particular, we identify the S5-S6 cleft (residues 83-
100) as a likely site for reorganization to yield an aggregation prone misfolded state, an 
observation consistent with recent experimental evidence [53] and the negative design 
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paradigm [52]. We also provide a plausible explanation for the phenomenon of increased 
reversibility of folding upon mutation of free cysteine residues.  We find good agreement 
between the positions identified by us to be crucial for folding kinetics and those identified 
by experiments [50] on other members of the super-fold family (Ig-like proteins) to which 
SOD1 belongs. Further, we find that mutations at six of the residue contacts we identify are 
implicated in FALS. 
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Table 5.1:  Mutations  in  the  identified  kinetically  important  residues  also  found  in  
patients  with FALS  In  the  first  column,  6  of  the  16  contacts  that  we  identify  are  
shown.  The second column lists mutations that disrupt these contacts and are found in FALS 
patients. 
 
 
 
 
Contact 
    
Mutation(s) 
Lys3-Glu21   Glu21Lys, Glu21Gly 
Glu49-Arg115    Glu49Lys 
Asp96-Ser34    Asp96Asn 
Lys30-Glu100    Glu100Lys, Glu100Gly 
Arg79-Asp101  Asp101Gly, Asp101Asn 
Glu49-Arg115    Arg115Gly 
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Table  5.2  Comparison  of  kinetically  important  residues Kinetically important residues 
in SOD1 were determined by (i) structural comparison with the protein 1TEN [50] using 
DALI [51] and (ii) by our simulations.  Nucleus  represents  high Φ-value residues in  
1TEN,  equivalent  positions  refer  to structurally  equivalent  positions determined by  
DALI  alignment  and  key  residues  in  the  vicinity of  equivalent  positions  identified  by  
our  simulations  are  shown  in  column  3.  N/A refers to no equivalent residue found. 
 
Nucleus  
(1TEN)   
Equivalent Position 
(1SPD) 
Key Residue
Ile20 Phe31  Lys30 
Glu49 Tyr36 His48 
Ile48 Asp83 Asp83 
Leu50 Asn86 N/A 
Ile59 Asp101 Asp101 
Thr66 His110  N/A 
Tyr68 Ile112 N/A 
Val70 Gly114 Arg115 
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Fig. 5.1 SOD1 thermodynamic properties Dependence on temperature of (a) average 
energy (b) RMSD in DMD simulations with unscaled Gō potential. The sigmoidal curves in 
both (a) and (b) show that SOD1 undergoes a collapse transition. Similar curves are obtained 
for DMD simulations with the scaled Gō potential.      
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Figure 5.2 Typical DMD trajectories near TF for (a) unscaled and (b) scaled Gō models. 
One trajectory is shown out of 4 for the unscaled Gō model and 5 for the scaled Gō model. In 
(b), a control trajectory with randomly chosen contacts (see text) strengthened is shown in 
grey. Histograms of energy values near TF, for (c) unscaled and (d) scaled Gō models, 
averaged over 4 and 5 trajectories respectively, are also shown. From (b) and (d) we observe 
that the intermediate state is not populated in the scaled Gō model but is present in the 
unscaled Gō model, indicating that the kinetics of the scaled Gō model is indeed two-state as 
observed in experiments [28, 29]. 
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Figure 5.3 Contact map (upper triangle) and CHARMM generated energy map (lower 
triangle) of the SOD1 monomer. The color shading in the energy map is assigned according 
to the interaction energy values; red indicates repulsive interactions and blue indicates 
attractive interactions. Energy values are in kcal/mol. 
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Fig. 5.4 Two projections of SOD1 monomer structure highlighting residues making the 
identified contacts important for the two-state folding of SOD1: Lys3-Glu21, Lys3-Glu153, 
Lys30-Glu100, Ser34-Asp96, Lys36-Asp92, Glu40-Lys91, Glu49-Arg115, Arg69-Glu77, 
His71-Asp83, Arg79-Asp83, Arg79-Asp101, His80-Asp83, Asp101-Val103, Glu121-Ser142, 
Asp125-Lys128, Glu133-Lys136. Figure generated using Kraulis' Molscript program and co-
ordinates from PDB structure 1SPD. 
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Figure 5.5 The S5-S6 cleft. The residues in the cleft which are identified as crucial for 
making the folding kinetics two-state in our model, are highlighted. This cleft represents one 
of the edges of the β-barrel and is a possible site for initiation of non-native contact formation 
as also found in Ref. [53], leading to aggregation. 
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 CHAPTER 6 
 
DYNAMICAL SIGNATURES OF FALS MUTATIONS 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been submitted as a manuscript to the journal Proceedings of the National 
Academy of Sciences, USA, and is formatted in the journal style.
6.1 Abstract 
More than 100 structurally diverse point mutations in the dimeric enzyme Cu, Zn 
superoxide dismutase (SOD1) leading to its aggregation are implicated in Familial Amyotrophic 
Lateral Sclerosis (FALS). Although it is known that SOD1 dimer dissociation is required for its 
aggregation, the common structural basis for diverse FALS mutations resulting in aggregation is 
not fully understood. Here, in molecular dynamics simulations of wild type SOD1 and three 
structurally diverse FALS mutants (A4V, G37R and H46R), we find that a common effect of 
mutations on SOD1 dimer is the mutation-induced disruption of dynamic coupling between the 
monomers. In the wild type dimer, the principal coupled motion corresponds to a “breathing 
motion” of the monomers around an axis parallel to the dimer interface, and an opening-closing 
motion of the distal metal-binding loops. These global motions are disrupted in all three mutants 
independent of the structural location of the mutation. We also find that the loss of coupled 
motions in mutant dimers occurs with the increased disruption of a key stabilizing structural 
element – the β-barrel plug – leading to the de-protection of edge-strands, and may thus be 
implicated in early events in aggregation. To rationalize the disruption of coupling, which is 
independent of the effect of the mutation on SOD1 global stability, we analyze the network of 
residue-residue contacts formed in the SOD1 dimer fold. We find that the dimer interface and 
metal-binding loops, both involved in coupled motions, are regions of high connectivity in the 
network. Thus, we postulate that a perturbation such as mutation-induced strain in the protein is 
transmitted readily to these areas and thereby disrupts coupled motions. Our results suggest that 
altered protein dynamics due to long-range communication within its structure may underlie the 
aggregation of mutant SOD1 in FALS. 
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6.2 Introduction 
Point mutations in the cytoplasmic homodimeric enzyme Cu, Zn superoxide dismutase 
(1) have been identified as the primary cause of approximately 20% cases of the disease Familial 
Amyotrophic Lateral Sclerosis (FALS) (2, 3). More than 100 distinct and structurally diverse 
FALS mutations, which result in identical symptoms are known (4), suggesting that all mutations 
affect an unknown common property of the protein, leading to toxicity. There is evidence that 
the motor neuron-specific toxic gain-of-function of the mutants is associated with intracellular 
aggregation, trafficking and/or degradation of misfolded SOD1 (5, 6). The inhibition of 
aggregation by over-expression of chaperones leads to increased cell viability (7).   
The molecular mechanism of misfolding and aggregation of SOD1, and how structurally 
and chemically diverse mutations lead to aggregation, is not fully-understood. We and others 
have previously demonstrated that the in vitro aggregation of SOD1 occurs via a pathway 
involving dissociation of the dimer and the loss of metals, followed by multimeric assembly of 
the apo-monomeric SOD1 (8-10). FALS mutations are likely to lead to enhanced aggregation by 
affecting one or more steps in the aggregation pathway leading to an increase in the population 
of the aggregation-prone apo-monomer. Inhibition of mutant SOD1 dimer dissociation by 
engineering an inter-subunit disulfide bond on the interface, or by small molecule binding 
drastically reduces or abolishes aggregation (8). For a subset of mutants, the decrease in the 
stability of the mutant apo-dimer correlates with the average survival-time of patients carrying 
the mutation, suggesting that stability of the dimer may be a “common denominator” underlying 
FALS(11, 12).  However, for other structurally-distinct mutants, mutation is found to stabilize 
the apo-state of the protein, while still causing disease, suggesting that the decreased stability is 
not sufficient for explaining the enhanced aggregation propensity of mutants(13). 
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The lack of specificity in mutations coincident with an identical aggregation phenotype 
indicates the high connectivity of the scattered mutation sites with sites that maintain the fold 
fidelity of SOD1. It is expected that mutants affect the global dynamics of SOD1 in the native 
state, and lead to greater sampling of aggregation-prone states. Indeed, several mutants are 
known to more dynamic – they are more susceptible to the reduction of the conserved disulfide 
bond in SOD1(14), display enhanced binding to hydrophobic beads(15), have greater H/D 
exchange rates(13), and have enhanced mobility in specific regions of the protein on the 
picosecond-nanosecond timescale, compared to wild type SOD1(16). Given the higher flexibility 
of the mutants, mutant SOD1 may induce aggregation by enhancing the propensity to locally (for 
both stabilizing and destabilizing mutants) and globally (for destabilizing mutants) unfold, 
leading to the exposure of aggregation-inducing structural elements. Therefore, understanding 
how structural perturbation associated with different FALS mutations influences the global and 
local dynamics of SOD1, particularly of the aggregation-prone regions, can provide clues for 
delineating the common underlying basis of mutation-associated aggregation.  
In many cellular processes, energy change associated with perturbations such as 
mutations or ligand-binding is transduced through a protein structure, linking residues within or 
between subunits (17, 18). This long-range communication within protein structures has been 
uncovered using both experimental and theoretical approaches, and these approaches have shown 
that the free energy change at one site is not transduced uniformly through the protein structure; 
instead it is directed to specific regions of the protein (19) . These regions are determined by the 
geometry and the connectivity of the structural network of the protein (20).  
 Here we address how and why diverse FALS mutations affect the local, near-native 
dynamics of the SOD1 dimer and monomer, and how the altered dynamics leads to the 
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disruption of fold fidelity in SOD1 that may result in its aggregation. We choose three 
structurally and thermodynamically diverse mutations: (i) A4V, a highly destabilizing mutation 
on the dimer interface; (ii) G37R, a destabilizing mutation in the “β-plug” region close to the 
hydrophobic core; and (iii) H46R, a mildly stabilizing mutation in an active-site loop. We find 
that independent of the effect on global protein stability and the location of mutation, mutant 
SOD1 displays a loss of coupling between the motions of monomer subunits in the dimer. 
Furthermore, we find that the hydrogen bond network stabilizing the putatively aggregation-
prone edge-strands and the hydrophobic β-plug region of the SOD1 is also weakened in the 
mutant dimers and monomers, and upon exposure of the wild type to aggregation-promoting 
conditions, compared to the native wild type. We rationalize the disruption of inter-monomer 
coupling in mutants by analyzing the connectivity properties of the SOD1 β-barrel fold, and find 
that the topology of the SOD1 fold may underlie the observed (loss of) coupling. Our results 
suggest that dynamics of SOD1 helps explain the observed diversity of mutations in SOD1 that 
lead to its aggregation in FALS. 
 
6.3 Methods 
Molecular dynamics simulations 
 We use the AMBER molecular dynamics (MD) simulation package with Parm99 set of 
parameters(21) to perform 5-ns long MD simulations of monomers and dimers of the wild type 
SOD (PDB accession code 1SPD) at 300 K and 400K (for the wild type dimer) and of three 
mutants A4V (PDB accession code 1N19), G37R (PDB accession code 1AZV) and H46R (PDB 
accession code 1OZT). Since apo-SOD1 has been postulated to be implicated in disease, we 
remove metals from structures in which metals are present, and use these as the starting 
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structures for simulations. In crystal structures of apo- SOD1 wild type native dimers, relatively 
minor structural rearrangements occur compared to the holo-protein, which mainly involve 
rearrangement of the metal-liganding His residues in the active site without changes in the 
overall fold of SOD1 (22). The prominent effect of metals is on the overall thermodynamic 
stability of the protein, which is considerably reduced by the loss of metals, and leads to an 
enhanced propensity to unfold (23). Since the unfolding of SOD1 dimer occurs on the 
millisecond-second timescale, therefore, on the picosecond-nanosecond timescale that are 
accessed by our simulations, the dynamical effects observed are likely valid for both the holo- 
and the apo-forms of SOD1. 
 The simulation protocol is as follows. Starting with the atomic co-ordinates from the 
crystal structures, hydrogen atoms are added and the protein is solvated in an octahedral box of 
TIP3P waters extending 10 Å from the protein. Counterions (Na+) are added at appropriate 
places in the box to ensure charge-neutrality using the LEaP module in AMBER. Periodic 
boundary conditions are applied throughout the simulation, and a non-bonded cutoff of 10Å is 
used. Long-range electrostatic interactions are treated by particle mesh Ewald method as 
implemented in AMBER. The system is equilibrated using the following protocol. First, the 
protein is fixed with positional restraints (spring constant 500 kcal mol-1 Å-2), and the solvent is 
energy minimized using 500 steps of steepest descent followed by 500 steps of conjugate 
gradient minimization with constant volume. After solvent equilibration, the system is energy-
minimized using 2500 steps of steepest descent without any restraints. Next, the system is heated 
from 0K to 300K (or 400K) in 20 ps of constant volume MD using a time step of 1.5 fs, a 
Langevin thermostat (collision frequency 1ps-1), weak positional constraints for the protein 
atoms (spring constant 500 kcal mol-1 Å-2), and SHAKE restrains for bonds with hydrogen . 
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Then, the whole system is equilibrated without constraints with 200 ps of NPT MD simulations 
using constant pressure periodic boundary with an average pressure of 1 atm and a relaxation 
time of 2 ps. SHAKE is used for bonds with hydrogen, the temperature is maintained at 300K (or 
400K) through a Berendsen-thermostat, by coupling to a bath with temperature 300 K (or 400 K) 
and time constant 0.1 ps. Finally, we perform a 5-ns MD simulation of the whole system using 
identical parameters as the final equilibration. A snapshot of the trajectory is stored every 0.2 
picosecond (100 timesteps). Each simulation is performed in parallel on 8-processors on a cluster 
of dual-processor nodes based on AthlonTM 2.8 GHz. 
 To compare the fluctuation of a given residue between various simulation trajectories, 
after superimposition of the trajectory on the starting structure and removal of rotational and 
translational degrees of freedom, we calculate a Z-score for the fluctuation value of the residue in 
the trajectory: Z(i) = (fi-<fi>)/σ  where the fluctuation of a residue, i, is fi, < fi > the average 
fluctuation of all residues in the protein, and σ is the standard deviation of the distribution of 
fluctuations. Thus, residues with a positive or negative value of Z(i) fluctuate more or less than 
the average fluctuation of the protein, respectively.  
 
Covariance matrices and Essential dynamics analysis 
 We calculate a Cα-covariance matrix that describes the correlation of the positional shifts 
of Cα-atoms in proteins.  
  ( )(ij i i j jc r r r r= − − )        (1), 
where ri and rj represent the coordinates of atoms i and j in a conformation, and <…> represents 
the average over the trajectory. The average is calculated over all structures after they are 
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superimposed on a reference (minimized crystal) structure to remove overall translational and 
rotational motion. To verify the robustness of the calculated correlation coefficients, we perform 
and the co-variance analysis over two non-overlapping 2-ns long sub-trajectories corresponding 
to the last 4 ns of simulation time and find that the two matrices thus obtained are highly similar 
to the matrix obtained for the complete trajectory (data not shown). 
 Diagonalizing the covariance matrix yields a set of eigenvectors and eigenvalues. The 
eigenvectors are directions in a 3N-dimensional space (where N is the number of Cα-atoms), and 
motion along a single eigenvector corresponds to concerted displacements of groups of atoms in 
the Cartesian “essential” sub-space. The eigenvalues are a measure of the mean square 
fluctuation of the system along the corresponding eigenvectors. The eigenvectors are sorted 
according to their eigenvalue, the first eigenvector having the largest eigenvalue.  
 
Graph theoretic analysis 
 We represent the SOD1 structures as an undirected, unweighted graph G={Ni, Eij}, 
with nodes Ni corresponding to each residue i, and edges Eij between the nodes Ni and Nj, if these 
are in contact. A contact between two residues exists if the distance between any pair of atoms 
(excluding hydrogen atoms) belonging to these residues is less than 4.2 Å. Two connected nodes 
are called neighbors of each other. To estimate the effect of perturbation induced by mutation at 
each site, we calculate for each residue: (i) the average minimal path Li to all other residues, a 
path between nodes Ni and Nj is defined as a set of edges that connect these nodes through 
neighbors. The length of this path is the number of edges on the path, and the minimal path is 
defined as the path of minimal length; (ii) the betweenness Bi, defined as the number of minimal 
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paths passing through the given residue. High betweenness of a node indicates that a large 
number of minimal paths pass through this node. The betweenness of a node Ni is therefore a 
measure of participation of this node in connectivity of the graph. For the residue-wise 
distributions of each of these properties Pi, we obtain a Z-score for each residue, which is a 
measure of the statistical significance: Z(Pi) = (Pi - <P>)/σ, where P is any property i.e. L or B, 
<P> is the average over all nodes and σ is the standard deviation of the distribution {Pi}.  
 
6.4 Results & Discussion 
 We perform all-atom molecular dynamics simulations of dimers and monomers of wild 
type SOD1 and three mutants for 5 nanoseconds each, in a box of water (see Methods). To 
understand the effect of mutation on the dynamics of the protein on the picosecond-nanosecond 
timescale, we compare dynamical properties, calculated from the simulation trajectories, of the 
mutants with the wild type, and the dimers with the monomers. The root mean square deviation 
(RMSD) of the backbone atoms from the respective minimized crystal structure in the protein is 
less than 2.5 Å for all dimers (Fig. 1(a)-(d)), and less than 2 Å for all monomers (Fig. 1(e)-(h)) 
for all monomers. The RMSD of the dimer interface mutant, A4V, monomer has an increasing 
trend with time, suggesting that a structural rearrangement occurs within this monomer occurs on 
the nanosecond timescale, and that a significant destabilization of the protein occurs as a result of  
the addition of hydrophobic groups (Ala to Val) on the water-exposed dimer interface of the 
monomer. However, with the exception of the A4V monomer, we find that all other trajectories 
do not show large drifts in RMSD, and sample near-native conformations (Fig.1(a)-(h)).  
 
Altered fluctuation patterns of mutant SOD1 dimers 
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 To understand whether and how mutation affects the dynamics of SOD1 dimer on a 
picosecond-nanosecond timescale, we calculate the fluctuations of each residue in the wild type 
and mutant dimers. We calculate the internal mobility of any given residue, i, i.e. fluctuations of 
the residue relative to the average fluctuation of all residues in the protein (see Methods). The 
resulting normalized fluctuation of a residue, Z(i), can be compared between trajectories by 
calculating the change in the internal mobility of the residue, ∆Z = Z(i, mutant)- Z(i, wild type). 
We find that mutants have a significantly altered pattern of mobility compared to wild type (Fig. 
1(i)-(k)). The changes in the patterns of mobility are qualitatively similar in the two monomers of 
the dimer, but not identical (only monomer A is shown in Figs 1(i)-(k)). This asymmetry in the 
dimer has been reported in previous shorter MD simulations on the 300 ps timescale(24), and we 
find that the asymmetry is preserved on the nanosecond timescale and is present in both wildtype 
and mutant SOD1 dimers, suggesting that the asymmetry on the picosecond-nanosecond time 
scale is an intrinsic feature of the dimer. In the A4V, H46R and G37R mutants, 62%, 53%, 64% 
of the residues in the dimer are more flexible than the wild type, respectively, indicating that as a 
consequence of the altered packing, residues are globally more flexible in the mutants than in the 
wild type dimer (Figs. 1(i)-(k)). However, there are several residues that are less flexible in the 
mutants, for example, the residues 70-80 in the zinc loop are more flexible in the wild type dimer 
than in the A4V and H46R mutants. On the other hand, the N- and C-termini and the residues 
133-138 in the electrostatic loop, which form a helix, are more flexible in all mutants, compared 
to the wild type. In good agreement with our calculations, these helix-forming residues 133-144 
have also been found to be more flexible in the G37R mutant crystal structure. The altered 
flexibility of mutant dimers suggests that certain modes of motion occurring in the wild type 
dimer are absent in the mutant dimers, and vice-versa.  
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 Distinct loss of inter-subunit coupling in mutant SOD1 dimers 
 To elucidate the types of motions that are altered by mutations in SOD1 dimer, for each 
mutant and wild type dimer, we calculate the covariance matrix of residues over the trajectories, 
which measures the coupling between the motion of any pair of residues on the picosecond-
nanosecond timescale accessed in the simulation (see Methods). We find that there are distinctly 
pronounced patterns of correlation between residues in the wild type dimer (Fig. 2(a)) at 300 K, 
which are significantly diminished in the three mutant dimers (Figs 2(b)-(d)). These couplings in 
the wild type dimer have been observed in previous shorter timescale MD studies(25). In all 
trajectories, secondary elements of the native structure show a high correlation with each other, 
indicating that the all dimers sample near-native states.  However, in the wild type dimer, there 
are a large number of long-range positively correlated (square III in Fig. 2(a)) and, more 
prominently, anti-correlated motions (square IV in Fig. 2(a)), including both intra- and inter-
monomer motions exhibited by pairs of residues. While a majority of the positively correlated 
motions are between residues that are sequence neighbors or are in contact in the native state, a 
majority of the anti-correlated motions are between residues in the active site loops (60-80 and 
120-140), and other regions of the protein, suggesting an opening-closing motion of the loops, 
which allows substrate diffusion to the active site of the enzyme. Consistent with our 
observations, previous studies of enzyme molecular dynamics by Bruice and co-workers (26) 
have also identified anti-correlated motions of the active sites to be signatures of enzymatic 
activity, since they represent an opening-closing motion of the active-site channel. To evaluate 
the timescale of the emergence of inter-monomer correlated and anti-correlated motions, we 
calculate the covariance matrices over ten non-overlapping sequence windows of 400 ps in each 
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trajectory, and find that on this timescale, only correlated motions between secondary structure 
elements within monomers persist in all dimers, and the differences between the mutants and the 
wild type dimer vanish. Thus, correlated motions between monomers arise on the nanosecond 
timescale, and are, remarkably, disrupted in the mutant dimers.  
 To quantify the degree of decoupling induced by the mutation, we calculate the 
contribution of inter-monomer correlated motions to the overall correlations in the dimer. This 
contribution is defined as 
 
inter
i,j
inter
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i,j i,j i,j
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ij ij ij
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∑
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,      (1) 
where cij is the absolute values of the correlation coefficient between residues i and j, the 
superscripts intra1 and intra2 represent correlations within the two monomers and inter 
represents correlations between the two monomers. The values of Cinter, the fraction of the 
correlation that is inter-monomer, are 0.26, 0.07, 0.12 and 0.14 for the wild type, A4V, H46R 
and G37R mutant dimers, respectively, showing that the coupling between the monomers is 
considerably reduced in all three mutants compared to the wild type. The values Cintra1 and Cintra2, 
defined similarly as Cinter, also change upon mutation (Table I). We find that the wild type has 
greater intra-monomer correlations than the mutants, indicating that strain introduced by the 
mutation disrupts not only inter-monomer motions, but also intra-monomer concerted motions of 
secondary structural elements. 
 To further elucidate the dominant motions in the wild type that lead to the observed 
coupling and that are disrupted in the mutants, we use the essential dynamics method, which is 
based on projecting the correlated fluctuations in the protein to a principal-components 
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“essential” sub-space (see Methods). The starting point of the essential dynamics is the 
covariance matrix and results are eigenvectors and eigenvalues of the covariance matrix, which 
represent the directions and amplitudes of the principal motions in the principal components sub-
space (Fig. 2(a)-(d)). We find that for the wild type, A4V, H46R and G37R mutants, the first 5 to 
10 modes, arranged in decreasing order of their eigenvalues, capture a majority (≈75%) of the 
protein motions. The remaining motions of the protein are thermal noise. The trends in 
eigenvalues obtained for the wildtype are in good qualitative agreement with a previous, 
significantly shorter timescale MD study(25). The first eigenmode of the dimers is projected in 
their respective structures indicate there are pronounced differences in the first, most dominant, 
mode between the wild type and the mutant dimers (Fig.3). Motions observed in the lower 
modes also differ between the wild type and the mutant (see Supplementary material), but their 
contribution to the overall dynamics is smaller compared to the first eigenmode. 
 In the first eigenmode, the wild type dimer exhibits a “breathing” motion around an axis 
parallel to the dimer interface, along with an opening-closing motion of its loops. This motion, 
which is global and is a coupled motion between the two dimers, is absent in all the mutants. 
Instead, the dominant modes of motion of mutant dimers are confined to the active sites and in 
some cases other loops of the protein. We note that the loss of global coupling in the mutants is 
irrespective of the location of the mutation: the A4V mutation is on the dimer interface, the 
G37R is in the so-called “β-plug” region and the H46R is in the metal-binding site. Also, the lack 
of coupling is independent of the effect of mutation on stability, A4V and G37R are known to 
destabilize the protein whereas H46R is known to stabilize apo-SOD1.  
 We postulate that breathing motions provide a mechanism for the dissipation of energy 
perturbations induced by the environment. However in the mutants, due the evident absence of 
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this breathing global mode on the picosecond-nanosecond timescale, the energy perturbation 
may instead cause the local unfolding of key structural features of the protein, and may thus 
enhance aggregation propensity, independent of the effect of mutation on the global stability of 
the protein. The local melting of secondary structure elements in proteins is known to occur on 
the nanosecond timescale (as observed in H/D exchange NMR experiments), whereas global 
unfolding occurs on the millisecond-second or higher timescales. 
  
Dynamical effects of dimer dissociation 
 Dimer dissociation is known to be required for the aggregation of SOD1, and SOD1 
folding is known to be a three-state process involving the folding of individual dimers followed 
by their association. The folding timescale of SOD1 is in the millisecond-second range(12), and 
given their ~4 kcal/mol stability, monomers are expected to be stable on the picosecond-
nanosecond timescale. To probe the dynamical effects of dimer dissociation on SOD1 we 
perform 5-ns long MD simulations of the wild type and 3 mutant SOD1 monomers, and compare 
monomer dynamics to that of the corresponding dimer on an identical timescale. We find that all 
monomer trajectories, except for the A4V monomer which has an increasing trend in RMSD, 
display lower or similar RMSD compared to the dimers, confirming that the monomers are stable 
on the picosecond-nanosecond timescale. Since monomers are on-pathway to aggregation, 
changes in the flexibility of monomer sub-structures upon dimer dissociation may provide 
structural clues to the propensities of specific areas of the monomer to induce aggregation. 
Therefore, we calculate the changes upon dimer dissociation in the flexibility of each residue 
relative to the rest of the protein (Fig. 1(l)-(o)). We find that, in the wild type protein, residues 9-
13, 25-27, 38-62, 82-86 and 151-153 are more rigid in the dimer whereas residues 37-43, 70-80, 
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88-95 and 125-142 are more rigid in the monomer. These findings are in good agreement with 
NMR experiments of Banci et al.(27), in which they find that 47-59, 76-86, and 151-153 are 
more rigid in the dimer whereas residues 131-142 and 88-95 are more rigid in the monomer. The 
disagreement between our findings and the data of Banci et al. is in the change of flexibility of 
residues 76-80, which may be attributed to the cumulative error of MD simulations and NMR 
order-parameter estimation procedures.  
 The differences in the rigidities of dimer and monomers follow similar trends in the 
stabilizing H46R mutant as the wildtype, but follow a different pattern in the A4V and G37R 
mutants. In A4V, the residues 134-138, part of the active site Zn-loop, are found to be more 
flexible in the monomer than in the dimer, and the increasing RMSD of the A4V with time can 
be attributed to the greater disorder in the Zn-loop. The Zn-loop is known to be a site of non-
native contacts in a crystal structure of multimeric SOD1 assembly(28). In G37R, the residues 
48-62, which form a loop at the dimer interface (residues 50-53 make inter-monomer contacts) 
are found to be less flexible upon dimer dissociation compared to wild type and other mutants. 
However, in all mutants, the region 88-95, which forms a loop at the edge-strand of SOD1 and is 
part of the stabilizing “β-plug” group of residues is found to be nearly equally flexible in the 
mutant dimers compared to monomers, in contrast with the wild type protein where it is found to 
rigidify upon dimer dissociation.  
 
Mutation- and dissociation-induced changes in the conformational stability of the β-plug 
 The group of residues 37-43, 90-92, 94 and 144 comprises the β-plug region of the SOD1 
dimer(29). The residues 90-95 are part of the loop connecting strands β5 and β6 in SOD1, which 
is the site of a putative edge-strand of the β-barrel, where the cylindrical hydrogen bonding 
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patterns which maintain the barrel geometry are strained(30). Based on a survey of the protein 
database, Richardson and Richardson have postulated that edge-strands are likely sites for 
aggregation in proteins(30). Previous experimental and computational studies have also 
identified the residues 90-95 as possible sites for edge-strand mediated aggregation, and it was 
postulated that a transient opening of the β5-β6 strands may expose backbone hydrogen bond 
donors and acceptors to other chains leading to aggregation(27). Therefore, we evaluate the 
effect of mutation on the dynamics of the loop formed by residues 90-95. We find that the 
mutant SOD1 dimers show mildly enhanced rigidity of the residues in the 90-95 loop. 
Concomitant with this increase in rigidity is the loss of stabilizing hydrogen bonds within the 
loop and with other residues of the β-plug region 37-43 (Table II), indicating that although the 
mutants are more rigid, they adopt an altered, locally destabilized conformation. The 
rigidification effect is also observed in the wild type protein, in a more pronounced manner, upon 
dimer dissociation. An examination of the first dominant eigenmode of the wild type dimer and 
monomer indicates that in the dimer, these loop-forming residues undergo a twisting motion such 
that the strands they connect, β5 and β6, maintain their hydrogen bonds with each other. On the 
other hand, in the monomer, residues 90-95 are rigidified so that the β5 and β6 strands now move 
away from each other, resulting in a transient opening of the SOD1 β-barrel, as previously 
predicted by Banci et al.(16)  
 The loss of the structural fidelity of the β5-β6 edge results from both mutations and dimer 
dissociation. To further evaluate if a mildly destabilizing environment (which promotes 
aggregation in vitro(31)) also induces the destabilization of the β-plug residues and disrupts their 
characteristic twisting motion, we perform a 5-ns long MD simulation of the wild type dimer at 
400K and perform essential dynamics analysis to obtain the principal components of motion. We 
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find that although there are large fluctuations in the protein as expected at high temperature, 
remarkably, the residues 90-95 are rigidified relative to the rest of the protein, and do not 
undergo a twisting motion observed at 300 K in the dominant eigenmode. Instead, the motion of 
the β5-β6 strands at 400 K is more monomer-like – involving the rigidification of the residues 
90-95 and a transient opening of the β-barrel at the edge. The dihedral angles of the backbone 
populated by residues 91-94 during the trajectories further reinforce the rigidification of the loop 
under destabilizing conditions. Residues 91-93 in the dimer undergo transitions between dihedral 
angles only in the wild type, but not upon mutation, dimer dissociation or, remarkably, at 400K. 
These twisting motions allow favorable hydrogen bonding interactions within the loop and 
between the residues 90-95 and 37-43 in the wild type, and a rigidification of the loop disrupts 
the stabilizing hydrogen bond network (Table II). Instead the strain in the loop is transmitted to 
the β5 and β6 strands which show increased propensity to move in opposite directions. 
Therefore, we conclude that mutation, dimer dissociation, and exposure to mildly destabilizing 
conditions, conditions known to promote aggregation, promote the disruption of the structural 
fidelity of the β-plug, and result in an increased propensity of the SOD1 β-barrel to transiently 
open.  
 The destabilization of the β-plug was previously observed in the crystal structure of the 
G37R mutant(29). Similarly, in an NMR study of the G93A mutant SOD1 dimer, it was found 
that the edge-strands had higher mobility compared to the wild type(16). However, both the 
residue 37 and 93 are part of the plug region, so it was not clear if plug destabilization is a 
general mechanism, or is limited to these mutants. Our results indicate that mutations in residues 
distal from the plug (such as residues 4 and 46) may also dynamically destabilize it, even though 
they have differing effects on the global stability of SOD1, leading to a transient opening of the 
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β-barrel. We have previously identified the charged residues in the β5- β6 loop to be critical for 
the folding fidelity of the monomer(32), and also observed in simplified models of SOD1 
aggregation that an opened SOD1 β-barrel has high propensity to swap strands with another 
similarly destabilized chain, particularly in the β5-βregion (Chapter 4). The enhanced 
destabilization of the β-plug region under three aggregation-promoting conditions reinforces a 
possible scenario of aggregation based on the opening of the SOD1 dimer. Locally destabilized 
SOD1 exposes the hydrogen bond donors and acceptors in the β5-β6 region, and destabilizes the 
β-plug of the protein by decreased interactions with the residues 38-43. Multiple open SOD1 
monomers stack together at their opened exposed edges, and lead to the formation of flat sheet-
like aggregates, which may retain the elements of the native structure (Figure 6). This 
mechanism is reminiscent of the “runaway domain-swapping” mechanism of aggregation 
proposed by Eisenberg and co-workers.  
 
Rationalizing the loss of inter-subunit coupling in mutants 
We observe that mutant SOD1 monomers do not undergo coupled motions in the dimer, 
in contrast with the wild type. Since the mutant and wild type structures are nearly identical (Cα-
RMSD < 1.5 Å), the disruption of coupling suggests that the strain induced in the protein by 
mutation is transmitted specifically to regions that undergo coupled motions, without affecting 
the overall fold of the molecule.  
In order to rationalize the observed loss of coupling between monomers in the mutants, 
we analyze the network of interactions formed in the structure of native SOD1 dimer and 
monomers (Fig. 5(a)), and characterize the distribution of minimal path lengths, Lij, from residue 
i to the residue j (See Materials and Methods).  For each residue i, we calculate the average 
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minimal path, a measure of the connectivity of the residue to the rest of the netwrok, to all other 
residues, <Li>, to the dimer interface <LiI> , and to the metal-binding site <LiM> , by averaging 
over the minimal paths to all other residues in the protein, to residues on the dimer interface and 
in the metal-binding site, respectively. For a monomer, the residues on the interface are 5-7, 17, 
50-53, 114 and 148-153, and the residues in the metal-binding site are 46, 48, 63, 71, 80, 83, and 
120 (Fig. 5(b)). For the dimer, we consider the corresponding residues from both monomers, as 
comprising the respective sites. 
The value <Li> is an indicator of the global connectivity of a given residue and a small 
value of <Li> (corresponding to a negative value of Z(<Li>)) indicates that any perturbation, such 
as a mutation, at the residue i will be transmitted effectively to all other residues in the protein.  
For the dimer, we find that there are five regions of the sequence that have high connectivity to 
the rest of the protein (Fig. 5(c)): residues 2-9, 16-21, 43-65, 109-119 and 144-153. All the 
residues on the dimer interface lie in the identified regions of high connectivity. Surprisingly, of 
the residues chelating the metals, residues 46, 48 and 63 are highly connected, even though these 
are not in the protein core, and away from the dimer interface. Similar results are obtained for the 
betweenness Bi-profile (Fig. 5(d)). Residues with high betweenness are the hubs in the network 
through which a large number of paths linking various pairs of residues pass. These observations 
indicate that both the dimer interface and the metal-binding sites in the dimer are highly 
connected to the rest of the protein, and mutations in these residues would likely lead to a global 
destabilization of the protein. Conversely, a perturbation in the protein at any site due to 
mutation is likely to affect both the dimer interface and metal coordinating sites through the 
network of contact interactions.  
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To probe whether effect of a mutation on the dimer interface is correlated with its effect 
on the metal-coordinating sites, we calculate the average minimal path of all residues to the 
dimer interface and metal coordinating residues (Fig. 5(c)). We find that these minimal distances 
<LiI> and <LiM> are highly correlated to each other (Fig. 5(e)) in the dimer, but not in the 
monomer (Fig. 5(h)). As control, we choose the β-plug region of both monomers, composed of 
residues, 36-40, 88, 90-92, 94-96, and 144, since we find that in MD simulations the hydrogen 
bonding network of this region is destabilized in mutants and in monomers (Fig. 5(b)), and find 
that the distribution of average minimal paths to this surface does not correlate with either <LiI> 
and <LiM>   (Figs. 5(f) and (g)). The correlations are also absent in the monomer (Figs. 5(i) and 
(j)). This shows that the correlation between the minimal paths to the dimer interface and the 
metal-binding site in the dimer is specific and significant. Thus, a perturbation such as mutation 
at any site in the protein is likely to disrupt the dimer interface, and the metal-sites. We postulate 
that this connectivity explains the disruption of the coupling between the two monomers, since 
the coupled elements, the interface and the metal-binding loops, are both likely perturbed by the 
mutation. 
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Table 6.1 Sum of correlations and anti-correlations within and between monomers 
Dimer Within Monomer1 Within Monomer2 Inter-monomer 
wild type 3983.1 (34%) 4880.12 (40%) 3173.67 (26%) 
A4V 1947.60 (49%) 1768.28 (44%) 290.62 (7%) 
H46R 2075.61 (48%) 1734.55 (40%) 524.46 (12%) 
G37R 2240.45 (46%) 1979.24 (40%) 724.84 (14%) 
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Table 6.2. Hydrogen bonds in the β-plug region in the MD trajectories 
Frequency intact Donor  
residue 
Donor 
atom 
Receptor 
residue 
Receptor 
atom wild type A4V H46R G37R 
39 O 43 HE2 0.97 0.96 0.93 0.96 
90 OD1 91 H 0.60 - - - 
90 OD2 92 H 0.31 0.79 0.76 0.81 
90 O 93 H 0.89 0.93 0.95 0.85 
90 O 94 H 0.90 - - - 
93 O 37 H 0.81 0.36 0.26 - 
93 O 38 H - 0.93 0.89 0.97 
94 O 90 H 0.99 - - - 
39B O 43B HE2 0.97 0.97 0.97 0.96 
90B OD1 91B H 0.28 - 0.37 - 
90B OD2 92B H 0.79 0.51 - 0.69 
90B O 93B H 0.99 0.97 0.96 0.94 
90B O 94B H 0.41 - - - 
93B O 37B H 0.86 0.42 - - 
93B O 38B H 0.44 0.90 0.96 0.95 
94B O 90B H 0.96 0.55 - 0.31 
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Figure 6.1 MD simulations of the SOD1 dimers and monomers (a)-(h) The root mean square 
deviation of the MD trajectories from the original minimized crystal structure. (i)-(k) Relative 
fluctuations of residues in the mutant dimers compared to fluctuation in the wild type. Only one 
monomer (A in the crystal structure of the wild type) is shown for comparison. (l)-(o) Relative 
fluctuations of residues in the wild type and mutant monomers compared to the fluctuation in the 
respective dimer. Residues found in NMR experiments to have enhanced flexibility in the 
monomer are shown in red, while residues identified as having enhanced flexibility in the 
monomer are shown in blue in (l) 
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Figure 6.2 Covariance matrices of dimers (a) wild type (b) A4V (c) H46R and (d) G37R 
dimers. Positive correlations (red) are below the main diagonal whereas anti-correlations (blue) 
are above the main diagonal. Squares I and II represent the correlations within the two 
monomers, and III and IV represent the correlations and anti-correlations between the monomers 
respectively. 
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Figure 6.3 Essential dynamics analysis of dimers. The first eigenmode obtained from essential 
dynamics analysis projected on the structures of (a) wild type (b) A4V (c) H46R, and (d) G37R 
dimers. In the wild type a global breathing motion of the monomers is indicated by arrows. (e) 
The magnitude of eigenvalues corresponding to the first 50 eigenvectors. A majority (~75%) of 
the overall motion is captured by the first 5-10 eigenvectors. 
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Figure 6.4  Motions of the β5-β6 loop in the first eigenmode of (a) wild type dimer at 300K (b) 
A4V dimer (c) wild type monomer, and (d) wild type dimer at 400K. The motion of the H46R 
and G37R is similar to the motions observed in (b) and (c) (data not shown). (e) The timecourse 
of the dihedral angle Φ for the residues 90-94 in the β5-β6 loop. Consistent with the higher 
flexibility of the loop observed in (a), the residues 90-93 undergo flipping motions in the wild 
type dimer at 300K, but are rigidified in all mutant dimers, monomer and at 400K (data for 
H46R and G37 dimers not shown). 
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Figure 6.5 The network of interactions in SOD1. (a) A representation of the graph of the 
SOD1  dimer. Each node corresponds to a residue, and an edge exists between the nodes if they 
 a van der Waal’s contact. The dimer interface residues are colored blue and the residues in
etal-binding sites are colored red. An example minimal path from L8 to the dimer interfac
and to the metal-binding sites is shown in green. (b) A representation of the dimer interfac
residues (blue), metal-coordinating residues (red) and residues constituting an unrelated surface
(yellow; see (e) and (h)). (c) and (d). The distribution of normalized average minimal paths from 
a given residue to all other residues in the protein and betweenness of each residue. The dime
interface residues are blue, metal coordinating residues are red. Both of these sets of residues are 
highly connected to the rest of the protein. (e)-(g)  and (h)-(j). The correlation between average 
mal paths from all residues in SOD1 dimer (or monomer) to the residues on the interface 
and the metal-binding sites (top panels). For a dimer, the metal-coordinating residues of each 
er are considered to compose the metal-binding site. As control, minimal paths to another
surface of SOD1 (b) shows no correlation with paths to the dimer interface (middle panels) or the 
tal-binding sites (bottom panels). 
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igure 6.6 A model for the role of the β-plug region in SOD1 misfolding and aggregation. 
) the loops 37-42 (orange) and (90-93) comprising the β-plug region are highlighted on the 
ative SOD1 dimer (b) A putative intermediate state observed previously in models of SOD1 
lding, in which the β-plug is disrupted leading to partial unfolding of SOD1 monomer. (c), (d) 
nd (e) front, back and top views, respectively, of a non-native dimer observed previously in 
odels of non-native SOD1 dimers observed under destabilizing conditions. The β-plug regions 
f the two dimers interact leading to the formation of an alternative dimer interface in which 
ere is extensive hydrogen bonding between β6 and β3 strands from different residues. 
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CHAPTER 7 
 
CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1 Summary 
 The aggregation of proteins is implicated in neurodegeneration in several human 
diseases. Uncovering the mechanisms of aggregation may not only lead to the possibility of 
designing rational therapies aimed at inhibiting aggregation, but is also important for 
understanding the general principles that govern the formation of aggregates. This 
dissertation aimed at the elucidation of the mechanism of aggregation of the homodimeric 
metallo-enzyme Cu, Zn superoxide dismutase (SOD1) whose aggregation in motor neurons 
is implicated in the familial form of the neurodegenerative disease Amyotrophic Lateral 
Sclerosis (FALS). More than 100 point mutations in SOD1, distributed all over the sequence 
and three dimensional structure of the protein, are involved causally in FALS.  
 We showed (1) that in vitro SOD1 aggregation is a multi-step reaction that minimally 
consists of dimer dissociation, metal loss from the monomers, and oligomerization of the apo-
monomers:  
                                       
-
off m agg
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holo apo2 2
k k k
k k
D M M+⎯⎯→ ⎯⎯→ A⎯⎯→←⎯⎯ ←⎯⎯  
where Dholo, Mholo, Mapo and A are the holo-dimer, holo-monomer, apo-monomer and aggregate 
respectively. We measured the rate and equilibrium constants corresponding to each step under 
aggregation-promoting conditions (pH 3.5) and showed that under near-physiological 
conditions (pH 7.8), where aggregation is drastically reduced, dimer dissociation is less 
thermodynamically favorable and extremely slow. These results indicated that FALS-linked 
SOD1 aggregation occurs by a mutation-induced increase in dimer dissociation and/or metal-
loss leading to an increase in apo-monomer formation. In accord with this expectation, we 
computationally estimated that 70 of 75 known FALS-associated point mutants in SOD1 
decrease the overall dimer stability and/or increase dissociation propensity. Thus, we 
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concluded that mutant forms of SOD1 result in FALS because mutations lead to higher than 
normal concentrations of Mapo, thereby leading to a significantly increased probability for 
forming protein aggregates. 
  To understand the mechanism of formation of oligomers and aggregates from the 
apo-monomer, we investigated the sequence and structural determinants of SOD1 
aggregation (2). We identified sequence fragments in SOD1 that have a high self-association 
propensity, and in molecular dynamics simulations of the SOD1 dimer folding and 
misfolding we identified regions of the protein that have a high propensity to form 
intermolecular interactions. These regions correspond to the two cross-over loops and two β-
strands in the Greek-key native fold of SOD1. These results indicated that the high 
aggregation propensity of mutant SOD1 may result from a synergy of two factors: the 
presence of highly amyloidogenic sequence fragments (“hot-spots”), and the presence of 
these fragments in regions of the protein that are structurally most likely to form inter-
molecular contacts under destabilizing conditions. We concluded that the balance between 
the self-association of aggregation-prone sequences and the specific structural context of 
these sequences in the native state – a balance that is altered by mutation – determines the 
aggregation propensity of SOD1.    
 In simplified models of SOD1 monomer folding, we identified residues and structural 
motifs crucial for maintaining the fold fidelity of SOD1(3). Remarkably, we found that these 
residues are located on the surface of the protein and not in the hydrophobic core. In particular, 
the structural fidelity of a particular region – the β-plug region – of SOD1 was found to be 
critical for maintaining the two-state folding of the SOD1 monomer observed in experiments. 
Mutations in some of the identified residues in the β-plug region are found in patients with the 
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disease. A possible role of the β-plug region in aggregation, which is also supported by NMR 
and crystallographic studies(4, 5), was further underscored in our molecular dynamics studies 
of wild type and mutant SOD1. We found that in the wild type dimer, the β5-β6 hairpin, a part 
of the β-plug region, undergoes a significant twisting motion on the picosecond-nanosecond 
timescale, and maintains a network of hydrogen bonds that stabilizes the rest of the β-plug 
region. However, upon dimer dissociation, mutation or exposure to mildly destabilizing 
conditions (400 K), this motion is absent and the network of hydrogen bonds stabilizing the β-
plug region is weakened. Along with the altered dynamics of the β-plug region, on the 
nanosecond timescale, the two monomers in the wild type dimer undergo a coupled 
“breathing” motion around an axis parallel to the dimer interface, but this coupling is 
significantly diminished in the mutants. Thus, we postulated that the loss of the global coupling 
mode in the mutants leads to a higher propensity to locally unfold in the β-plug region. The 
destabilized β-plug region may lead to the formation of non-native inter-molecular contacts, as 
evidenced in a crystal structure of SOD1 assemblies and in our models of non-native dimers, 
thus implicating the β-plug region as a crucial determinant of SOD1 aggregation mechanism. 
 
7.2 Implications and future directions    
 The studies outlined in this dissertation have provided insights, at the level of the 
primary, secondary, tertiary and quaternary structure of SOD1 into its aggregation 
mechanism. These insights have several implications for research in the fields of SOD1 
aggregation and FALS in particular, and protein aggregation in general.  
 A finding in our work is that the SOD1 aggregation is a multi-step process, 
involving dimer dissociation as a first step. This finding immediately suggests a therapeutic 
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strategy aimed at the design of small molecules that stabilize the SOD1 dimer. Ray et al. 
have recently followed this strategy and identified small molecules from a high-throughput 
screen that stabilize the native SOD1 dimer(6). They have shown that drug binding 
diminishes or abolishes aggregation of several mutants in vitro, and it is likely that these 
molecules may be good initial leads for drug candidates against aggregation in FALS. Thus, 
taken together, an important implication from these studies is that a biochemical/biophysical 
approach taken by us, and by Ray et al., is promising for therapeutic strategy development. A 
more detailed understanding of the mechanism of aggregation, and of the aggregate 
structures, may suggest other avenues and targets for more effective intervention.  For 
example, another finding in this dissertation is the identification, in computational models at 
multiple scales, of the β-plug region of the SOD1 molecule as an important site for mutation-
induced disruption of structure (Chapters 4, 5, and 6). The disruption of the β-plug by 
mutations is possibly a property common among all mutants, and therefore, represents 
another process that, like dimer dissociation, may be targeted for drug discovery.  
 For the open problem of understanding the major driving forces and developing 
general frameworks for understanding protein aggregation (Chapter 1), the methods 
developed and used here for identification of aggregation-prone regions within a protein can 
easily be extended to other protein sequences. In particular, the combination of sequence-
based and structure-based approach for determination of aggregation-prone regions 
underscores the importance of considering the structural context while interpreting the 
aggregation propensities of isolated peptide fragments from protein sequences. Our 
mechanistic studies using multiple-scale computational models also support the crucial role 
of edge-strands (7) in aggregation, the β-plug region identified in our models at multiple time 
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and length scales is the site of contact between edge-strands in the SOD1 barrel. The 
exposure of hydrogen bonding donors and acceptors at the edge-strands leads to putatively 
“domain-swapped” structures and the exposure of putatively aggregation-prone sequences in 
SOD1. These findings imply that several driving forces are simultaneously co-operatively 
involved in the misfolding and aggregation of protein chains.   
 By themselves and in conjunction with other developments in the field, our studies 
suggest several lines of enquiry that may help detail, at atomic resolution, both the molecular 
mechanism of SOD1 aggregation and the structure of SOD1 aggregates. First, the rate and 
equilibrium constants for the aggregation of mutant SOD1 under identical conditions as the 
wild type can be measured to evaluate the effect of mutations on individual steps of the 
aggregation pathway. Using the rates and equilibrium constants for various mutants, 
structure-activity relationships between the site of mutation and the effect on rates can be 
obtained.  
 Second, the putatively aggregation-prone regions of the SOD1 identified in our 
study (Chapter 4) can be synthesized as peptide fragments, and their aggregation behavior 
can be studied to evaluate their self-association propensity. If it is found that the identified 
peptide fragments aggregate in isolation, it will suggest that the aggregation of SOD1 is 
driven by the self-association of specific sub-sequences in the protein. If the above scenario 
is viable, these hot-spot peptides can be incubated with SOD1 under aggregation-promoting 
conditions. If it is found that the peptides have an ability to diminish or abolish aggregation, a 
therapeutic strategy to prevent aggregation may then involve the design of peptides or small 
molecules structurally analogous to these aggregation hot-spots, such that the designed drugs 
can competitively bind unfolded SOD1 and prevent further propagation of the aggregate.    
 183
 Third, partial proteolysis or H/D exchange of aggregation reaction mixtures 
combined with mass spectrometry can be used to select from the leads generated for 
structures of non-native dimers (Chapter 4) by looking for consistency between solvent-
exposed sites identified in these experiments and in the models. To refine the models, solvent 
exposed sites obtained by the proteolysis-mass spectrometric approach can be used as 
constraints to guide the computational approach used to generate putative oligomeric 
structures. This combination of experimental techniques and computational models, if 
successful, can have wide applicability in uncovering the aggregation mechanism of other 
proteins. Fourth, recent evidence Cleveland and co-workers(8) shows that association of 
misfolded and/or oligomerized SOD1 with mitochondria may be involved in the motor-
neuron specific origin of toxicity in ALS. We have developed techniques (Chapter 2) that can 
be used to isolate aggregate species of various sizes in vitro. With the possibility of isolating 
mitochondria from cell cultures, these aggregates can be used to enquire about the molecular 
basis of the SOD1-mitochondrion interaction. In particular, this experimental system can be 
used to test the hypothesis that there is a size-range of oligomers that interacts aberrantly 
with the mitochondria, thus causing cytotoxicity. 
 Thus, it is hoped that the insights gathered from the studies in this dissertation will 
provide avenues to delineate at atomic resolution the mechanism of protein aggregation, and 
to probe the molecular basis of cytotoxicity, thereby aid the development of rational 
therapeutic strategies against debilitating neurodegenerative diseases. 
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